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INTRODUCTION 
Pyruvate kinase (EC. 2.7.1.40) catalyzes the following 
reaction 
Phospho-enolpyruvate + ADP --------~ Pyruvate + ATP 
In liver this reaction is not only important as the last step 
of glycolysis, but it also needs to be inhibited under conditions 
in which P-enolpyruvate is synthesized during gluconeogenesis. The 
start of the investigations reported here was related to the 
mechanism of this inhibition. 
STATEMENT OF THE PROBLEM 
1-3 From the early investigations of the group of Tanaka it 
was clear that several isoenzymes of pyruvate kinase exist. At 
the end of 1970 two types of pyruvate kinase were distinguished, 
the Liver- (L) ann Muscle (M) type. The so-called L-type, the pre-
dominant type in liver, was known to show an allosteric response 
to one of its substrates, phospho-enolpyruvate, and its activity 
was further found to be influenced by glycolytic and gluconeogenic 
intermediates. Fru-1,6-P2
2 
and other phosphorylated hexoses 4 
increase the apparent affinity for the substrate P-enolpyruvate. 
On the other hand ATP 3 and alanine5 act as allosteric inhibitors. 
Furthermore the amount of enzymes is influenced by the diet and/ 
or hormones 6 . 
The H-type of pyruvate kinase was considered to be a non-
allosteric enzyme, and hormones and/or diet have no influence on 
the amount of enzyme present. The main differences between both 
isoenzymes known at the start of this investigation are summarized 
in TABLE I. 
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TABLE I 
PROPERTIES OF L- AND M-TYPE PYRUVATE KINP.SES (known at the end 
of 1970) 2 
Mol. weight 
K ADP 
m 
K0 . 5 P-enolpyruvate 
Ki ATP 
activators 
inhibitors 
kinetics 
M-type 
250,000 
0.27 mM 
0.075 mM 
3.5 mM 
unknown 
ATP 
Hichaelis-Menten 
L-type 
208,000 
0.10 mM 
0.84 mM 
0.10 rru"l 
Fru-1,6-P 2 and other phosphorylated hexoses 4 
ATP, alanine 5 
allosteric7- 9 
The L-type was known to be present in liver2 , kidney 5 and 
erythrocytes 2 , while the occurrence of the H-type was reported for 
liver, muscle, leucocytes, brain, heart and hepatoma cells 2 . The 
pyruvate kinase from adipose tissue was considered to be an inter-
mediate typelO,ll with properties of both L- and H-types. For a 
more detailed revieYT reference is made to Seubert and Schoner 12 . 
As already mentioned, this study was started with the problem 
of the mechanism to prevent pyruvate kinase activity under gluco-
neogenic conditions. The liver contains both L- and H.-type pyruvate 
kinases. If both isoenzymes were located in the same compartment, 
the regulation of 
N-type has a high 
the allosteric L-type would be useless, since the 
affinity for P-enolpyruvate and 
not diminished during gluconeogenesis. Keeping in 
its activity is 
mind that the 
liver is quite a heterogeneous organ, containing parenchymal and 
non-parenchymal cells, the study of the cellular localisation of 
both L- and 1>1-types was the start of the present study. 
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CHAPTER I 
INTERCELLULAR DISTRIBUTION AND REGULATION OF THE PYRUVATE KINASE 
ISOENZYMES 
A. Intercellular distribut~on of liver pyruvate kinases. 
1 2 
The presence of both L- and H-type pyruvate kinase in the 
same cell would make the regulation of the enzyme with the 
lower apparent affinity for P-enolpyruvate (that is the L-type) 
rather useless. This re~ulatory problem would be overcome if 
the isoenzymes were located in different cells (parenchymal and 
non-parenchymal cells) or by a different compartrnentation in 
the same cell. To test the first possibility rat liver paren-
chymal and non-parenchymal cells v1ere separated from each other 
and the isoenzyme distribution in these cells was investigated 
(Appendix paper I). It could be shown that the L-type pyruvate 
kinase is the only type present in the parenchymal cell while 
the Kupffer cell preparations are enriched with the M-type as 
compared to a total liver homogenate. These Kupffer cell pre-
parations still contained considerable L-type activity. At 
about the same time Crisp and Pogson1 obtained similar results 
for mouse liver and subsequently Bonney et a1. 2 and Garnett et 
al. 3 confirmed our findings for rat liver. 
Later, the liver cell isolation techniques were improved 
(Appendix paper II). With the aid of collagenase and hyaluroni-
dase4 it is possible to isolate intact liver cells. A further 
purification of the non-parenchymal cell preparation made it 
possible to exclude the occurrence of the L-type pyruvate 
kinase in these cell types. 
From the localisation studies on pyruvate kinase reported here 
the conclusion can be reached that gluconeogenesis in liver is 
confined to the parenchymal cells. This is supported by Crisp 
and Pogson1 , who reported that the gluconeogenic enzymes 
glucose-6-phosphatase and fructose-1,6-phosphatase are respec-
tively solely and mainly located in the parenchymal cell. 
The high peroxidase and relatively low catalase activities 
found in the non-parenchymal cells as compared to the paren-
chymal cells are consistent with the antimicrobial function of 
these cells in liver5 . Localisation of peroxidase in the non-
parenchymal cells and a low activity of catalase in these cells 
as compared to parenchymal cells, had been suggested earlier by 
histochemica16 and ultrastructural? studies. 
B. Regulation of L-type pyruvate kinase from rat liver 
Tanaka and co-workers 8- 10 have shown that the L-type pyruvate 
kinase from rat liver is under allosteric control. These 
findings were further explored by Carrninatti et a1. 11 , Rozengurt 
et a1. 12 and De Asiia et a1. 13 v1ho proposed that the allosteric 
model of Monad et a1. 14 was valid for this isoenzyme. The 
enzymatic activity of the L-type can be modulated to a great 
extent (for a review see Seubert and Schoner15). In Appendix 
paper III is shown that Glc-1,6-P 2 is an allosteric activator of 
the L-type. Due to the presence of 15 ~M Glc-1,6-P 2 in liver (a 
concentration which does not fluctuate between glycolytic and 
gluconeogenic conditions 16 ) the regulation of the already 
activated enzyme by the fluctuating Fru-1,6-P2 concentrations 
will be impossible. An active enzyme under gluconeogenic con-
ditions, however, seems unlikely as the substrate P-enolpyruvate 
is needed for glucose formation. Appendix paper IV shows that the 
enzyme possesses additional properties to regulate its apparent 
affinity for P-enolpyruvate and its allosteric activators. An 
oxidation of thiol groups can result in an enzyme which will be 
inactive in the presence of effector concentrations found under 
gluconeogenic conditions17 • A decreased sensitivity of the 
enzyme for its activators is also brought about by a lowering 
of the P-enolpyruvate concentration while in the presence of 
the physiological inhibitors alanine and ATP the decrease in 
13 
affinity is enlarged (Appendix paper V). It could be shown that 
in the presence of the physiological concentrations of ADP, 
P-enolpyruvate, GSH, ATP and alanine the enzyme is inactive. 
The only effective activator in a physiological concentration 
range is Fru-l,6-P 2 • However, even the lowest reported 
Fru-1,6-P2 concentration (5 ~M) 18 will result in a nearly fully 
active enzyme. The same observation was made by Llorente et a1. 19 
and it has been suggested by Sols and Marco18 that due to the 
binding of protein (mainly aldolase} the free Fru-l,6-P 2 concentra-
tion will be lowered. Two other additional possibilities exist: 
a) A change in the enzyme itself can influence its apparent 
affinity for Fru-l,6-P2 , as is shown in Appendix papers IV and v. 
b) The heterogeneity of the liver can influence the Fru-l,6-P2 
concentration available for the L-type (Appendix paper V) . 
However, at the moment no definite answer can be given to the 
question of the extent to which the three possibilities mutually 
contribute to the overall regulation of pyruvate kinase by 
Fru-1,6-P2 • 
As already mentioned the group 
the allosteric model of 1-1onod et 
of De 
' 14 a •• 
AsUa et al. 11- 13 applied 
to L-type pyruvate kinase 
from rat liver to explain the properties found. This model has 
also been applied to the L-type from other mammalian cells 20,Zl 
22-25 . 26 
and yeast . The pnosphorylated hexoses can serve as an 
excellent tool to test the conformation of the activator site 
(which is a reflection of the conformation of the enzyme; see 
Appendix paper V}~ By comparison of the apparent affinities for 
various phosphorylated hexoses in the presence of ATP and alanine 
we were able to show that the latter two compounds introduce a 
different conformation probably because each binds to a 
different site. This conclusion is confirmed by stability 
experiments at 53°c. Alanine and ATP both stabilize the enzyme 
at this temperature. However, when under saturating alanine con-
centrations ATP is added, a further stabilization occurs. The 
same phenomenon is observed when alanine is added to the ATP-
saturated enzyme. Rozengurt et a1. 27 showed recently that the 
allosteric activators K+ and Fru-1,6-P 2 each induce a different 
conformation. Together with our data this means that the model 
of Monad et a1. 14 can no longer give an adequate description of 
the properties of the L-type pyruvate kinase, and the evidence 
we obtained leads us to conclude that sequential conformation 
changes28 are involved in the allosteric transitions of the 
enzyme. 
C. Regulation and properties of the M-types of pyruvate kinase 
Jimenez de AsUa et a1. 29 showed in 1971 that theM-type 
pyruvate kinase from rat liver is inhibited by a series of 
amino acids while the M-type from muscle is only inhibited by 
phenylalanine30 , suggesting heterogeneity of M-type pyruvate 
kinases in various organs. For diagnostic purposes we are 
interested in the identification of certain leucocyte enzymes, 
since sometimes a loss of activity of a liver enzyme is reflected 
31-33 by a loss of the same type of enzyme in the leucocytes • So we 
decided to investigate the properties of the leucocyte enzyme 
more closely (Appendix paper VI). From the amino acid inhibition 
pattern it could be concluded that the leucocyte enzyme resembles 
the M-type from liver and that it differs from the muscle M-type. 
It was further found that the amino acid inhibition could be 
fully relieved by the addition of Fru-l,6-P2 {Appendix paper VI) o 
These are properties, which usually are only found with allosteric 
enzymes. Therefore our interest was focussed on the kinetics of 
the enzyme. It appears that the M-type from leucocytes exhibits 
allosteric properties towards P-enolpyruvate in the presence of 
a physiological concentration of alanine (1 roM). Therefore, we 
extended the proposed R~T model of the L-type also to the var~ous 
M-types. Since the amino acid inhibition pattern of the leucocyte 
enzyme was similar to that of the liver M-type, we suggested that 
also the liver M-type possessed allosteric properties; this 
suggestion is in contrast to earlier reports 8 ' 29 , 34 on the proper-
ties of this isoenzyme. Appendix paper VII shows that the amino 
acid inhibition is indeed of an allosteric nature, and that in 
the presence of alanine the response to P-enolpyruvate is 
sigmoidal. From the pH dependence of the KO.S for P-enolpyruvate 
it can be concluded that the enzyme has a pK value of 7oS. This 
a 
finding is supported by the electrophoretic study of Whittell 
35 
et al. , in which it was found that this isoenzyme at pH 7.0 
15 
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slightly migrated to the anode and that at pH 8.0 the migration 
was greatly enhanced, whereas the mobilities of the other iso-
enzyrnes did not change. 
In the presence of alanine, the activity as a function of the 
P-enolpyruvate concentration is characterized by two different 
n values, which suggests the possible presence of two inter-
convertible forms of M-type pyruvate kinase. These forms should 
then possess different affinities for alanine and/or P-enal-
pyruvate (Appendix paper VII) . 
From the electrophoratic study of Imamura et al. 36 , 37 it is 
clear that the pyruvate kinase from adipose tissue behaves 
similar to the M-type from liver. Pogson38 , 39 showed for the 
adipose tissue enzyme that it can be isolated in two different 
forms depending on the isolation procedure. Isolation of the 
adipose tissue enzyme in the presence of EDTA yields an enzyme 
(called by Pogson Pyk-A) with a lower apparent affinity for 
P-enolpyruvate (KO.S of 0.6 mM). The enzyme isolated in the 
absence of EDTA (Pyk-B) has a relatively high apparent affinity 
for P-enolpyruvate (KO.S of 0.067 mM). Walker and Potter40 
further found that both these forms are present in cultured 
liver cells and that their relative concentrations are influenced 
by the culture conditions. Culture in the absence of added glucose 
results in an enzyme 'V'lith properties identical to the Pyk-A form 
of Pogson38 , 39 , while the Pyk-B form is obtained when the cells 
are cultivated in the presence of added glucose. Although it is 
known that the enzyme pattern of the cell can be changed during 
cultivation (for example the L-type pyruvate kinase normally 
present in liver cells is replaced by theM-type), this finding 
suggests that the Pyk-A form of the M-type of pyruvate kinase is 
probably not only an isolation artifact. The presence of both 
forms in our M-type preparation of rat liver could explain the 
two different n values obtained in the presence of 1 mM alanine 
(Appendix paper VII). we, therefore, investigated the possibility 
whether both these forms can occur under physiological conditions 
(Appendix paper VIII). It appears that with Mgf2+ concentrations 
41 ree 
reported to be present in vivo two forms of the enzyme are 
present. In Appendix paper VIII a scheme is presented which 
. 42-44 
explains the kinetic properties found. Recent reported stud1es 
have provided evidence that in the B~A equilibrium a tetramer-
dimer transition may be involved. 
The study of the B~A transition showed {Appendix paper VIII) 
that a prolonged storage of the enzyme in the A form makes the 
transition to the B form more difficult. This property allows the 
detection of the A form. When after isolation of the enzyme under 
conditions which favour the B form, the A form is still found, 
.the conclusion is justified that the A form was present in vivo. 
With this approach we investigated the enzyme from liver, leuco-
cytes, thrombocytes, intestine and fibroblasts {kindly made 
available by Dr. M.F. Niermeyer, Dept. of Cell Biology and 
intestine a considerable amount 
A form (Appendix paper 
Genetics) . Only \>lith rat small 
of the enzyme was found in the 
means that at least in rat small intestine the A form 
IX) . This 
of M2-type 
pyruvate kinase is present in vivo45 . This finding is supported 
by Osterman and Fritz 46 , who state that their electrophoretic 
finding might be related to our kinetic observations with the 
:111-type of liver. 
The physiological meaning of the B~A equilibrium is not 
completely clear at the moment. The main physiological regulator 
seems to be Fru-1,6-P 2 (Appendix paper VIII). At low Fru-1,6-P 2 
levels the equilibrium can be shifted to the A form which is 
more sensitive to amino acid inhibition. This shift may induce 
a glucose-sparing effect and can be of importance during limited 
carbohydrate availability. Further investigations in intact cells 
(leucocytes) are however necessary to test this hypothesis. 
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CHAPTER II 
ON THE MOLECULAR BASIS OF ERYTHROCYTE PYRUVATE KINASE DEFICIENCY 
It was shown by Ibsen et al. 1 , Jacobson and Black2 and Staal 
et a1. 3 that purified erythrocyte pyruvate kinase is very similar 
to the L-type pyruvate kinase from rat liver. During our investiga-
tions on the regulatory properties of L-type pryuvate kinase from 
rat liver we found that the kinetic properties of this type are 
markedly influenced by the reduction state of the thiol groups 
(Appendix paper IV). The lack of relationship between the pyruvate 
kinase activity and the degree of hemolysis in erythrocyte pyruvate 
kinase deficient patients prompted us to investigate the possibility 
that the alteration in pyruvate kinase might be a secondary defect. 
Because the reduction state of the thiol groups in the red blood 
cell is important for the lifespan of these cells4 ' 5 , the degree 
of reduction could form a link between altered pyruvate kinase 
and the increased hemolytic activity found in the pyruvate kinase 
deficient patients. 
Appendix paper X shows that the kinetic properties of the 
erythrocyte enzyme incubated with oxidized glutathione are identical 
with the kinetic data described in the literature for pyruvate 
kinase from most of the pyruvate kinase deficient patients. Also 
the thermostability of the oxidized enzyme and the enzyme from 
pyruvate kinase deficient patients seems to be identical 6 . These 
properties suggest that pyruvate kinase of the hemolytic patients 
might be altered by oxidation of the thiol groups of the enzyme. 
Further support for this possibility 
with a reduced glutathione reductase 
is the description of patients 
. . 7-9 . . . 
actlVlty . Def1c1ency 1n 
glutathione reductase increases the GSSG concentration which might 
affect pyruvate kinase. 
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hnother way to approach the molecular basis of pyruvate kinase 
deficiency is presented in Appendix paper XI. Incubation of abnormal 
pyruvate kinase, from the class of patients characterized by a loss 
of allosteric interactions towards the substrate P-enolpyruvate, 
with mercaptoethanol changes the kinetics from abnormal to normal. 
From a comparison of the ATP inhibition curves of pyruvate kinase 
from the patients with the normal enzyme, it could be concluded 
that the loss of allosteric behaviour towards P-enolpyruvate was 
not the consequence of a loss of cooperative interaction between 
the subunits, but could be explained by a shift in the Rr:=T 
equilibrium to the R state (Appendix paper XI) . The possibility of 
restoring abnormal kinetics to normal by in vitro incubation indi-
cates that the abnormality observed in freshly isolated cells might 
be a secondary effect. Since thiol groups are involved in this 
alteration one patient (M.V.), who possesses also a lowered gluta-
thione reductase activity 10 , was treated with riboflavine. This 
treatment restored the glutathione reductase activity to its normal 
value. Furthermore when after six months treatment pyruvate kinase 
was isolated from the patient's red blood cells, the kinetic 
behaviour towards P-enolpyruvate appeared to be normal11 • The 
clinical state of this patient had improved too as could be con-
cluded from hematological data. During the six months treatment with 
riboflavine no blood transfusions were necessary, while before treat-
ment these were required every month. 
Of course the afore-mentioned hypothesis does not exclude the 
occurrence of a real pyruvate kinase deficiency as a primary cause 
for hematological diseases 12- 15 . However, due to the high sensitivity 
of the enzyme to its cellular environment,an altered pyruvate kinase 
does not mean that this abnormality is the primary lesion for an 
increased hemolysis. By measurements of other enzymes a second ab-
normality may be detected and a therapy based upon this defect may 
help the patients. 
21 
REFERENCES 
1. Ibsen, K.H., Schiller, K.t'!. and Haas, T.ll. (1971) J. Biol. Chern. 
246, 1233-1240 
2. Jacobson, K.\"i. and Black, J.P .. (1971) J. Biol. Chern. 246, 5504-
5509 
3. Staal, G.E.J., Koster, J.F., Karnp, H., Van Nilligen-Boersma, L. 
and Veeger, c. (1971) Biochim. Biophys. Acta 227 , 86- 96 
4. Kosower, N.s., Song, K.R. and Kosower, E.l'.J. (1969) Biochim. 
Biophys. Acta 192, 23-28 
5. Jacob. H.S. and Jandl, J.H. (1962) J. Clin. Invest. 41, 1514-1523 
6. Blume, K.G., Arnold, A., LOhr, G.H. and Beutler, E. (1973) 
Clin. Chim. Acta 43, 443-446 
7. SchrOter, w. (1970) Klin. wochenschr. 48, 1407-1414 
B. Kleeberg, U.R., Heirnpel, H., Kleihauer, E. and Olischliiger, A. 
(1971) Klin. Wochenschr. 49, 557-558 
9. Nowicki, L. Behnken, L. and Biskamp, K. (1972) Klin. ~'Vochenschr. 
so, 566-569 
10. Gaetani, G.F., Garre, c., Ajmar, F. and Bianchi, G.L. (1973) 
Biomedicine 19, 469-474 
11. Staal, G.E.J., Van Berkel, Th. J.C., Nyessen, J.G. and Koster, 
J.F. in preparation 
12. Nakashima, K., .r.Uwa, S., Oda, s., Tanaka, T., Imamura, K. and 
Nishina , T. (1974) Blood 43, 537-548 
13. Imamura, K., Tanaka, T., Nishina, T., Nakashima, K. and !.tiv;a, s. 
(1973) J. Biochem. 74, 1165-1175 
14. Nakashima, K. (1974) Clin. Chirn. P.cta 55, 245-254 
15. Boivin, P. (1971) Enzymopathies (Gajdos, ~A., ed.) Vol. 1, pp. 
190-218, !'1asson and co., Paris. 
22 
CHAPTER III 
SUHt1ARY OF THE PROPFRTIES OF THE VARIOUS ISOENZYH.ES OF PYRUVATE 
KINJI.SE 
In this chapter the properties of the various isoenzymes are 
summarized in TABLES and are meant to facilitate the comparison 
of the properties of the isoenzymes. TABLE I shows the nomenclature 
used by the most important groups working in this field. The 
different nomenclature is rather confusing and has not contributed 
to a clear understanding of the relation between the various iso-
enzymes. After the first report of Tanaka et a1. 9 on the existence 
of two isoenzymes of pyruvate kinase, called L-type and M-type, the 
uniformity was given up by the groups of Susor17 and Bigley19 using 
their own nomenclature. Because there was no clear understanding of 
the relationship between the various isolated forms of pyruvate 
kinase, it was common use to give simply the source of the isolated 
enzyme. From the work of Jimenez de AsUa et a1. 21 it became apparent 
that the H-type from liver was distinct from the M-type of muscle. 
1 2 Subsequently, Imamura et al. ' v1ere able to show by electrophoretic 
studies that the isoenzymes could be divided in three major forms; 
called L-type, ~1 2-type and 
the adipose tissue enzyme, 
as H2-type. 
H1-type. This made it possible to identify 
which was studied earlier in detail 3 ' 4 , 
A comparison of the properties of the kidney enzymes, which were 
studied by Costa et al. 7 ' 8 , indicate that their type-II is similar to 
the L-type fro~ liver. Since the so-called type-I from kidney is 
isolated in the presence of EDTA and the kinetic properties are 
identical to the Pyk-1\ form of the H2-type, it seems likely that the 
A form of r,1 2-type pyruvate kinase is responsible for the "unique 
properties" ascribed to type-I. Carbonell et al. 11 , 12 suggested the 
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TABLE I 
THE VARIOUS NOMENCLATURE AS THEY ARE USED IN THE LITERATURE 
Author Notation 
Imamura et al. 1 ' 2 L-Type M2-type M1-type Erythrocyte Type 3 4 Pogson ' Pyk A Pyk B 
Walker et al. 5 ' 6 Type I Type IliA Type IIIB Type II 
7 8 Costa et al. ' Type II Type I 
Tanaka et al. 9• 10 L-Type M-Type M-Type L-Type 
11 I2 Carbonell et al. ' Class L Class A Class M 
13 14 Ibsen et al. ' Type L Type K Type M 
Osterman et al. 15 • 16 PK-1 PK-2 PK-4 PK-3 
17 18 Susoretal, ' Pyk-B Pyk-C Pyk-A Pyk-D 
. 19 20 B1gley et al. ' PK-I PK-Il PK-III PK-III PK-I 
use of the term Class A for the H2-type because this enzyme was first 
investigated in adipose tissue3 ' 4 ~1hile Ibsen et al. 13 ' 14 use the 
term type-K because this group studied this type first in kidney. 
Osterman et al. 15 ' 16 follow the IUPAC-IUB Commission recommendations 
which are based upon the electrophoretic mobilities of the enzymes. 
However, this electrophoretic behaviour is dependent upon the pH and 
the buffer system used. (For example the mobility of the L-type is 
greatly influenced by the concentration of Fru-I,6-P2 present in the 
buffer systemlS,lG,lB.) Osterman et al.IS,lG prepare their tissue 
homogenates in the presence of EDTA and for this reason they detect 
two activity hanGs after electrophoresis of enzyme preparations 
. 19 20 from tissues which only contain H2-type. Blgley et al. ' , too 
isolate the pyruvate kinase enzymes in the presence of EDTA (10 mH), 
a condition which again results in the presence of the Pyk-Jl. form 
of the r-1 2-type (called by Bigley et a1.
19
,
20 PK II (See TABLE I). 
The kinetic properties of the purified erythrocyte pyruvate 
kinase are nearly identical to the L-type from liver22 However, 
Imamura et al. 1 ' 2 showed that in fresh hernolysates the electrophoretic 
behaviour is slightly different from the L-type from liver. It is 
stated by Imamura et a1. 23 that the enzyme in the hemolysate contains 
subunits of both L- and M2-type. Purification of this enzyme can 
easily lead to a dissociation into subunits, while during reassocia-
tion preferentially L- and ~12 -type isoenzymes are formed. 
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'I'J\.BL:E II shows the tissue localisation of the various iso-
enzymes. This TABLE is mainly based upon the electrophoretic studies 
of Imamura et al. 1 • The relative amounts of the L- and M2-type in liver 
and kidney are valid for feeding conditions 12 The amount of L-type can 
be influenced to a great extent (in liver from 97 ~rool/min/g tissue 
under glycerol feeding to 17 ~moles/min/g tissue under 48 h of star-
. 12 12 
vatlon ) . Sandoval et al. stated that in contrast to the adap-
tive L-type, the r-1 2-type is constitutive. However, for rat small 
intestine it was shown that in the tissue the M2-type could be adap-
tive (Osterman and Fritz and unpublished results). 
TABLE II 
THE OCCURRENCE OF THE ISOENZYMES IN THE VARIOUS MAMMALIAN TISSUES 
Tissue 
Liver 
Kidney 
Adipose tissue 
Leucocytes 
Thrombocytes 
Fibroplasts 
Intestine 
Testis 
Ehrlich ascites turnover 
cells 
Hepatomas 
Placenta 
Spleen 
Stomach 
Lung 
Ovary 
Muscle 
Heart 
Brain 
Erythrocytes 
Type of isoenzyme (nomenclature of Imamura et al. 1, 2) 
L-Type 
90% (pa renchy-
mal cells) 
30% 
M 2-Type 
10% (non-paren-
chymal cells) 
70% 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
M1-Type Erythrocyte Type 
+ 
+ 
+ 
+ 
25 
TABLE III summarizes the kinetic constants of the main effectors 
for the various isoenzymes. The reported constants are valid at pH 
7. 5 and were measured under comparable circumstances. t'ii th all three 
major isoenzymes the kinetic behaviour towards ADP obeys Michaelis-
Menten kinetics with about the same Km values. In contrast to the 
equal apparent affinity for the substrateADP the Ko.s for P-enal-
pyruvate of the L-type is markedly higher as compared to both 
M-types. This difference disappears in the presence of high 
Fru-1,6-P2 concentrations. The main difference between the M2-
type and L-type is the relative insensitivity of the M2-type towards 
ATP inhibition. Recently Dunat.,ay and Weber24 , 25 pointed out that 
also for the two forms of phosphofructokinase in rat liver the main 
difference is related to the difference in ATP sensitivity. Whether 
these differences in ATP inhibition are related to the regulation 
of gluconeogenesis deserves further attention. This relation between 
phosphofructokinase and pyruvate kinase is of special interest be-
cause, as pointed out in Appendix paper V and VIII, the activity of 
both L- and M2-type are dependent upon the product of the phospho-
fructokinase reaction Fru-1,6-P2 . 
TABLE III 
COMPARISON OF THE VARIOUS PROPERTIES OF THE ISOENZYMES 
Property L-Type M2-Type Me Type 
Mol. W. 208.000 PykA Pyk B 250,000 
100,000 200,000 
K, ADP (mM) 0. 27 0.30 0.30 0.28 
Ko. 5 P-enolpyruvate (mM) o. 8 0.5 0,05 0.075 
K(app) ATP (mM) 
1 
0.1 3.5 
K}app) ala (mM) 0.10 0. 01 0.10 
K(app) phe (mM) 1.0 0. 01 0.07 5 
1 
Relief of amino acid inhibi-
tion by Fru-1,6-P2 complete none complete none 
Kinetics allosteric, allosteric allosteric allosteric 
sequential model 
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SUIIHARY 
The intercellular distribution of the isoenzymes of pyruvate 
kinase of rat liver has been investigated. The L-type pyruvate 
kinase is located in the parenchymal cells. TheN-type is located 
in the non-parenchymal cells. From this distribution we can con-
clude that the non-parenchymal cells cannot significantly contri-
bute to gluconeogenesis. The intercellular distribution of catalase 
and peroxidase also showed main functional differences between non-
parenchymal and parenchymal cells, the former only possessing a 
major phagocytic and antimicrobial action. 
The requlatory properties of the various types of pyruvate 
kinase were investigated. The kinetic behaviour of the L-type 
pyruvate kinase from rat liver can be influenced to a great extent 
by the reduction state of the thiol groups of the enzyme. It can 
be concluded that under physiological effector concentrations the 
enzymatic activity is mainly dependent upon the Fru-1,6-P 2 concen-
tration in the parenchymal cells. A comparison of the effect of 
various phosphorylated hexoses on the L-type leads to the conclusivn 
that sequential conformation changes are involved in the allosteric 
transitions of the enzyme. 
The H-type pyruvate kinase from leucocytes and liver shows in 
the presence of a physiological concentration of alanine an 
allosteric response towards the substrate P-enolpyruvate. The 
kinetic data obtained at physiological effector concentrations allow 
one to conclude that the activity of this type of pyruvate kinase is 
also dependent upon the Fru-1,6-P 2 concentration in the cell. An 
additional phenomenon is the observation of two kinetic forms of the 
enzyme under physiological conditions. At least in rat small 
intestine these forms with different kinetic properties are present 
in vivo. 
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The molecular basis of erythrocyte pyruvate kinase deficiency 
was investigated. OxiQation of enzyme thiol groups reveals an 
altered pyruvate kinase. The kinetic and thermostability properties 
of this oxidized enzyme are identical with the enzyme from most of 
the pyruvate kinase deficient patients. Pyruvate kinase, isolated 
from erythrocytes of patients and characterized by a loss of 
allosteric behaviour towards P-enolpyruvate, can be converted 
{by incubation with mercaptoethanol) into normal enzyme with 
respect to kinetic behaviour. It is concluded that an altered 
pyruvate kinase in erythrocytes from patients suffering erythrocyte 
pyruvate kinase deficiency might be caused by the high sensitivity 
of the enzyme to its cellular environment. It is suggested that 
the primary cause(s) for altered pyruvate kinase might be related 
to activities of enzymes that regulate the redox state of the 
thiol groups within the red blood cell. 
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SAHENVATTING 
De intercellulaire verdeling van de isoenzymen van pyruvaat 
kinase in rattelever is onderzocht. Het L-type pyruvaat kinase is 
gelocaliseerd in de lever parenchymcellen. Ret M-type daarentegen 
in de niet-parenchymale cellen. Uit deze verdeling kan geconcludeerd 
worden dat de niet-parenchymale cellen niet significant bij kunnen 
dragen tot de qluconeogenese activiteit in de lever. De intercellu-
laire verdeling van de enzyrnen catalase en peroxidase wijst oak op 
belangrijke functionele verschillen tussen parenchymale en niet-
oarenchy~ale cellen en is in overeensternming met een fagocyterende 
en bacteriedodende functie van de niet-parenchymale cellen. 
De kinetische eigenschappen van het L- en M-type pyruvaat 
kinase \-Jerden bestudeerd. De kinetische eigenschappen van het L-
type pyruvaat kinase uit rattelever kunnen sterk beinvloed worden 
door de reductietoestand van de -SH groepen van het enzyrn. Uit een 
onderzoek naar de regulatie van het enzyrn onder fysiologische 
effector concentraties kan geconcludeerd worden dat de enzyrnatische 
activiteit voornarnelijk afhankelijk is van de fructose-! ,6-difosfa.;:t 
concentratie in de parenchymcel. Uit een vergelijking van het effect 
van diverse gefosforyleerde hexosen op het L-type bleek dat opeen-
volgende structurele veranderingen optreden bij de allosterische 
overgangen in het enzyrn. 
Het H-type pyruvaat kinase uit leucocyten en lever vertoont in 
aanwezigheid van de fysiologische concentratie alanine een alloste-
risch gedrag ten opzichte van het substraat fosfoenolpyruvaat. Uit 
de kinetische onderzoekingen gemeten bij fysiologische effector 
concentraties, kan geconcludeerd worden dat ook de activiteit van 
dit meest voorkornende type pyruvaat kinase afhangt van de fructose-
1,6-difosfaat concentratie in de verschillende cellen. Verder werd 
waargenornen dat dit type in twee verschillende vormen voor kan 
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komen met verschillende kinetische eigenschappen. Voor rattedarm 
kon worden aangetoond dat beide vormen in vivo aanwezig zijn. 
Een onderzoek werd verricht naar de moleculaire basis van ery-
throcytaire pyruvaat kinase deficientie. Aangetoond werd dat de 
eigenschappen van het erythrocytaire enzym sterk beinvloed worden 
door oxidatie van -SH groepen in het enzym. De kinetische eigen-
schappen en thermostabiliteit van het geoxideerde enzym zijn 
identiek met het in de literatuur meest beschreven "mutant" 
enzym dat geisoleerd kan worden uit pyruvaat kinase deficiente 
personen. Een andere groep patienten bezit een "gemuteerd" enzyrn 
dat zijn allosterische respons ten opzichte van fosfoenolpyruvaat 
verloren heeft. Als dit enzym c:re!ncubeerd ~mrdt in aanwezigheid 
van mercaptoethanol dan ~10rdt een enzym verkreqen dat kinetisch 
niet te onderscheiden is van het normale enzym. De conclusie kan 
getrokken worden dat een veranderd erythrocytair pyruvaat kinase 
in patienten met erythrocytaire pyruvaat kinase deficientie ver-
oorzaakt kan worden doordat het enzym zeer gevoelig is voor de 
reductietoestand in de eel. De primaire oorzaak voor een ver-
anderd pyruvaat kinase zal dan zijn een mutatie in een van de 
enzymen die deze reductietoestand van de thiol groepen in de rode 
bloedcel reguleren. 
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SUMMARY 
r. Parenchymal cells were isolated from rat liver by using EDTA +lysozyme 
or citrate. These cells contained only the L-type pyruvate kinase (ATP:pyruvate 
phosphotransferase, EC 2.J.I.40). 
z. Kupffer cells were isolated from rat liver by using pronase. The Kupffer cell 
preparation showed a ratio of M-type to L-type pyruvate kinase ro-zo times higher 
than the ratio in a total liver homogenate, suggesting that Kupffer cells only (proba-
bly) contain the M-type pyruvate kinase. 
3· The results obtained suggest that gluconeogenesis is confmed to the paren-
chymal cells of rat liver. 
INTRODUCTION 
Pyruvate kinase (ATP:pyruvate phosphotransferase, EC 2.J.I.40) catalyses the 
last step of glycolysis. Its activity is important in the regulation of the dynamic bal-
ance between gluconeogenesis and glycolysis in the liver. During glycolysis the en-
zyme must be active; during gluconeogenesis, on the other hand, activity leads to 
wastage of energy. In liver there are two types of pyruvate kinase1. The L-type 
pyruvate kinase shows an allosteric response to one of its substrates, phosphoenol-
pyruvate (PEP), and its activity is further influenced by glycolytic and gluconeogenic 
intermediates'. Fru-r,6-P2 (ref. 3), Glc-r,6-P2 (ref. 4) and other phosphorylated 
hexoses5 increase the apparent affinity for the substrate PEP. On the other hand ATP 
acts as an allosteric inhibitor3 . L-Alanine, a precursor of gluconeogenesis inhibits the 
L-type pyruvate kinase6 . The abundance of this type of pyruvate kinase is regulated 
by the diet and by hormones7• 
The M-type pyruvate kinase is a non-allosteric enzyme as can be concluded 
from the Michaelis-Men ten kinetics. From the properties of the two types of pyruvate 
kinase one could conclude that only the L-type is involved in the regulation of the 
Abbreviation: PEP, phosphoenolpyruvate. 
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dynamic balance between glycolysis and gluconeogenesis. Since the liver contains 
different types of cells, it is possible that the two types of pyruvate kinase have a 
different loE:alization. In order to investigate the localization differences of pyruvate 
kinases, we isolated Kupffer and parenchymal cells from rat liver. 
MATERIALS AND METHODS 
Type L- pyruvate kinase was isolated from rat liver according to the isolation 
procedure described earlier4• Type l\I pyruvate kinase was isolated by the method of 
Passeron et a/.8• Pyruvate kinase was assayed by following the decrease in absorbance 
at 340 nm in the coupled reaction with lactate dehydrogenase at room temperature 
according to Valentine and Tanaka'. The triethanol-HCl buffer (o-4 M, pH 7·5) was 
replaced by Tris-HCl buffer (0.25 M, pH S.o). Parenchymal cells were obtained by a 
method described by Hommes et a/. 10 and were centrifuged for 5 min at 50 X g and 
washed with the isolation medium except that EDTA and lysozyme were omitted. 
This procedure was repeated five times and the final precipitate was homogenized in 
0.25 M Tris-HCl (pH S.o) containing r mM mercaptoethanol. After centrifugation at 
20 ooo X g for 20 min the pyruvate kinase activity was measured. The final precipitate 
contained only parenchymal cells, as shown by light microscopy. 
Kupffer cells were isolated by a method based on that described by Mills and 
Zucker-Franklin11. Wistar rats were anaesthesized with nembutal; the liver was 
perfused with o.g% NaCI or Hank's balanced salt solution and after it becanie.a light 
tan colour it was sliced into 3-5 mm fragments and placed in ro ml Hank's balanced 
salt solution containing 0.25°/0 pronase. After 30 min vigorous shaking at 37 °( the 
mixture was filtered and subsequently centrifuged for 5 min at 6oo X g. The cells 
were resuspended by addition of Hank's balanced salt solution and recentrifuged. The 
procedure was repeated four times. The cells were then homogenized, centrifuged for 
20 min at 20 ooo X g and the pyTuvate kinase activity was measured. 
Pronase was obtained from Cal Biochem. Lysozyme, ADP, PEP, lactate dehy-
drogenase and NADH were obtained from Boehringer (Mannheim, Germany). All other 
reagents were of analytical grade 'purity. 
RESULTS 
In Fig. I are plotted the activities of the isolated L-and M-type pyruvate kinases 
versus the PEP concentration at fixed [ADP] and pH 8.o. The isolated M-type pyru-
vate kinase follows the Michaelis-Menten kinetics, and is not influenced by Fru-r,6-P2• 
In contrast, the L-type pyruvate_ kina.c:;e shows a sigmoidal curve, which can be con-
verted into a hyperbolic curve by adding 0.5 mM Fru-r,6-P2• From the curves ob-
tained with the isolated L-type it can be concluded that Fru-r,6-P2 , at least under our 
assa,v conditions, stimulates the enzyme activity at r ml\I PEP by a factor of rr.o ± 
0.3 (n = 6). From these results (Fig. I) it is possible to calculate the activity ratio of 
the L- and M-types. It was found that in crude liver homogenates at I mM PEP an 
average activation of 7.1 was obtained by adding 0.5 mM Fru-r,6-P2• From this it 
was calculated that the L-type contributes about 6I% to the overall pyruvate kinase 
activity prior to Fru-r,6-P2 addition. 
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Fig. I. The v vs [PEP] plot of the partly purified L-and M-type pyruvate kinase at [ADPJ = 
2 mM in presence and absence of Fru-r,6--P2 (0.5 mM). 0-0, L-type pyruvate kinase; A-A. 
L-type pyruvate kinase in the presence of Fru-I,6-P2 ; e-e. M-type pyruvate kinase in the ab-
sence or presence of Fru-r,6-P2 • 
Fig. z shows the pyruvate kinase activity of the homogenate of isolated paren-
chymal cells, tested under the same conditions as in Fig. I. From this plot we con-
clude that only the L-type pyruvate kinase is present in parenchymal cells. Also, 
when parenchymal cells were isolated with citrate (27 mM) in Hank's balanced salt 
solution instead of EDTA and the lysozyme-containing medium (described in Mate-
rials and Methods) the same result was obtained. 
I ~------.---=_=,:::~~~-=-='~----, 
~ 04001: 
- ' ~ 0200 
-4----e---;,~- w 
[PEP) mM 
0 
E 
r·---- -·------------------, 
"~---~---.---------
040:.. 
:; 020~ 
0o ·· ----2-----4----- --e 
[PEP) mM ' 
Fig. z. The v vs [PEP] plot of pyruvate kinase activity in the parenchymal cell homogenate in 
the absence and presence of Fru-r,6-P2 (0.5 mM). 0-0. without Fru-r,6-P2 ; A-A, with Fru-
r,6-P2. 
Fig. J. The v vs [PEP] plot of pyruvate kinase activity in the Kupffer cell homogenate in the ab-
sence and presence of Fru-r,6-P2 (0.5 mM). 0-0, without Fru-r,6-P2 ; A-.A. with Fru-r,6-P2. 
Fig. 3 shows the pyruvate kinase activity versus [PEP] of the Kupffer cell 
homogenate. This plot is completely different from the one obtained with parenchymal 
cells (Fig. 2). The activity increment at I mM PEP, due to 0.5 mM Fru-r,6-P2, in Fig. 
3 is 2.2 fold, which indicates that theM-type is enriched in the homogenate. We can 
calculate that the LJM ratio in this Kupffer cell preparation is o.I35 (compare the 
value of r.56 in a crude liver homogenate), indicating a relative increase of theM-type 
contribution of at least ro fold. The Fru-r,6-P2 stimulations obtained with different 
preparations of crude liver, parenchymal cell and Kupffer cell homogenates are 
summarized in Table I. 
Biochim. Biophys. Acta, 276 {1972) 425--1-29 
TH. J. C. VAN BERKEL eta/. 
"L\BLE I 
RELATIVE ACTIVITIES OF L~ ANO ;\'I-TYPES Ol•' PYRUVATE KINASE 
For the measurement of activity see Fig. I and Materials and Methods. 
Source of homogenate n 
Whole rat liver 6 
Parenchymal cells 6 
Kupffcr cells 6 
* Fru-I,6-P2 absent. 
Fru-r,6-P. 
stimu!atl~~ 
at rmM PEP 
Ratio of activities* 
L-/.lVI-type pyruvate 
kinase 
I. 56 
00 
0.0]-0.16 
Since pronase and lysozyme are proteolytic enzymes, a possible criticism exists: 
these enzy'mes might preferentially digest olle of the two types of pyruvate kinase. 
Therefore we incubated the isolated L-and M-types from rat liver with either lysozyme 
(0.05°/0 ) or pronase (0.25%)- This concentration of lysozyme did neither affect the L-
nor the M-type activity, even after 2 h incubation. That no preferential digestion by 
lysozyme occurred, could also be concluded from the fact that when citrate was used 
instead of lysozyme in the isolation of parenchymal cells, the same results were ob-
tained. Pronase on the other hand affected the L-type in the presence ofFru-r,6-P2 to 
the same extent as theM-type. When isolated L-type was incubated with pronase, the 
acti-vation of the reaction was increased' bY the addition of Fru-r,6-P2. Therefore, the 
activity ratio of L to M-type pyruvate kinase for Kupffer cells (as shown in Table I) 
may be overestimated. However, it is likely that during the isolation procedure, 
pyruvate kinase is protected from the added proteolytic enzymes by the cell mem-
brane. 
DISCUSSION 
The data presented show that only the parenchymal cells of rat liver cOntain 
the L-type pyruvate kinase and it is highly suggestive that the Kupffer cells only 
contain theM-type. It is generally accepted that the L-type is involved in the regula-
tion of glycolysis and that the enzyme can be switched off during gluconeogenesis. It 
is, therefore, likely that gluconeogenesis is also located solely in the parenchymal cells. 
Tanaka et al. 2 already in r967. mentioned the occurrence of L-and M-type pyruvate 
kinase in liver and noticed a linkage between the L-t"ype pyruvate kinase and gluco-
kinase (EC Z.J.r.rz). Their data also suggested a linkage between theM-type with hexo-
kinase (EC Z.J.r.I). They concluded "that there may be two kinds of glycolysis path-
way in the liver. One of these is catalysed by hexokinase and type M pyruvate k.inase 
and rnight be called the basal pathway. The other is catalysed by glucokinase and t'ype 
L pyruvate kinase and is a regulatory pathwa¥. The rate of the basal pathway would 
not be influenced by dietary and hormon<ll conqitions, and ~t would meet the minimum 
demands_ 9f the cell. The rate of tile regulatory pathway would fluctuate in responSe 
to dietar.r and hormonal conditions aa9 it would meet ·Spec~al demands of the cell". 
VVe agree with this .parallelism, since Sapag-Hagar _et al.12 showed that gluco~~nase is 
present in parenchymal cells and hexokinase is virtually restrict.eq. to the non-
parenchymal tissue. In the present paper it is shown that the L-type pyruvate kinase 
B~ocliim. Biophys. A;ta, 276 (·~972) 425~429 
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is confined to the parenchymal cell. Therefore, it is clear now that the two pathways, 
distinguished by Tanaka et al. 2 , are even localized in two different liver cell types. The 
parenchymal cell responds to the metabolic changes of the liver, whereas the Kupffer 
cells lack such a possibility. 
NOTE ADDED IN PROOF (Received June r6th, 1972) 
Recently, Crisp and Pogson 13 showed that also in mouse liver the L-type pyruvate 
kinase is confined to the parenchymal celL 
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DIFFERENCE SPECTRA, CATALASE- P.ND PEROXIDASE ACTIVITIES OF ISO-
LATED PARENCHY!-'J\L AND NON-Pl'~RENCHYHA.L CELLS FROH RAT LIVER 
Th.J.C. van Berkel 
~\l'ith technical assistance of J .K. Kruijt 
Department of Biochemistry I, Faculty of Medicine, Erasmus Uni-
versity Rotterdam (The Netherlands) 
SUMMARY. The reduced minus oxidized difference spectra from iso-
lated parenchymal and non-parenchymal cells from rat 1 iver indi-
cate that the non-parenchymal cells contain a considerable amount 
of peroxidase. This interpretation is favoured by the more than 
30 times higher specific activity of peroxidase (EC 1.11.1 .7) in 
the non-parenchymal cells as compared to the parenchymal cells. 
The catalase (EC 1.11.1.6) activity in the non-parenchymal cells 
is 4 times lower than in the parenchymal cells. These results are 
consistent with an antimicrobial function of the non-parenchymal 
cells in 1 iver. 
The mammalian liver consists primarily of hepatocytes (paren-
chymal cells} and reticula endothelial cells (Kupffer cells). As 
much as 35% of the liver cells are non-parenchymal cells represen-
ting 5 to 10% of the liver mass 1 . In an earlier paper2 we have 
shown that parenchymal cells contain only L-type pyruvate kinase 
(EC 2.7.1.40) while the H2-type was enriched in the non-parenchymal 
cells. From this distribution pattern we concluded that Kupffer 
cells do not significantly participate in gluconeogenesis. Histo-
chemical studies have indicated that the main function of the 
Kupffer cells in the liver might be related to their phagocytic 
properties 3 . To obtain more information on the function and proper-
ties of the non-parenchymal cells, we separated intact parenchymal 
and non-parenchymal cells from rat liver and determined the diffe-
rence spectra of these cell types. For the reason that the results 
were indicative for a large amount of peroxidase in the non-
parenchymal cells, we also investigated the distribution of 
peroxidase and catalase activities between the different cell types. 
It is concluded that the biochemical data obtained are consistent 
with phagocytic and antimicrobial functions of the non-parenchymal 
cells in rat liver. 
MATERIALS AND METHODS. Parenchymal eel ls were isolated from r~t 
liver essentially according to the method of Berry and Friend, 
using collagenase {0.05%) and hyalurinidase (0.10%) as proteolytic 
enzymes in Hank's balanced salt solution. The cells were purified 
by differential centrifugation for 2 min at 45 g. The cells were 
resuspended in Hank 1 s balanced saltsolution and recentrifugated. 
This procedure was repeated 4 times. By centrifugation at this 
speed the non-parenchymal cells can be removed effectively from 
the pare-nchymal cells. The cells obtained, of which at least 90% 
excluded trypan-blue and were therefore considered to be intact, 
were not contaminated, as judged by 1 ight microscopy. 
The non-parenchymal eel ls were isolated by two different 
methods both of which were based on a method described by Hills 
and Zucker-Franklin5. The first method was as described earlier2. 
ln the second me4hod a total eel 1 suspension, obtained by the 
Berby and Friend method, was incubated with 0.25% pronase for 
1 h . All parenchymal cells were destroyed after 1 h and the non-
parenchymal cells were collected by centrifugation for 5 min at 
600 g. The cells were resuspended in Hank 1 s balanced salt solution 
and recentrifugated. This procedure was repeated 4 times. The non-
parenchymal cells isolated by both methods did not differ in the 
assays and spectra mentioned under RESULTS. 
Pyruvate kinase was assayed as described earl ier 2 . Catalase 
was determined according to Bergmeyer7 whi Je peroxidase was 
8 measured with 3,3 1 -diamino benzidine (DAB) as hydrogen donor 
Difference spectra were run on a Perkin-Elmer 356 and on an 
Amino DW-2 spectrophotometer set for split-beam optics. 
RESULTS 
Fig. 1 shows the reduced minus oxidized spectrum of a homo-
genate of a typical parenchymal cell preparation. The interpre-
tation of the maxima and minimum is indicated in the figure. The 
dotted line gives the succinate-reduced (antimycin A present) minus 
oxidized spectrum which allows the detection of cytochrome b. 
Fig. 2 gives the same kind of spectra for a homogenate of a typical 
non-parenchymal cell preparation. It can be seen that this 
difference spectrum differs markedly from that of the parenchymal 
cells (Fig. 1). Although the amount of protein present in the 
experiment of Fig. 2 is half of the amount used in Fig. 1, the 
peak in the 430 nm region is even higher. This high peak interferes 
with the determination of the mitochondrial cytochrome spectra. The 
succinate-reduced minus oxidized spectra show that at least the 
cytochrome b content of the different cell types is about equal. 
From these spectra we can conclude that thP liver parenchymal cells 
show a normal cytochrome spectrum as for example is also found with 
2 
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Fig. Difference spectra of the parenchymal cell homogenate. 
--reduced (with dithionite) minus oxidized (0.05% HzOz). 
----reduced (with succinate (10 mM) +antimycin A (l.j )JQ)) minus 
oxidized (0.05% H2 0z). The protein concentration with both 
spectra was 5.1 mg. 
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Fig. 2 Difference spectra of the non-parenchymal cell homogenate. 
-=::-reduced {with dithionite) minus oxidized (0.05% HzO?.)).----
reduced (with succinate (10 mM) +antimycin A (4 )JQ)) m1nus oxidized 
(0.05% H2 o2 ). The protein concentration with both spectra was 2.54 
mg. 
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intestinal cells9 , while the non-parenchymal cell spectrum seems 
to be related to spectra obtained with leucocytes 10 . As the leuco-
cyte spectrum is considered to be the consequence of the high 
peroxidase content of these cells11 , the distribution of the 
activities of peroxidase and catalase between the different cell 
types was determined. To ascertain the intactness of the cells 
pyruvate kinase v1as used as a marker because this enzyme is sole-
ly located in the cytoplasm and does not adhere to membranous 
structures (unpublished) • Table I shows the pyruvate kinase acti-
vities of the liver homogenate, the parenchymal and non-parenchymal 
cells. In accordance with an earlier report 2 , parenchymal cells 
do only contain the L-type pyruvate kinase while the activity on 
protein base further supports the intactness of the cells used. 
From the absence of Fru-1,6-P2 activation it can be concluded 
that the non-parenchymal cells contain exclusively M2-type pyruvate 
kinase. This is a further evaluation of earlier obtained results 2 
in which the non-parenchymal cell fraction also contained a con-
siderable amount of L-type pyruvate kinase probably due to the 
impurity of the earlier non-parenchymal cell preparations. 
TABLE I 
INTERCEllULAR DISTRIBUTION OF L-AND M2-TYPE PYRUVATE KINASE 
Source of homogenate activity at activity at 
1 mM P-enolpyruvate 1 mM P-enolpyruvate 
(nmol min-1 mg-1 + 0.5 mM Fru-1,6-P 2 protein) (nmol min-1 mg-l 
protein) 
+ SEM ( n) + SEM ( n) 
\olho I e rat I i ve r 18. 1 + 2. D ( 1 0) 124. 4 + 1 0. 5 ( 1 D ) 
Parenchymal ce 11 s 11. 8 + 1.1 ( 8) 1 34. 6 + 16.3 ( 8) 
Non-parenchymal ce I Is 28.3 + 4. 4 ( 5) 27.6 + 5. 0 ( 5) 
4 
Table II shov1s the peroxidase and catalase activities in the 
different cell preparations. It can be seen that the non-
parenchymal cells contain 30 times more peroxidase activity than 
the parenchymal cells, and that on the other hand catalase activity 
is more concentrated in the parenchymal cells. The reason for the 
relatively lov1 catalase activity in the liver homogenate as com-
pared to activity in the parenchymal cell homogenate cannot be 
explained at the ~ornent but miqht be related to the results of 
Puji"'rara et al. 12 v;ho observed the same phenomenum with the enzyme 
collagenase. 
TABLE I I 
INTERCELLULAR DISTRIBUTION OF PEROXIDASE AND CATALASE 
Source of homogenate 
Whole rat 1 iver 
Parenchymal cells 
Non-parenchymal cells 
DISCUSSION 
peroxidase 
(~mol min-1 mg-1) 
+ SEM (n) 
7.0 + 
2..6 ; 
80.8 + 
0. 5 
0. 3 
1 2. 7 
( 4) 
( 5) 
( 5) 
catalase 
(.!Jmol min-1 mg-1) 
+ SEM (n) 
618 + 
1472 + 
368 + 
92 
315 
38 
( 4) 
( 5) 
( 5) 
The results clearly demonstrate the heterogeneity of liver 
tissue. Conclusions drawn from work with total liver homoqenates 
must be taken with caution when the different cellular contribu-
tions are not taken into account. The high specific activities 
obtained with the parenchymal cell homogenates, together with the 
trypan blue exclusion, clearly illustrate the usefulness of the 
reported cell preparation for cellular distribution studies. A 
quality test for the non-parenchymal cells is more difficult to 
assess although also for these cells the trypan blue exclusion 
is indicative for intactness. 
From the distribution of the L- and M2-type pyruvate kinases 
we can conclude that, at least in adult liver, the M2-type is 
solely located in the non-parenchymal cells. Of course this does 
5 
not exclude an occurrence of this type in parenchymal cells under 
special conditions (fetal or regenerating liver cells13 ). However, 
under all conditions the M2-type is the only type present in non-
parenchymal cells which excludes a significantly contribution of 
these cell types to gluconeogenesis 2 . 
From histochemical studies it was concluded earlier that the 
Kupffer cells from rat liver contain peroxidase-like activity 
whereas the parenchymal cells were hardly positively stained14 , 15 . 
The present paper shows that peroxidase is about 30 times more 
active in the homogenate of non-parenchymal cells as compared to 
the homogenate of parenchymal cells. For reason that this enzyme 
]6 is involved in antimicrobial systems , the present data, together 
with the lower catalase activity, support an antimicrobial function 
of the non-parenchymal cells in liver. 
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THE INFLUENCE OF GLUCOSE r,6-DIPHOSPHATE ON THE 
ENZYMATIC ACTIVITY OF PYRUVATE KINASE 
J. F. KOSTERa, R. G. SLhD\ G. E. J. STAALb A~D TtL}. C. -... -A~T BERKELa 
''Depo.i'-'tm;?nt of Biochemist;·y I, lvi erhcal F aculiy, Rotterdam (The J>i etherlandsj and IP H ae;;nato!og;crd 
Depav!-IJ';ent, State University Hospital, Utrecht (The Nethe;·!ands) 
(Received "1\fow~mber 25tlt, 197i) 
I. The influence of Glc-r,6-P2 on hepatic and ced blood cell pyruvate kinase 
(.ATP': pyruvate phosphotransfera::)e, E(:~ 2.7.1-40) is quite similar to that ofF:ru-1.6 
Pt.· T~"1C hexose diphosphates can replace each other in stimulating pyruvate kinase; 
after maximal stimulation by one CJf the compounds, the other is not capable of fur-
ther stimulation. 
z. The regulatory role of Fru-r,6-P2 on the activit~{ of pyruvate kinase is dis-
cussed in vie·w of the results obtained. 
A large number of studies l1a·ve been devoted to the regulation of pyn.J.vatc 
kinase (ATP: pyruvate phosphotransferase, EC Z.J.L40), one of the key enzymes in 
glycolysis. It v;ms found that there aTe t'vo types1, aM (musde) t;rpe and a L (liver) 
It turned out that the L type exhibits allosteric propenit:s a_ll.owing regu~ato::-)' 
funchun. The glycolytic intermediate Fru-I,6-Pt. is able to :stimulate the actlvii:y cf 
the L type and dla:1ges the S-shaped re-lationsftip between substrate concentratiur: 
and velocity i:r:to o:. nm-mal hyperbolic cme2 . The [F'ru.-1,6-PsJ of the liver fluctua.te:o; 
'I.Vith the nutritioaal state c-wd, therefore, it '1.-V'as assumed that Fru-r,6-P 2 has "' 
regulatory in::l.ue;,1ce on pyruvate kinase. Furthermore, it \'Fas fm:.nd. that alanine 
inl1ibits the; heps.tic pyruvate kinase reaction3, vl'hich can be of iElportance during 
gluconeogenesis. In OUl studies1'' 5 on hepatic and erythrocytic pyn::.vate kinase it vvas 
found ti.1at the phosphorylated hexoses are able to stimulate the pyruvate kinase 
reaction and to overcom~ the ATP inhibition. In this study vve compare the influences 
of Glc-r,6-P2 and Fru-I,6-P2 ore the enzymatic reactiOJL 
r, .. JATERIALS AKD METHODS 
-Y'ilistar rats, :rr;_aintained on a normal diet and wat.:T ad Zibi!vm, were decapitated 
~!~~ tl1~]ivers removed. I.iver homogenates ·were prepared i;;. 0.15 M NaCl contaimng 
Abb:reviation: FEP, phosphoenolpyruvate. 
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TABLE I 
THE EFFECT OF GLC-I,6-P2 (o.2 mM) AND FRn-I,6-F2 (0.2 mM) 0~ ":HE ACTIVITY OF HEPATIC 
PYRUVATE KINASE IN (0.25 M) TRIS-HCl BUFFER (pH 7.5) WITH [PEP] = 0.5 ml\I A!'fD [ADPJ = 
0.3 mM 
Addition Activity (%) 
None roo 
Glc-r,6-P2 2I8 
Fru-r,6-P2 228 
r mM mercaptoethanol and centrifuged for 6o min at roo ooo x g. From the super-
natant, the partially purified L type preparations were obtained according to the 
method of PASSERON et al. 6 . The preparations were finally dissolved in 0.25 M Tris-
HCI buffer (pH 7.5) containing r mM mercaptoethanol. Red blood cell pyruvate 
kinase was isolated from human erythrocytes according the isolation procedure 
described previously5 . The enzymatic activity was assayed by following the decrease 
of absorbance at 340 nm in the reaction coupled with lactate dehydrogenase as 
described by BUCHER AND PFLEIDERER7. The activities shown are initial reaction 
rates. 
ADP, PEP (phosphoenolpyruvate), NADH, Fru-r,6-P2 and Glc-r,6-P2 were 
obtained from Boehringer (Mannheim, Germany). Glc-r,6-P2 was free of Fru-r,6-P2, 
when analysed by the method of BUCHER AND HoHORST6. All other reagents were of 
analytical grade purity. 
v(~mole{min fmg 
protein) 
0.4 
• 
.. 
0.2 
0.1 
2.0 3.0 
[PEP] (mMI 
4.0 
e con'trol 
A wHh Glc-1,6-P2 
• • 
5.0 
Fig. r. The v versus [PEP] plot for hepatic pyruvate kinase at [ADP] = 0.3 mM, in the absence 
(Git-(D) and presence of 0.2 mM Glc-r,6-P2 (A-A). 
RESULTS 
Table I shows that Glc-r,6-P2 is able to stimulate the hepatic pyruvate kinase 
reaction. This stimulation is about equa] to the stimulation obtained with Fru-r,6-P2 
(Table !), at least under these conditions. 
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v (~A~/:m~lo:l ________________________________________ -; 
• 
0.4 • 
1!1' control 
0.3 A with Glc-1,6-P2 
Q.1~~_j 
1.0 2.0 3.0 4.0 5.0 6.0 
[PEP J (mM) 
Fig. 2. The v versus (PEP] plot for red blood cell pyruvate kinase at [ADP] = z mM, in the 2.-b-
sence (@D-1$) and presence of o.z rnivi Glc-r,6-P2 (J!.-A), 20 pg of protein added. 
100 
60 
1.0 
l,epotic pyr. kina~e red blood cell pyr.kina:.e 
eo-® con>To.l io m-o conrrol I 
&-& wE•h Gk-1,6-<: 2 ~ !:r,-1/J. with Glc-1,6-P2 . 
~. l ~ <~"af~_._ 
40~ ® 
,J 
I 
2.0 3.0 4.0 1.0 2.0 3.0 -'l.O 
[AT PJ (mM) 
Fig. 3A. The ATP inhibition plots for hepatic pyruvate kinase at [PEPJ = o.j mY! and [ADPJ 
o.s mJ\I. ~<$, control; A-A, with Glc-1,6-P~ (o.z m1l). 
Fig. 3B. The ATP inhibition plot for red blood cell py:ruvate kinase at [PEP] = 0.5 m~vi <::.nci 
[ADPJ = 0.5 mM; @-----~, control; &~A, with Glc-r,6-P~ (c.z mM), zo f.lg protein added. 
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Glc-r,6-P2, not only stimulates the pyruvate kinase reaction, but is also able to 
transform the S-shaped curve into a normal hyperbolic one (Fig. r). These results are 
quite similar to the results obtained with the ligand Fru-r,6-P2 (refs. r, 2). At pH 5-9 
the effects of Fru-r,6-P2 disappear. The same results were obtained with Glc-r,6-P,; 
no stimulation occurs at all. Fig. 2 shows the influence of Glc-r,6-P2 on the red blood 
cell pyruvate kinase reaction at pH 7.6. These results are similar to the results ob-
tained with the hepatic pyruvate kinase. 
Similar to Fru-r,6-P,, Glc-r,6-P2 is able to reverse the ATP inhibition on the 
pyruvate kinase reaction (Fig. 3A). This is also the case with red blood cell pyruvate 
kinase (Fig. 3B I. 
It is clear from these data that the effects of Glc-r,6-P, and Fru-r,6-P, are 
quite similar. In liver both ligands have a synergistic effect only at low (<so ,uM) 
concentration (Fig. 4). Fig. 5 shows that with the red blood cell pyruvate kinase at 
%activity 
e control 
.6. Fru-1,6-P 2 added 
200 
160 
120 
80 
40 
0.2 0.4 0.6 0.8 1.0 
Glc-1,6-P2 (mM) 
Fig. 4· The v versus [Glc-I,6-P2] for hepatic pyruvate kinase in the presence and absence of 
Fru-r,&-P2; ........ control; .&.-.4., with Fru-r,6-P2 (o.2 mM), [PEPJ = o.s mM and [ADPJ = 
0.3mM. 
sao ,uM, Glc-r,6-P2 Fru-r,6-P2, does not further stimulate, but that in the absence of 
Fru-r,6-P2 half-maximal stimulation by Glc-r,6-P2 is obtained at 6o ,uM. 
At a [Fru-r,6-P,] of so ,uM the hepatic pyruvate kinase is practically fully 
stimulated; however, at ro ,uM the stimulation is already about go% of the maximal 
obtainable. For Glc-r,6-P2 the concentration necessary for full stimulation is about 
so ,uM; at a concentration of·lO ,uM the stimulation is about 6o% of maximal obtained. 
For the red blood cell pyruvate kinase the situation is somewhat different. At ro ,uM 
of Fru-r,6-P2 the reaction is fully stimulated but for Glu-r,6-P2 the pyruvate kinase 
reaction is still not fully stimulated at a concentration of zoo ,uM. 
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v (b.A/min) 
• • 0.20 
• • 
0.15 
• control 
• Fru-1,6-P2 added 
• 
0.10 • 
• 
0.05 
0.05 0.10 0.15 0.20 0.25 0.5 
[Gic-1,6-P2J (mM) 
Fig. 5· The v versus [Glc-r,6-PJ for red blood cell pyruvate kinase in the absence and presence of 
Fru-I,6-P2 ; ......... control; .&-A, with Fru-r,6-.P2 (0.5 mM). [PEP] = 0.5 mM and [ADP] = 
0.5 mM, 20 j.tg of protein added. 
DISCUSSION 
From the data presented it is clear that the effects of Fru-r,6-P2 and Glc-r,6-P2 
are quite similar. The concentration of Fru-r,6-P2 in the liver fluctuates during 
feeding and fasting (5-20 pM)9. However, the [Glc-r,6,P2] remains constant at about 
I5pM10 At this concentration of Glc-r,6-P2 the hepatic pyruvate kinase is more than 
So% stimulated, while at 5pM Fru-r,6-P2 pyruvate kinase is already stimulated for 
so~/0 . This means that Fru-r,6-P2 cannot have any regulatory function on hepatic 
pyruvate kinase. For red blood cell pyruvate kinase it was shown that Fru-r,6-P2 has 
already a fully stimulating effect at ro pM, while for Glc-r,6-P2 the concentration has 
to be more than 200 pM. However, the [Glc-r,6-P,] in the red blood cell is 300 pM11 
According to BARTLETT11, the red blood cell [Fru-r,6-P,] is 200 pM. With these con-
centrations the pyruvate kinase in the erythrocyte is fully stimulated. This means that 
the enzyme is in the R state5. For the red blood cell it is rather doubtful! if a regulation 
of pyruvate kinase is necessary. The rate of glycolysis is governed by the activities of 
hexokinase (ATP: n-hexose 6-phosphotransferase, EC 2.J.I.I) and phosphofruc-
tokinase (ATP: n-fructose-6-phosphate r-phosphotransferase, EC 2.J.LII), in which 
the concentrations of adenine nucleotides also play an important role1•5 •12 .ta. 
Although there will be some wasting of ATP during the gluconeogenesis due to 
cycling', the pyruvate kinase reaction must be inhibited in order to increase the PEP 
concentration which is necessary for the gluconeogenesis. However, this regulation 
cannot be done by a fluctuating Fru-I,6-P2 concentration of the liver. 
Biochim. Biophys. Ac/,a, 25$ (I972) 763-768 
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SUMMARY 
r. Reduced L-type pyruvate kinase (ATP:pyruvate phosphotransferase, EC 
2.7.1.40) from rat liver can be converted into an oxidized form by incubation with 
oxidized mercaptoethanol and oxidized glutathione. This interconversion can be 
completely reversed by incubation with reduced mercaptoethanol. 
2. The kinetic and allosteric properties of the reduced and oxidized forms are 
described. 
3· The results are discussed in view of a possible regulation of the enzyme. 
INTRODUCTION 
Pyruvate kinase (ATP: pyruvate phosphotransferase, EC 2.7.r.4o) catalyses 
the last step of glycolysis. Its activity is important in the regulation of the dynamic 
balance between gluconeogenesis and glycolysis in the liver. In the liver two types of 
pyruvate kinase are presentl. The L-type pyruvate kinase shows an allosteric response 
to one of its substrates phosphoenolpyruvate (PEP). Its activity is influenced by 
Fru-r,6-P2, Glc-r,6-P2 and other phosphorylated hexoses2-'- These compounds in-
crease the apparent affinity for the substrate PEP. On the other hand ATP and ala-
nine act as allosteric inhibitors'·'· It has been generally accepted that the L-type 
pyruvate kinase, localized in the rat liver hepatocytes7, must be inhibited during 
gluconeogenesis in order to increase the [PEP] necessary for gluconeogenesis. In a 
previous paper4 we pointed out that the L-type pyruvate kinase cannot be regulated 
by a fluctuating [Fru-I,6-P2] in the liver. The ATP concentration in vivo only fluc-
tuates between 2 and 3 mM (refs 8 and g) and, therefore, some authors6 •10 assumed 
that during gluconeogenesis alanine is the most important inhibitor of pyruvate 
kinase activity. However, during gluconeogenesis the [alanine] in the liver is lowered 
(65%) due to an increased flux into the gluconeogenic pathway11 . These properties 
would lead tn an uninhibited enzyme under gluconeogenic conditions, which is rather 
Abbreviation: PEP, phosphoenolpyruvate. 
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unlikely. Another possibility is that the reduction state of the enzyme plays an 
important role in its regulation. We investigated the influence of sulfhydryl com-
pounds on the activity of the enzyme, after preliminary studies with coenzyme A 
(containing glutathione) indicated an influence of thiol groups on the allosteric be-
haviour of pyruvate kinase. 
MATERIALS AND METHODS 
Pyruvate kinase type L was isolated from rat liver according to the isolation 
procedure described earlier4 , except that during this procedure r mM mercaptoetha-
nol was omitted and the final preparation was dissolved in 0.25 M Tris-HCl pH 8.0. 
Pyruvate kinase activity was assayed by following the decrease in absorbance at 
340 nm in a coupled reaction with lactate dehydrogenase at 23 °C according to Va-
lentine and Tanaka"- The triethanol-HCl buffer (0.4 M, pH 7.5) was replaced by 
Tris-HCl buffer (0.25 M, pH 8.o). Oxidized mercaptoethanol was prepared by bubbl-
ing 0 2 through a roo-mM solution of reduced mercaptoethanol for 24 h. Oxidized 
L-type pyruvate kinase was prepared by incubating the enzyme for 6 h at 5 oc with 
I mM oxidized mercaptoethanol or 2.5 mM oxidized glutathione. 
ADP, PEP, NADH, Fru-r,6-P2, Glc-r,6-P2 and oxidized glutathione were ob-
tained from Boehringer (Mannheim, Germany). Glc-r,6-P2 was free of Fru-r,6-P2, 
when analysed by the method of Bucher and Hohorst13 . Reduced glutathione was 
obtained from Sigma. All other reagents were of analytical grade purity. 
RESULTS 
Fig. r shows the v vs [PEP] plot at [ADP] ~ 0.5 mM for the freshly prepared 
pyruvate kinase (L-type) and the oxidized enzyme (preincubated with oxidized 
mercaptoethanol; compare Materials and Methods). In the presence of Fru-r,6-P2 
0~;::::::::::=:=;:::::::::::_ 
0 2 6 8 10 
[PEP]mM 
Fig. 1. The v vs [PEP] plot ofthe freshly isolated and oxidized I.Aype pyruvate kinase at [ADP] = 
o.s mM measured in the presence and absence of Fru-1,6-P2 (0.5 mM). lll!ll-11!, the activity of the 
freshly isolated L-type pyruvate kinase; 'V"-T, the activity of the freshly isolated L-type pyru-
vate kinase measured in the presence of Fru-1,6-P2 ; A-&, the activity of the oxidized L-type 
pyruvate kinase (by oxidized mercaptoethanol); e-e, the activity of the oxidized L-type pyru-
vate kinase (by oxidized mercaptoethanol) measured in the presence of Fru-1,6-P2 • 
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the freshly prepared enzyme gives an apparent Km value of o.r mM for PEP, whereas 
in the absence of Fru-r,6-P2 a K 0 , 5 value of 2.5 mM was obtained. Oxidation of the 
enzyme leads to a marked change in these activity curves. In the presence of Fru-
r,6-P2 the Km value for PEP is increased to 0.7 mM and the K 0 , 5 value in the absence 
of Fru-r,6-P2 was not measurable. This means that at least under our test conditions 
the oxidized enzyme cannot reach its maximal activity in the absence of Fru-r,6-P2 • 
The addition of Fru-r,6-P2 stimulates the enzymatic activity to the same value as 
obtained with the freshly prepared enzyme, indicating that no loss of maximal acti-
vity occurred after oxidation of the enzyme. 
~A/min 
6 8 10 
[PEP] mM 
Fig. z. The v vs [PEP] plot of the oxidized L-type pyruvate kinase (by oxidized glutathione) and 
the oxidized L-type pyruvate kinase after incubation for I hat IO oc with I mM mercaptoethanol 
(reduced enzyme) measured in the presence and absence of Fru-I,6-P2 ; A-A, the activity of the 
oxidized L-type pyruvate kinase (by oxidized glutathione); 8-ct, the activity of the oxidized 
L-type pyruvate kinase (by oxidized glutathione) measured in the presence of Fru-I,6-P2 ; 
1111-111, the activity of the reduced L-type pyruvate kinase; v-V, the activity of the reduced L-
type pyruvate kinase measured in the presence of Fru-I,6-P2 . 
Fig. 2 shows that the L-type pyruvate kinase can also be oxidized by incu-
bation with oxidized glutathione In the absence and presence ofFru-r,6-P2 the same 
pattern was obtained as in Fig. I. Fig. 2 also shows that oxidation of the enzyme is 
a reversible process. By incubating the oxidized enzyme with I ruM reduced mercap-
toethanol for I hat IO °C (reduced enzyme) the same kinetic data were obtained as 
with the freshly isolated enzyme. The K 0, 5 value in the absence of Fru-r,6-P2 be-
comes again 2 mM and the apparent Km for PEP in the presence ofFru-r,6-P2 is again 
lowered to o.I ruM. The same curves were obtained when the enzyme was oxidized by 
using oxidized mercaptoethanol and incubated again with reduced mercaptoethanol. 
When the oxidized enzyme was incubated with reduced glutathione (5 mM), inter-
mediate curves were obtained (Fig. 3). 
From Figs I, 2 and 3 we can conclude that there exist at least two forms of 
pyruvate kinase with different kinetic properties, which can be interconverted, prob-
ably by oxidation and reduction of the -SH groups of the enzyme. 
The increase in Km value for PEP in the presence of Fru-r,6-P2, obtained with 
the oxidized enzyme as compared with the reduced enzyme, might be of physio-
logical importance. Therefore the enzymatic activity of the oxidized and reduced 
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~A/min 
02 
0.1 
' 
5 8 10 
[PEP]mM 
Fig. 3· The v vs [PEP] plot of the oxidized L-type pyruvate kinase after incubation for I h at 
Io oc with 5 mM reduced glutathione measured in the presence and absence of Fru~I,6-P2 • 
11~111, the activity of the oxidized L-type {by oxidized mercaptoethanol) incubated with reduced 
glutathione; 8~8, the activity of the oxidized L-type (by oxidized mercaptoethanol) which has 
been incubated with reduced glutathione measured in the presence of Fru-I,6-P2 ; A~A, the ac-
tivity of the oxidized L-type (by oxidized glutathione) incubated with reduced glutathione; 
v~v, the activity of the oxidized L-type (by oxidized glutathione) incubated with reduced glu-
tathione measured in the presence of Fru-I,6-P2 . 
~A! min 
0.3 
0.08 0.10 
[Fru-1.6-f2] mM 
Fig. 4· The v vs [Fru-I,6-P2] plot of the oxidized L-type pyruvate kinase and the oxidized L-type 
after incubation for I hat IO oc with 5 mM reduced glutathione or I mM mercaptoethanol at [PEP] 
= I mM. 8--81, oxidized L-type pyruvate kinase (by oxidized mercaptoethanol); £~.&., oxidized 
L-type pyruvate kinase (by oxidized glutathione); 1111-111, oxidized L-type pyruvate kinase (by 
oxidized glutathione) after incubation with reduced glutathione; V-V, oxidized L-type pyruvate 
kinase (by oxidized mercaptoethanol) after incubation with reduced mercaptoethanol. 
enzymes as a function of the [Fru-r,6-P,J was studied. Fig. 4 shows that the reduced 
enzyme is already fully activated at 5,uM Fru-r,6-P2, while the oxidized enzyme 
reaches this maximal activity at a concentration of about 30 J.tM Fru-1,6-P2. Fig. 4 
also shows the difference in maximal activities of the reduced and oxidized enzymes 
at [PEP] = I mM and [ADP] = 0.5 mM. When the oxidized enzyme is incubated 
with reduced mercaptoethanol, the same curve is obtained as with the freshly pre-
pared enzyme. Incubation of the oxidized enzyme with reduced glutathione gives 
IZZ TH. J. C. VAN BERKEL eta/. 
~A/min 
0.2 
0.1 
Q.4 0.5 
!Glc-1,6-f2] mM 
Fig. 5- The v vs [Glc-r,6-P2] plot of the oxidized L-type pyruvate kinase and the oxidized L-type 
after incubation for r h at ro oc with 5 mM reduced glutathione orr mM mercaptoethanol at 
[PEP] = r mM. e-18, oxidized L-type pyruvate kinase (by oxidized mercaptoethanol); A.-A, 
oxidized L-type pyruvate kinase (by oxidized glutathione); 11-11, oxidized L-type pyruvate 
kinase (by oxidized glutathione) after incubation with reduced glutathione; V-V, oxidized L-
type pyruvate kinase (by oxidized mercaptoethanol) after incubation with reduced mercapto-
ethanol. 
an intermediate curve; when this enzyme is further incubated with reduced mercap-
toethanol, the same curve is obtained as with the freshly prepared enzyme. 
Fig. 5 shows that the oxidized enzyme is rather insensitive to Glc-I,6-P2 stimu-
lation. "When the oxidized enzyme was incubated with reduced glutathione for I h, 
a more marked stimulation by Glc-I,6-P2 is found. Incubation with (reduced) mer-
captoethanol for I h gives the same stimulation with Glc-r,6-P2 as it is found with 
the freshly isolated enzyme. From Figs 4 and 5 the conclusion can be drawn that the 
oxidized enzyme is rather insensitive to Glc-r,6-P2, whereas Fru-r,6-P2 is still able 
to stimulate the enzyme, although the concentration necessary for maximal stimu-
lation has increased from 5 ftM with the reduced enzyme to 30 ftM for the oxidized 
enzyme. 
DISCUSSION 
From the data presented it is clear that the L-type pyruvate kinase can exist 
in two fonns with different kinetic properties. The two forms can be interconverted 
by incubation with oxidized or reduced mercaptoethanol or glutathione. Since these 
compounds affect the -SH groups of proteins, it seems likely that thiol groups are 
involved in the interconversion. When glutathione (5 mM) was used to reduce the 
oxidized enzyme, the results obtained were not identical with those obtained with 
mercaptoethanol (I mM) as a reducing agent. Th~. might be due to incomplete re-
duction of the enzyme with glutathione, suggesting at least two different types of 
-SH groups in the enzyme, involved in the interconversion. 
For pyruvate formiate lyase from Escherichia coli14 •15 and also for xanthine 
oxidase (EC 1.2.3.2) from rat 1iver16- 18 an enzyme regulation by the oxidation and 
reduction of thiol groups has been shown and it is also likely that these interconver-
sions are enzyme-catalysed. Also the fructose-r,6-diphosphatase (EC 3.I.3.rr) acti-
vity from rabbit liver seems to be influenced by SH reagents19-2I_ For plants there-
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dox state of the SH groups of a number of enzymes is a general kind of control22• 
The existence of such an enzyme-catalysed interconversion for rat liver pyruvate 
kinase cannot be concluded from the presented data. The in vitro oxidation is a rather 
slow process (for full oxidation 6 hare required, data not shown) and subsequent re-
duction takes I h. These data are obtained with the partially purified enzyme. By 
analogy with other enzymes, it is tempting to speculate the existence of an in vivo 
enzyme-catalysed interconversion. One condition for physiological regulation is full-
filled in that the interconversion is reversible. 
The difference in kinetic properties between the oxidized and reduced enzymes 
makes regulation of the enzymatic activity possible. In the oxidized enzyme the inter-
action of the PEP binding sites is raised (Figs I and z) and Fru-I,6-P2 is still able to 
stimulate the reaction. However the [Fru-I,6-P2] needed for full activity is approxi-
mately 6 times higher than for the reduced enzyme and exceeds the liver [Fru-I,6-
P2] (ref. 23). This decrease in affinity for PEP and Fru-I,6-P2 can be important during 
fasting, when PEP is needed for gluconeogenesis. In this view the markedly decreased 
influence of Glc-r,6-P2 (of which the concentration in the liver remains constant dur-
ing fasting and feeding, at least in the mouse24) on the oxidized enzyme is of great 
importance. These properties can make the interconversion of the two forms of pyru-
vate kinase (L-type) of physiological importance, if a system exists which can cata-
lyse these interconversions more rapidly than under our in vitro conditions. 
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ON THE REGULATION AND ALLOSTERIC MODEL OF L-TYPE PYRU-
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SUMMARY 
I. The influence of P, and the phosphorylated hexoses Fru-1 ,6-P2 , Fru-6-P, 
Fru-1-P, Glc-1,6-P,, Glc-6-P, Glc-1-1' and Gai-1-P on L-type pyruvate kinase from 
rat liver has been investigated at physiological ADP, P-enolpyruvate, GSH, ATP 
and alanine concentrations. At 0. I mM P~enolpyruvatc and in the presence of 2 mM 
MgATP + l mM alanine the enzyme is inactive and the only effective activator in 
a physiological concentration range is Fru-1,6-P2• 
2. The phosphorylated lu:xoses were used as a probe for the conformation of 
the enzyme. A comparison of the efrects of MgA TP and alanine on the "affinities" * 
for the hexoses reveals the foi!Gwing differences. (a) MgATP (2 mM) and alanine 
(I mM) increase the concentration of Glc-1,6-P, and Glc-6-P necessary for half-
mJximal activation to the same extent: however, MgA TP and alanine introduce a 
different cooperative interaction towards Glc-1,6-P2 and Glc-6-P at low P-enal-
pyruvate concentrations. (b) MgATP (2 mM) has less influence on the '"affinities" 
for Fru-1,6-P, and Fru-6-P as compared to alanine (I mM). (c) Enzyme modification 
by oxidation of the thiol groups increases the effect cf MgATP on the "affinity" for 
Glc-1,6-P2 , whereas the influence of alanine is decreased. These results reveal the 
conclusion that MgA TP and a-lanine introduce a ditTerent conformation, probably 
by binding at different sites. The results are difiicult to explain by the R ~ T equi-
librium model of Monod, Wyman and Changeux. and indicate that sequential con-
formation changes are involved in the allosteric transitions cf the enzyme. 
INTRODUCTION 
Pyruvate kinase (ATP:pyruvate phosphotransferase, EC 2.7.1.40) catalyses 
the last step of glycolysis. Its activity is important in the regulation of the dynamic 
balance between gluconeogenesis and glycolysis in the liver. In the liver two types of 
pyruvate kinase are present [1]. The M 2-type is located in the non-parenchymal 
cells [2, 3] and although this type possesses regulatory properties [4~8], its presence 
in a cell seems to exclude gluconeogenesis. The L-type is located in the parenchymal 
* With "'affinity" is meant the relative ability of a compound to activate the enzyme; this ability 
is concluded from the concentration of activator necessary for half maximal activation. 
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cells [2, 3] and responds to diet and hormones [9]. Although the L-type pyruvate 
kinase possesses many regulatory properties, the mechanism to inactivate the enzyme 
under gluconeogenic conditions is still uncertain [10~13]. From the effect of the 
allosteric activators P,, phosphorylated hexoscs [I OJ and glucose-! ,6-diphosphate 
(Gic-!,6-P,) [II] on the L-type pyruvate kinase it was concluded that the presence of 
these compounds in rat liver will result in a fully auive enzyme under both glycolytic 
and gluconeogenic conditions. Jt WJS concluded that in the liver Glc-1 ,6-P2, of which 
the concentration is quite constant, makes the regulation of the pyruvate kinase 
activity by Fru-1,6-P2 impossible [11]. However, these conclusions were based on 
experiments in which 0.5 mM P-cnolpyruvate was used a!)d in which effectors, such 
as alanine and ATP were absent. Recent studies on pyruvate kinase from yeast [141 
and erythrocytes [ISJ have shown that the alllnity• of the enzyme for Fru-1,6-P2 is 
increased by an increment in the P-enolpyruvate concentration. This flnding made 
it important to reinvestigate the alllnity of pyruvate kinase for Pi and the phos-
phorylated hexoses at a more physiological P-enolpyruvate concentration (0.1 ruM) 
to see to what extent the relatively high P-enolpyruvatc concentration, which has 
been employed earlier, influences the measured aJlinities for these compounds. The 
affinity of L-type pyruvate kinase for Fru-1,6-P2 is also influenced by MgATP and 
alanine [12). for the reason that these compound~ are both present in liver we 
investigated also the influence cf Pi and the phosphorylated hexoses in the presence 
of the physiological concentraticns of MgATP (2 mM) and alanine (l mM). Under 
these conditions it can be concluded to what extent Pi and the phosphorylated hexoses 
contribute to the overali activity of pyruvate kinase in vivo. 
Our earlier studies v..~ith L-ty_re pyruvate kina~e frcm rat liver [16] and erythro-
cytes [17] have shown that the kinetic properties cf the L-type are highly dependent 
upon the reduction state cf the thiol groups, properties also found by Kutzbach and 
co-workers [13, 18]. For this reason we isolated and assayed the enzyme in the 
presence of the physiclogical reductant reduced glutathione (GSH). 
In the course of this investigation we became aware of the value of P1 and 
the phosphorylated hexoses as probes for the conformation of the enzyme. The 
similarity in structure cfthese ccmpounds and their similar kinetic behaviour [lO, l!J 
has led to the conclusion that these ccmpounds bind at the same activator site. A 
change in conformation of this site by an effector will influence the aftlnity for Pi and 
the phosphorylated hexoses (this will be reflected in the concentration required for 
half maximal activation) and their way of binding (re!lected in the Hill coefficient). 
In this way we can compare the e1Tects of MgATP and alanine on the conformation 
of this activation site while also the effect of increasing P-enolpyruvate concentration 
can be determined. 
MATERiALS AND METHODS 
Wistar rats, maintained on a normal diet and water ad libitum, were decapi-
tated and the livers were removed. Liver homogenates were prepared in 0.15 M NaCJ 
containing 5 mM reduced glutathione (GS'H) and centrifuged for 60 min at !00000 X g. 
From the supernatant, the partially purified L-type preparation was obtained accord-
ing to the method of Passeron et al. [ 19]. The preparations were dissolved in 0.25 M 
Tris-HC! buffer (pH 7.5) containing 5 mM GSH. The enzymatic activity was assayed 
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following the decrease in absorbance at 340 nm, at room temperature (22 "C) in a 
reaction mixture (3.0 ml) containing, unless indicaled otherwise, 25 mM Tris-HCI 
buffer (pH 7.5), 0.1 mM KCI, I mM ADP, 0.12 mM NADH, 0.1 mg lactate dehydro-
genase, 20 mM MgCI 2, 0.1 mM P-enolpyruvate and 5 mM GSH. 
The applied Mg2+ and K + concentrations are rather high, as compared to the 
free concentration found in liver [20]. Therefore the reported experiments at 0.1 mM 
P-enolpyruvate were repeated at a free Mg2+ concentration of I mM (calculated by 
a method based on that of Morrison and co-workers [21, 22], which will be described 
in detail (Van Berkel, Th. J. C., in preparation)). The K +concentration was lowered 
from 100 to 25 mM. These changes in ion concentrations did not t:hange the obtained 
affinities for the phosphorylated hexoses. 
ADP, P-enolpyruvate, NADH, P, and the phosphorylated hexoses were 
obtained from Boehringer (Mannheim, Germany). The phosphorylated hexoses were 
analysed for the presence of Fru-1,6-P2 by the method of BetCher and Hohorst [23]. 
Only Fru-6-P contained about 0.03% Fru-1 ,6-P2 , which contamination was removed 
enzymatically by the addition cf aldolase, followed by dcprotcinization with tri-
chloroacetic acid. 
Control assays were performed v.ith Pi or the phosphorylated hexoses used, 
in the absence of P-enolpyruvate. When MgA TP or alanine or both were present, 
corresponding blanks were pe1 fcrmed in the prc~ence cf these ccmpounds. In all 
cases there was no change of NADH absorption. Duplicates of the reported experi-
ments were run with twice the amount of lactate debydrc,genase to exclude possible 
effects on this enzyme reaction. Doubling the amount Gf lactate dehydrogenase did 
not influence the results obtained. 
RESULTS 
Affinity for Pi and the plw.Jplwrylated hexose.\' at 0.1 1i1AJ P-enolp)'rlH'ate and physi-
ological effector concentrations 
In preliminary studies on the effect cf phosphorylated hexoses at 0.1 mM 
P-enolpyruvate, the L-type pyruvate kinase was isolated in the absence of a thiol 
group reductant. The obtained allinity of the enzyme for Fru-1,6-P2 was markedly 
decreased, as compared to the enzyq1e isclated in the presence of I mM mercapto-
ethanol (data not shown). The purpose cf this study was to verify if the phosphory-
lated hexoses can influence the pyruvate kina~c activity under physiological con-
ditions. Therefore we isolated the enzyme in the presence of the physiclogical reduc-
tant GSH (5 mM) [24]. 
Fig. I shows the influence cf Glc-1,6-P, at 0.1 mM P-enclpyruvate on the 
activity of L-type pyruvate kinase under various conditions. At 0.1 mM P-enolpyru-
vate the concentration of Gk-1 ,6-P2, necessary for half-maximal activation, is 120 
,uM. In the presence of 2 mM MgA TP or I mM alanine the Glc-1 ,6-P2 concentration, 
necessary for half-maximal activation, is incrca~.ed to about 300 .uM, whereas in the 
presence of both alanine + MgATP the enzyme activity is hardly influenced by the 
applied Glc-1 ,6-P2 concentrations. Since the Glc-1 ,6-P2 concentration in liver is abcut 
IS ,uM [25], we can conclude that Glc-1,6-P, is not able to activate pyruvate kinase 
in the presence of the physiological concentrations of alanine and MgA TP. 
Glc-6-P is somewhat less effective at a P-cnclovruvate concn of 0.1 rnM as 
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Fig. 1. The activity vs Glc-1,6-P2 concn plot for L-type pyruvate kinase at p-enal pyruvate concn = 
0.1 mM, ADP concn = 1 mM and 5 mM GSH. ()~0, control curve; 0-Ll, in the presence of I 
mM alanine; 11-11, in the presence of 2 mM MgATP; 8~8. in the presence of 1 mM alanine + 
2mM MgATP. 
compared to Glc-1 ,6-P2 (see Table 1). The effects of 2 mM MgA TP and I mM alanine 
on the affinity for Glc-6-P are comparable (figure not shown). ln the presence of both 
inhibitors also the influence of Glc-6-P has almost disappeared, which seems to 
exclude a role of Glc-6-P in the regulation of pyruvate kinase (26]. 
Furthermore the following phosphorylated hexoses, Glc-1-P, Fru-!-P, Fru-6-P 
TABLE I 
THE AFFINITY OF L-PYRUVATE KINASE FROM RAT LIVER FOR THE PHOSPHORYLATED 
HEXOSES AND P1 AT SEVERAL P-ENOLPYRUVATE CONCENTRATIONS 
The values are the concentrations of hexoses (.uM) and P 1 (mM) necessary for half maximal activation. Tl:e ccrre-
sponding Hill values are calculated. The P-enolpyruvate concentrations used are indicated. 
·-------------------
Control n Value +alanine 11 value +MgATP 
(2 mM) 
11 value Alanine (1 mM) + n value 
MgATP (2 mM) 
P-Enolpyruvate concn = 0. I mM 
Fru-I,6-P2 1.2 2.6 
Fru-6-P No effect 
Glc-1,6-P, 120 2.7 
Glc-6-P 190 2.7 
No effect 
P-Enolpyruvate concn = 0.25 mM 
Fru-1 ,6-P2 1.2 2.1 
Fru-6-P > 1500 
Glc-l,6-P2 70 2.0 
Glc-6-P 70 2.1 
PI >30 
P-Enolpyruvate concn = 0.50 mM 
Fru-1,6-Pz 0.4 1.1 
Fru-6-P 900 
Glc-1,6-P, 50 1.6 
Glc-6-P 50 1.5 
PI 16 3.2 
(1 mM) 
3.2 2.6 
No effect 
290 3.3 
590 2.4 
No effect 
3.6 
No efil.::ct 
210 
200 
No effect 
2.1 
No effect 
170 
170 
>30 
2.9 
2.9 
2.9 
1.9 
2.2 
1.9 
1.8 
No effect 
310 
590 
No effect 
2.0 
No etfect 
230 
230 
No clfect 
1.5 
1500 
170 
170 
>30 
2.8 
2.0 
1.9 
2.8 
2.1 
2.2 
2.3 
2.1 
2.0 
4.5 
No effect 
>1000 
>1500 
No effect 
5.0 
No effect 
600 
600 
No effect 
4.5 
No effect 
500 
500 
No effect 
3.9 
3.0 
3.0 
3.0 
2.3 
3.1 
3.2 
5u 
and Gal-1-P were ksted in a concentration range between 0 and 1.5 mM and for Pi 
between 0 and 30 mM. Under the applied conditions (identical as for Figs I and 2) 
these. compounds did not influence the pyruvate kinase activity, even in the absence 
of MgATP or alanine. These obtained data, at 0.1 mM P-enolpyruvate and physi-
ological effector concentrations, make it unlikely that P, and the phosphorylated 
hexoses (except Fru-1 ,6-P2) are able to influence the pyruvate kinase activity in vivo. 
Fig. 2 shows that under the applied conditions the only activator in a physi-
ological concentration range will be Fru-1,6-P2 • In accordance with other reports [12, 
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Fig. 2. The activity vs Fru-1,6-P2 concn plot for L-type pyruvate kinase at p-enal pyruvate= 0.1 mM, 
ADP concn = 1 mM and 5 ruM GSH. 0-0, control curve; o~o, in the presence of 1 ruM alanine; 11-a, 
in the presence of 2 mM MgATP; •-•, in the presence of 1 mM alanine+ 2 mM MgATP;A-..t.., in the 
presence of 1 mM alanine+ 2 mM MgATP, the enzyme was isolated and assayed in the absence of 
GSH. 
13] it can be observed that the aftinity or the enzyme for Fru-1,6-P2 is high even in 
the presence of both MgA TP and alanine. This figure shows also that the affinity 
for Fru-1,6-P2 of the enzyme, isolated in the presence ofGSH, is more influenced by 
I mM alanine as compared with 2 mM MgATP. This figure shows further that the 
enzyme isolated in the absence cf the phy~:iclogical reductant has a markedly lower 
affinity for Fru-1,6-P, and is practically inactive at 5 ,uM Fru-1,6-P,. 
The phosphorylatf!d hexoses and Pi as a probe for the conformation of the enzyme 
As already mentioned in Introduction, the phosphorylated hexoses and P1 can 
he used as a probe for the conformation of ~he activator site. Frcm the similarity of 
the structure uf these compounds and from data reported elsewhere [10, II] it can 
be concluded that these compounds bind on the same activator site. The use of these 
compounds has the advantage over fluorescent dyes that their influence is measured 
as enzymatic activity, which excludes a non-spcdfk reaction. Furthermore, the 
affinity for these ccmpounds can be measured accurately, which is an advantage over 
the relative insensitivity cf the fluorescent probe methods [28]. 
Table I shows then values calculated frcm the Hill plots (not shown) and the 
corresponding concentrations of phosphorylated hexoses necessary for half-maximal 
activation. At a P-enolpyruvate concentration of 0.1 mM the enzyme has a higher 
6u 
affinity for Glc-1,6-?2 than for Glc-6-P, both in the abence and presence of MgATP 
and/or alanine. From the obtained 11 values we can conclude that the activators bind 
in a cooperative way. 1 mM alanine or 2 mM MgATP increase the Gk-1,6-?2 con-
centration necessary for halt·-maximal activation to the sam~ extent. However, the 
n value in the presence of alanine is significantly higher as in the presence cf MgATP 
which means that the conformational state of the enzyme in the prc::-:cnce cf alanine 
differs from that with MgATP. The same phencmcnon is observed v.ith Glc-6-P as 
activator, whereas v..ith Fru-1,6-P2 as activator no signilicant diOCrcnce is observed. 
At 0.25 mM ?-enol pyruvate the dill'crence in .. allinity .. between Glc-1 ,6-?2 
and Glc-6-P has disappeared (middle of Table I). This indicates that by increasing 
the P-enolpyruvate concentration not only the aflinity for Gk~ I ,6-P2 and Glc-6-P 
increases, but tllat there is also a change in spclilicity. The activator site can no 
longer discriminate between Glc-1,6-P2 and Glc-6-P. Such behaviour cannot be 
explained by a simple shift of the R ,_ · T equilibrium to the R state and indicate that 
P-enolpyruvate changes the conformation of the activator site in such a way that the 
phosphate on the C 1 place of the glucose molecule docs no longer influence the effector 
binding. At 0.25 mM P-enolpyruvate the cooperativity toward Fru-1 ,6-P2, Glc-!,6-?2 
and GJc-6-P is decreased as compared with 0.10 mM P-cnolpyruvatc. Also at this 
P-enolpyruvate concentration the cooperativity for Glc-l,6-P2 and Glc-6-P in the 
presence of alanine is higher than in the presence of MgATP. 
A further increase in P-enolpyruvate concentration to 0.5 mM results in a 
higher aflinity for the phosphorylated hexoses and P,. The binding of Fru-1,6-?2 is 
no longer cooperative, while the coope'·ativity towards Glc-1 ,6-P2 and Glc-6-P is 
further decreased. The coopcrativity in the presence of alanine is also decreased, 
while this does not occur in the presence of MgATP. This leads to a disappearance 
of the difference in n values observed at 0.25 and 0.1 mM P-~Jwlpyruvate. A com-
parison of the effects of MgATP and alanine on the allinity for the phosphorylated 
hexoses reveals the following differences. (a) 2 mM MgA TP increases the concen-
tration of Glc-1,6-P2 and Glc~6-P necessary for half-maximal activation to the same 
extent as 1 rnM alanine; the influence of MgATP on the allinity for Fru-l,6-P2 and 
Fru-6-P, however, is less when compared to the influence of alanine. (b) Although 
MgATP and alanine increase the concentrations ofGlc-l,6-P2 and Glc-6-P, necessary 
for half-maximal activation to the same extent, they introdm:e a different cooperative 
interaction towards these activators at 0.25 and 0.10 mM P-enolpyruvate. These 
differences indicate that MgATP and alanine introduce a different conformation, 
probably by binding to difTerent sites. The evidence for binding to different sites is 
presented in Fig. 3. In this figure is plotted the influence ofGlc-1,6-P2 on the enzyme, 
isolated in the absence of a thiol group reductant. The influence of alanine on the 
affinity for Glc-1,6-?2 is decreased, as compared to Fig. 1 (half maximal activation 
at 190 ,uM instead of 290 ttM). whereas the eftect of MgATP on the contrary is 
increased. Incubation of this enzyme with 5 mM GSH at 10 "C for 1 h converts the 
enzyme into a form with the same kinetic properties as reported in Fig. I, suggesting 
that the modification is the consequence of oxidation of thiol groups. This difference 
in response to modification of the enzyme strengthens the earlier statement that 
MgATP and alanine bind to different allosteric sites. 
These results can also explain the discrepancies described ln literature between 
the sensitivities for MgATP and alanine [12, 29] of L-type pyruvate kinase, which 
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Fig. 3. The activity vs Glc-!,6-P2 concn plot for L-typc pyruvc:te kinase at p-enolpyruvate ~~- 0.1 mM 
and ADP concn c I mM. The enzyme was isolated anti assayed in the absence of GSH. C~O, 
control curve; O~Cl, in the presence of 1 mM alanine; Ill- Ill, in the presence of 2 mM MgATP; 
e--Cit, in the presence of I mM atmine -t- 2 mM MgATP. 
has been extensively discussed by Seubert and Schaner (30J in a recent review. 
Schoner et al. [29] puriJied the enzyme in the atsencc cf a thiol group reductant and 
found the enzyme more sensitive to MgATP than to alanine, v.·hile the oppcsite was 
found by Llorente eta!. [12) \Vith elude enzyme extracts. It seems likely that in the 
enzyme, as isolated by Schcner et al. [29J, thic.l groups are oxidized during the iso-
lation procedure, which would explain their kinetic prcpc1tics {tf. Fig. 3). With the 
enzyme, isolated according lo Llorente et al. [ 12], such a modification would not 
occur. 
DISCUSSION 
The influence cf P, and the phosphorylated hexcses on L-tyre pyruvate kinase 
frcm rat liver has led to the conclmion that the presence cf the~e ccmpounds in liver 
results in an active enzyme under beth glycclytic and gluconecgei~ic conditions [10,11 ]. 
Our data show that the atf:nity cf L-ty~e pyruvate kinase fer P, and the phos~hory­
lated hexoses is increa~ed by raising the P-enclpyruvate concentration. The affinities 
for P, and the phosphorylated hexoses were tested earlier [10, II] at 0.5 mM P-encl-
pyruvatc. LoVvering cf the P-enclpyruvate ccT;ccJ:traticn to an in vivo value [32] 
results in lower afiJJ~itics J'cr pi and t]lC phophclylated hCXCECS, which are further 
decreased, when the inhibitcrs MgATP und/or alanine are also present. Frcm the 
affinities, obtained at pllysiclcgical n1ncentrations c:f P-enclpyruvate, MgATP and 
alanine it can be concluded that P; and the phosp!wrylated hexoses (except Fru-1 ,6-P2) 
in their physiological concentration range [25, 26] will not be able to activate pyruvate 
kinase. These findings reduce the number of possible regulatory legends to a great 
extent. 
The extrapolation of in vitro data to the in vivo regulation of an enzyme needs 
some assumptions. However, it has been shown for the L-type frcm yeast, which is 
very similar to the L-type frcm rat liver, that its prcpcrties in situ are comparable to 
data obtained in vitro [32, 33]. For reason that the L-type pyruvate kinase is inactive 
in the presence of physiological concentrations of P-enolpyruvate, MgATP and 
8u 
alanine it seems reasonable to conclude that in the liver cell the enzymatic activity 
will be dependent upon the Fru-1,6-P2 concentration. However, as a consequence of 
the high affinity for Fru-1,6-?2 , the enzyme will be active even in the presence ot the 
lowest reported Fru-1 ,6-P2 concentration for liver. For this reason Sols and Marco [27] 
proposed that under fasting conditions the free Fru-l,6-P2 concentration in liver will 
be lower than 5 ,uM due to binding to aldolase. To our opinion two other additional 
possibilities exist: 
(A) A change in the enzyme itself can influence its affinity for Fru-1,6-?2 as 
is shown in Fig. 2 and cf. (13] and (16]. Since feeding influences the GSH/GSSG 
ratio in liver (10 under feeding and 4 under fasting conditions; unpublished), the 
enzyme was isolated in the presence of the various ratio's cf GSH and GSSG. How-
ever, the afilnity for Fru-1,6-P2 was found to be equal to the anJnity obtained for the 
enzyme isolated in the presence of 5 mM GSH alone. Further investigations are 
therefore required to see if such an enzyme mcdifkation can occur within.the cell. 
(B) This possibility is based on the heterogeneity eft he liver. 35% of the liver 
cells is of non-parench:ymal origin. These cells cont1 ibute to about I 0% of the liver 
mass [34]. Under glycolytic conditions it is reasonable to assume that Fru-1,6-P2 is 
equally divided between the dilfercm cell types. The Fru-1 ,6-?2 concentration under 
this conditicn is 30 ~M, in which the non-parenchymal cells will contribute 3 nmoles/g 
and the parenchymal cells 27 nmclesjg. Under fasting ccnditicns, gluconeogenesis is 
introduced in the parenchymal cells and not in the non-parenchymal cells [2, 3]. The 
Fru-1,6-P2 concentration under these conditions is 5 pM of which 3 nmclesjg are 
located in the non-parenchymai cells and the other 2 nmolesjg are contributed by the 
parenchymal cells. Since these cells occupy 90 ~:) of the liver mass, the Fru-1,6-P2 
concentration in these cells will be 2.2 ,uM. How much the above mentioned three 
possibilities mutually contribute to the overall regulation of pyruvate kinase by 
Fru-1,6-P2, cannot be said and deserve more experimentation in which isolated 
parenchymal cells may be a useful object. 
The use of phosphorylated hexoses as a probe for the conformation of the 
enzyme makes it clear that the two-state model of Monod <t .1. (35] cannot explain 
our results with the phosphorylated hexoses. From the different behaviour of the 
enzyme towards the phosphorylated hexoses in the presence of A TP or alanine we 
can conclude that these inhibitors induce a different conformation. The different 
behaviour towards modification suggests that these difTerent conformations are the 
consequence of binding at different allosteric centers. Recently Rozengurt et al. (36] 
showed that K + and Fru-1,6-?2 introduce diftercnt conformation states rather than 
a unique R state as predicted by the model of Monod et al. [35]. Our results obtained 
in the presence of MgA TP and alanine show that these inhibitors introduce a different 
T conformation and suggest that sequential conformation changes [28] are involved 
in the allosteric transitions of the enzyme. 
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SUMMARY 
r. The influence of pH and amino acids on the activity of pyruvate kinase 
(ATP: pyruvate phosphotransferase, EC 2.J.I.40) from leucocytes were studied. 
2. The data can be explained by the model of Monad, Wyman and Changeux. 
It is proposed that this model is also valid for the other various types of pyruvate 
kinase. 
INTRODUCTION 
It is generally accepted that the mammalian glycolytic enzyme pyruvate kinase 
(ATP: pyruvate phosphotransferase, EC 2.J.I.40) exists in two different forms1: 
L(liver) type and M(muscle) type. L-type pyruvate kinase is present in liver, ery-
throcytes and kidney2 and the enzymatic activity of this form is allosterically mo-
dulated by phosphoenolpyruvate (PEP), K+, Fru-r,6-P2, Glc-r,6-P2, phosphorylated 
hexoses, ATP and alanine3- 7. TheM-type is present in muscle, brain, heart, liver, 
kidney and leucocytes2• The M-type was called a non-allosteric enzyme as could be 
concluded from the Michaelis-Menten kinetics. From the differences in kinetic be-
haviour between the M- and L-type it was concluded that the metabolic changes in 
the cell affect the M-type pyruvate kinase less than the L-type. Recently Jimenez 
de Asua et ai.' showed that the M-types from liver and muscle can be inhibited by 
amino acids. From these inhibition studies they concluded that the M-type pyruvate 
kinase exists at least in two different forms. It was subsequently discovered by Sols 
(personal communication) that the glycolytic intermediate Fru-r,6-P2 is able to 
reverse the inhibition of the liver M-type by alanine. 
Since the M-type of pyruvate kinase is found only in Kupffer cells9 ' 10 and the 
M-type occurs also in the leucocytes2, we intended to investigate more closely the 
kinetic behaviour of the leucocyte enzyme. This is of special interest in the question 
as to what extent the leucocyte enzymes are related to the Kupffer cell enzymes, in 
connection with the use of leucocyte enzymes in metabolic liver disease. 
Abbreviation: PEP, phosphoenolpyruvate. 
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MATERIALS AND METHODS 
Leucocytes were isolated according to the method described by Wyss et al. 11• 
Finally, the cells were sonicated for I min at zr kHz, and centrifuged for ro min 
at ro ooo X gmax· In the supernatant, pyruvate kinase activity was assayed by fol-
lowing the decrease in absorbance at 340 nm in the coupled reaction with lactate 
dehydrogenase at room temperature, according to the method of Valentine and 
Tanaka12. The triethanol-HCl buffer (o-4 M, pH 7·5) was replaced by Tris-HCl buffer 
(o.zs M, pH 7·5 or 8.5 as indicated in the figures). For the assay at pH s.g, a o.r M 
Tris-maleate buffer was used. 
ADP, PEP, NADH and Fru-r,6-P2 were obtained from Boehringer (Mann-
heim, Germany). L-Alanine was obtained from Merck (Darmstadt, Germany). L-
Proline, L-tryptophan, L-phenylalanine, L-glutamate, DL-valine and L-threonine were 
obtained from British Drug Houses Ltd. All other reagents were of analytical grade 
purity. 
RESULTS 
Fig. I shows the dependence of the leucocyte pyruvate kinase activity on the 
PEP concentration at an ADP concentration of 2 mM and pH 7·5 in various con-
ditions. The activity in the absence of alanine shows,. in agreement with Campos 
et al.'3, normal Michaelis-Menten kinetics at this pH. From the Hill plot (insert Fig. 
r) an n value of I. I can be calculated, suggesting no cooperative interaction between 
0.200 
0 ~o~o",----~,~.s~----~,~o================~,o 
[PEP]mM 
Fig. I. LlA ;,'s [PEP] plot of M-type leucocyte pyruvate kinase at pH 7·5 with [ADP] = 2 ml\'I 
in various conditions. D-0, control;~-@!;, with r ml\1 alanine; and 0-0, with r mM alanine 
and 0.5 mM Fru-r,6-P2• Added protein, 8411g. 
the binding sites of PEP, at least under these conditions. In the presence of alanine 
(r rnM) a curve is obtained which is slightly sigmoidal and has the same V as in the 
absence of alanine. Under these conditions a Hill coefficient of I. 7 can be calculated. 
However, addition of Fru-r,6-P2 (o.s mM) converts the sigmoidal curve into a hyper-
bolic one (n = r.r). From this plot it can be concluded that Fru-r,6-P2 overcomes 
the alanine inhibition, which is accompanied by a loss of the cooperative interaction 
between the PEP binding sites. These properties resemble those of the L-type pyru-
vate kinase. Therefore we investigated the influence of pH, since pH affects the al-
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losteric properties of the L-type pyruvate kinase. In Fig. 2, leucocyte pyruvate kinase 
activity versus PEP concentration at an ADP concentration of 2 mM and pH 8.5 
is plotted. With the normal activity curve no significant cooperativity is found (n = 
r.2). In the presence of a-lanine (r mM) ann value of r.8 is obtained, whereas the K 0 .5 
for PEP is increased from 0.2 mM at pH 7.5 to 0.75 mM at this pH. Fru-I,6-P2 
( 0.5 mM) is still able to overcome the alanine inhibition and lowers the n value from 
r.S to o.g. At pH 5.9 no inhibition of alanine (I mM) could be observed (not shown) 
and the K 0.5 for PEP in the presence or absence of alanine (I mM) is 0.05 mM. The 
same value is obtained when alanine (I mM) plus Fm-I,6-P2 (0.5 mM) are present. 
005 
' 109"v,.v 
0 
0 0
_, --·-a·,~ ----,;:,o:--:--'=::::;;,s;====,:;o::::::=::c 
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Fig. 2. LIA vs [PEP] plot of M-type leucocyte pyruvate kinase at pH 8.5 with [ADP] = 2 mr.-1 in 
various conditions. D-0, control; 8-\1, with r mM alanine; and 0-0, with r mM alanine and 
0.5 mM Fru-r,6-P2• Added protein, 6o flg. 
Fig. 3 shows. the influence of the alanine concentration at 0.5 mM PEP and 
ADP concentration of z m:\1 at' pH 7·5 on the pyruvate kinase activity before and 
after addition of 0.5 ml\I Fru-r,6-P2. The curve obtained in the absence of Fru-1,6-P 2 
is sigmoidal. Addition of ·Fru-r,6-P2 overcomes the alanine inhibition, even at high 
concentrations of alanine (5-IO rnM). 
It is known that alanine does not inhibit the muscle M-type pyruvate kinase, 
but that phenylalanine inhibits this enzyme8 • Fig. 4 shows the influence of phenyl-
alanine on the leucocyte pyruvate kinase in the absence and presence of Fru-r,6-P2. 
"/o Ocl1V1fy 
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Fig. 3· The influence of alanine on the activity of M-type leucocyte pyruvate kinase at [PEP] = 
o.s mM, [ADP] = z mM and at pH 7-5- 0-0, control; and ----·· the addition of Fru-r,6-P2 (o.smM). 
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Fig. 4· The influence of phenylalanine on the activity of M-type leucocyte pyruvate kinase at 
[PEP] = o.r mM, [ADP] = 2 mM and at pH 7·5· 0-0, control; and 8-0, the addition of 
Fru-r,6-P2 (0.5 mM). 
In the absence of Fru-r,6-P2 a sigmoidal curve is obtained, while Fru-r,6-P2 can only 
overcome this inhibition completely up to 2 mM phenylalanine. At high phenyl-
alanine concentration this restoration of activity is impaired. 
In Table I the influences of various amino acids on the activity of the leucocyte 
pyruvate kinase are summarized. When these results are compared with the effects 
of amino acids on the activity of the liver and muscle M-type8, it follows that the M-
type of leucocytes is very similar to the liver M-type. With valine, threonine and 
proline, added in a final concentration of I mM, no inhibition is found and addition 
of Fru-r,6-P2 has no effect.-Increasing this concentration to 5 mM results in a striking 
inhibition, suggesting that these compounds act also as allosteric inhibitors, while 
the restoration of activity by Fru-r,6-P2 is dependent on the amino acid used. With 
valine, proline and alanine the activity is fully restored, whereas with phenylalanine, 
threonine and tryptophan the activity is only restored to the extent of Sr-86%. 
TABLE I 
THE INFLUENCE OF VARIOUS AMINO ACIDS ON THE LEUCOCYTE M-TYPE PYRUVATE KINASE AT [PEP] 
= O.I mM, [ADPJ = 2 mM and pH 7·5 IN THE ABSENCE AND PRESENCE OF Fru-I,6-P2 
(o.5 mM). 
Addition 
L-Phenylalanine 
L-V aline 
L-Proline 
L-Tryptophan 
L-Glutamate 
L-Alanine 
L-Threonine 
------·· 
Concentration % of activity 
(mM) 
-Fru-r,6-P2 +Fru-r,6-P2 
1 57 IOI 
5 2 8r 
roo I05 
5 48 97 
101 I01 
5 4' 100 
93 97 
5 34 86 
I07 I02 
5 93 92 
38 102 
5 20 99 
roo 98 
5 65 86 
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DISCUSSION 
The similarity in inhibition by amino acids of the activity of the M-type of 
leucocytes and the M-type of liver pyruvate kinase makes it very likely that these 
types are quite similar. Moreover, Fru-I,6-P2 is able to overcome the amino acid 
inhibition of the M-type of leucocytes, as has also been shown for the liver M-type 
pyruvate kinase (A. Sols, personal communication). We have shown previously9 
that the M-type of liver is confined to the Kupffer cells. The similarities described 
here between leucocyte and Kupffer cell pyruvate kinase support the common reti-
cula endothelial origin of these cell types, as suggested earlier (cj. ref. 14). 
From the presented kinetic data it must be concluded that theM-type ofleuco-
cytes can show cooperative interaction between the binding sites for PEP. The curves 
obtained in the presence of the allosteric inhibitor alanine are sigmoidal and are very 
similar to the normal activity curves obtained with the L-types of liver5•15 or ery-
throcytes16. At pH 5-9 the latter enzymes obey Michaelis--Menten kinetics with re-
spect to PEP and cannot be activated by Fru-r,6-P2 . At pH 7·5 these enzymes have 
a sigmoidal response to PEP and this response is transformed into a normal hyper-
bolic relationship by the addition of Fru-r,6-Pl5 •16 . At pH 8.5 these effects are more 
pronounced8 . The results obtained with the M-type of leucocytes are quite similar, 
but the presence of alanine (r mM) is required. The inhibition curves of alanine and 
of phenylalanine show that these compounds act as allosteric inhibitors. When 
s-ro mM phenylalanine is present, Fru-r,6-P2 is not able to overcome the inhibition, 
which makes it clear that phenylalanine and Fru-r,6-P2 act as allosteric antagonists. 
These properties are in complete agreement with the two-state R~T model of Monod 
et al.l7 , applied originally to the allosteric L-type liver pyruvate- kinase by Rozengurt 
et a/.15 and extended to human erythrocyte L-type pyruvate kinase by Staal d al.16 . 
For the leucocyte enzyme we can state that this enzyme is normally in the R 
state, while alanine and phenylalanine are able to convert this R form into the T 
form. The effect of Fru-r,6-P2 can be explained by a simple reconversion of the T 
state to the R state. It is likely that this model is also valid for the liver M-type pyru-
vate kinase, whereas the allosteric inhibition by phenylalanine on the activity of 
muscle M-type pyruvate kinase18 indicates that this model may even be extended 
to the muscle M-type pyruvate kinase. Probably, the differences in kinetic behavi-
our of the various isoenzymes of pyruvate kinase are the result of a different allosteric 
constant (L). This L value is different from zero for the various L-types and zero for 
the various M-types, at least at physiological pH and in the absence of modifiers. It 
is likely that this difference in L value is the consequence of structural differences be-
tween the various pyruvate kinase isoenzymes. 
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SUMMARY 
r. The influence of the pH on the activity of the M-type pyruvate kinase 
(ATP:pyruvate phosphotransferase, EC z.J.L40) from rat liver has been studied. 
The K 0 _5 for the substrate phosphoenolpyruvate was pH dependent and above 
pH 7.25 sigmoidal curves have been obtained. Fructose-1,6-diphosphate was able 
to convert these curves into a hyperbolic relationship. 
2. It was found that alanine acts as an allosteric inhibitor. The inhibition 
could be fully abolished by the addition of fructose-r,6-diphosphate. The alanine-
inhibition is dependent on the pH and on the phosphoenolpyruvate concentration. 
J. It is concluded that most of the properties can be explained by the model of 
Monad, Wyman and Changeux. 
INTRODUCTION 
It is generally accepted that the mammalian glycolytic enzyme pyruvate kinase 
(ATP:pyruvate phosphotransferase, EC 2.J.L40) exists in two different forms1: 
L(liver) type and M(muscle) type. The L-type pyruvate kinase is present in liver, 
erythrocytes and kidney2 and the enzymatic activity of this f~rm is allosterically 
modulated by phosphoenolpyruvate (PEP), K +, fructose- r ,6-diphosphate (Fru-r ,6-P 2), 
glucose-r,6-diphosphate, phosphorylated hexoses, ATP and alanine3- 7. The M-type 
is present in muscle, brain, heart, liver, kidney and leucocytes2•8• The M-type was 
called a non-allosteric enzyme, as could be concluded from the Michaelis-Menten 
kinetics. Recently Jim<enez de Asua et a/.9 showed that the M-types from liver and 
muscle can be inhibited by amino acids. From these inhibition studies they concluded 
that there are at least two different forms of M-type pyruvate kinase. From our 
studies with M-type pyruvate kinase from leucocytes8 it was concluded that this 
Abbreviations: PEP, phosphoenolpyruvate; Fru-r,6-P2 , fructose-x,6-diphosphate. 
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enzyme show~ cooperative interaction towards PEP in the presence of the inhibitors 
alanine and phen):lalanine, Fru- I ,6~P 2. completely reversed this inhibition and 
normal :\Iichaelis-:\Ienten kinetics were obtained. On the basis of the similarity in 
inhibition by amino acids oft he :\'1-ty.'pe pyruvate kinase ofleucocytes and theM-type 
of liver, it was suggested that these .JI-type:; are quite similar. However Jim{·nez de 
:\sUa ct alY \ven· not able to show cooperative interaction between the PEP binding 
sites in the presence of amino acids. Therefore, we studied the nature of the amino 
acid inhibition of this enzyme at different pfi: values, especially in connection with 
the earlier propo . .;ed R ~ T modt>l for the !\{-type pyruvate kinase8. 
For co:nparisr)n with the properties of the L-type pyruvate kinase from rat 
liver, we also isolated L-type by (:--JH 4).~S04 precipitation of the cyto:-)ol between 20 
and 45 (~() saturation. The 1\f-type, on the other hand, is isolated in the 55~70°;~ 
(~'JH4 )2.S04 fraction. The properties obtained with the L-type were found to be similar 
to the results obtained by Rozt>ngurt ct a/. 10 (compare also Van Berkel et a/. 11 ). This 
makes it possible to compare our results obtained with tlte "1-type with the properties 
of the L-tyve described b~' Hozengurt et al.w. 
YIATERI.'\LS AI\ P :V!ETHOIJS 
Type L pyruvate kinase was isolated from rat liver according to the isolation 
procedure descrilwd earlier5. Type ~'1 pyruvate kinase was isolated hy the method 
of-Passeron d a/. 12 , except that during this procedure r m:\'1 mercaptoethanol was 
omitted and the final (NH 4L."!S04 precipitation (between 55 and 70°/0 ) was dissolved 
in 0.25 l\1 Tris-·HCI of pH 7.25, 7·5, 7·75, 8.o or .S.5, as indicated in the legends. The 
purification was about ro to 12-fnld. For the assay at pH 5·9 or 6.5 the enzyme was 
dissolved in o.r-1\I Tris--maleate buffer of the corresponding pH. 
Pyruvate kinase was assayed by following the decrease in absorbance at J.fO nm 
in the-nmpled· reaction with lactate dehydrogenase at room temperature according 
to \'alentine and Tanaka13. The triethanol -HCJ buffer (o . .f :\1, pH 7.5) was replan•d 
by Tris--HCl buffer (0.25 :\1, pH 7.25, 7.5, 7-75,-H.o or 8.5, as indicated in the figures). 
For the· a<say at pH S·<J and ().5 a o.I :\I Tris--maleate buffer was used. 
ADP, ATP, PEP, ~ADH, Fru-I,6~P2 and oxidi?,ed glutathione were obtained 
from Boehringer (~fannheim, Gt'rmany). L-Alanine was obtained from J.lerck (Darm-
stadt, German_\·). Reduced glutathione. \\·as obtained from Sigma Chemical Co. All 
other reagent:-; were of analytical grade purit~·. 
RESULTS 
Fig. I show:-. the dependence of the liver M-type pyruvate kinase on the PEP 
c,o~t-:entration at an ADP concentration of 2 mJ!I at pH 7·5 and pH K.o before and 
aJ;~~.~·~.the addition of Fru-I,6-P2 • The activit~· at pH 7·5 shows only a slight sigmoidal 
response_ .. on increasing the PEP concentration (n .,.-::: 1.3), suggesting that the co-
operative in-teraction behveen the PEP binding sites at this pH, at least under these 
conditions, is very slight. \Vith the addition of Fru-r,b-1-"\:J we only find a significant 
increase of the activity at very low PEP concentrations (up to 0.05 mM). Fru-r,6-P~ 
lowers the n value, calculated from tlw Hill plot (insert Fig. r), from 1.3 to r.o. At 
pH R.o the relation betweE-n thP activity and the PEP concentration is clearly 
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Fig. 1. M-typc pyruvate kinase activity vs PEP concentration at pH 7·5 and pH S.o with 2 mM 
ADP. e-e, control; •-•, with 0.5 ml\1 Fru-1,6-P2 • The inserts are the Hill plots of the values 
obtained. The calculated Hill coefficients (n) are indicated. 
sigmoidaL Then value is raised from 1.3 at pH 7-5 till I.J at pH 8.o. Also the K 0_5 
value for PEP has markedly increased from o.o6 mM at pH 7-5 to 0.14 mM at pH 8.0. 
At this pH Fru-r,6-P2 markedly stimulates the enzymatic activity at low PEP 
concentrations and lowers the n value ton = I.I, which allows the conclusion that 
TABLE I 
EFFECT OF pH ON THE PEP SATURATION CURVE OF THEM-TYPE PYRUVATE KINASE FROM RAT LIVER 
i\.ssay conditions as indicated in the legend to Fig. r. nH signifies Hill coefficient. 
pH K 0 . 5 (mM) nn 
5-9 o.os I. I 3 
fl.j 0.06 LI4 
7-25 0.07 1.13 
7-5 0.06 1.28 
7-75 O.Il LJS 
S.o o.q I.6g 
S.s 0.14 1.73 
IJ4 
3~ 20 
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Fig. 2. M-type pyruvate kinase activity vs PEP concentration at pH 5-9 and pH 7-5 with z mM 
ADP. ct--8, r mM alanine present; 11-11, both 1 mM alanine and 0.5 mM Fru-r,6-P2 present. 
The inserts are the Hill plots of the values obtained. The calculated Hill coefficients (n) are in-
dicated. 
the decrease in the K0 .5 value is accompanied by a loss of cooperative interaction 
between the PEP binding sites. Since alterations in the pH may play a regulatory 
role in vivo, we investigated the effect of the pH on the allosteric behaviour of the 
enzyme more closely. Table I shows that no cooperativity is observed when the pH 
is equal to or less than ].25. However, when the pH is raised from 7.25 to 8.o the 
cooperativity increases, and this is accompanied by an increase in the K 0.5 value. 
By plotting the pK0 .5 against the pH, according to Dixon and Webb14, a pKa value 
for the enzyme of about 7·5 is calculated. Similar calculations for the L-type pyruvate 
kinase from rat liver lead to a pKa value of 6.9 (ref. ro). According to Wieker and 
Hess15 this method of Dixon and Webb14 can lead to erroneous results with allosteric 
enzymes, if the dissociation constants are not sufficiently separated from each other. 
However, this objection is not valid in this case, because both with L- and M-type 
only one pKa value is found. Therefore, we can compare the pKa value found for the 
M-type with the value found by Rozenggrt et al-" for the L-type. 
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It has been reported that the alanine inhibition of the M-type pyruvate kinase 
from rat liver was pH independent9 • Since the alanine inhibition of the M-type from 
leucocytes was found to be pH dependent•, we investigated the influence of pH on the 
alanine inhibition of our preparation of the M-type from liver. Fig. 2 shows the 
activity as a function of the PEP concentration in the presence of I roM alanine 
before and after the addition of Frn-1,6-P, at pH 5-9 and pH 7·5· At pH 5·9 in the 
presence of I mM alanine the K 0 .5 for PEP has hardly increased and the n value ob-
tained is 1.37. With the addition of Frn-1,6-P2 the n value has decreased to I.II, 
suggesting that the small degree of cooperativity is lost. At pH 7·5 the alanine inhi-
bition is more pronounced and alanine (r roM) increases the K 0 .5 value for PEP from 
0.06 mM to 0.70 mM. Also at this pH Frn-1,6-P2 counteracts the cooperativity be-
tween the PEP binding sites. At low PEP concentration (up to 0.25 mM) in the 
presence of I mM alanine a n value of o. 78 is found, which might indicate negative 
cooperativity16 . This n value < r.o at low PEP concentration was quite repro-
ducible. With four different preparations at pH 7·5 we found n values between 0.7 
and 0.8. At higher concentrations of PEP the n value is about 2.4, which indicates a 
positive cooperativity. Table II summarizes the K 0 . 5 and n values for PEP in the 
TABLE II 
EFFECT OF pH ON THE PEP SATURATION CURVE OF THEM-TYPE PYRUVATE KINASE FROM RAT LIVER 
I:-< THE PRESENCE OF I mM ALANINE 
Assay conditions as indicated in the legend to Fig. 2. nHI signifies Hill coefficient at low PEP 
concentrations. nHu signifies Hill coefficient at higher PEP concentrations (cf. Fig. 2). 
pH K 0 . 5 {mM) nnr nHn 
5-9 O.OJ 1.37 
6.j O.Ij o.8g I.8g 
7· 25 0.]2 o.8o 2.j6 
7·5 0.68 0.78 2.36 
7·75 I.6j 0 ·55 2.45 
S.o 1.70 0.53 2.60 
8.5 1.76 O.jg 2.j8 
presence of I roM alanine at different pH values. From this table it can be concluded 
that also in the presence of I mM alanine the K 0 .5 for PEP rapidly increases between 
pH 7-5 and pH 8.o, suggesting that the same ionizing group as obtained in the 
absence of I mM alanine influences the activity. A further increase in pH does not 
alter the K 0 .5 value, as is also the case when alanine is absent {cf. Table 1). 
Fig. 3 shows the influence of alanine at 0.1 mM PEP at pH 7-5 and pH 5·9· 
At pH 7·5 the shape of the alanine inhibition curve is hyperbolic, which is in agree-
ment with Jimenez de AsUa et al. 9• At alanine concentrations up to 2.5 mM, Fru-
I,6-P2 is able to restore the activity completely. At higher concentrations of alanine 
the restoration of activity is incomplete. When the reaction is carried out at pH S-9. 
the plot obtained is sigmoidal. When the n value is measured according to the method 
of Jensen and Nester17, a value of 2.01 is obtained. At this pH, the activity is com-
pletely restored with the addition of Frn-r,6-P2. From this plot it can also be con-
cluded, that alanine inhibition is pH dependent, which is at variance with the con-
clusion reached by Jimenez de Asua et al.'. It appears that the pH dependence is 
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% pH 5.9 with Fru-1,6-P2 
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• 
pH 7.5 with Fru-1,6-P 
2 
100 • 
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pH 5.9 n=2.01 
40 
20 - pH 7.5 n-=1.20 
0 
0 2 3 4 5 10 [alanine J mM 
Fig. 3· The influence of alanine on the activity of liver M-type pyruvate kinase at 0.1 mM PEP 
2 mM ADP and pH 5-9 or 7·5· 0-0, reaction at pH 7.5; 11-11, reaction at pH 7-5 in the pre-
sence of 0.5 mlVI Fru-r,6-P2 ; 0-0, reaction at pH s.g; 8--8, reaction at pH 5·9 in the pre-
sence of 0.5 m::vi- Fru-r ,6-P 2 . The calculated Hill coefficients (n) are indicated. 
influenced by the concentration of alanine used. At 0.2 mM alanine and pH 7·5 an 
inhibition of 57% is found whereas 0.2 mM alanine is not inhibitory at all at pH 5·9· 
In Fig. 4 the alanine inhibition curve at I mM PEP is shown. It can be observed 
that the alanine inhibition curve at I mM PEP and pH 7·5 is sigmoidal. An value of 
2.35 is found. When we compare this with the n value of r.zo obtained at 0.1 miVI 
PEP, we can conclude that there is a antagonistic interaction between the PEP-and 
the alanine binding sites. At pH 5·9 and r mM PEP alanine does not inhibit the 
enzymatic activity up to concentrations of 5 mM. Only at 10 mM alanine a small 
% 
a<:tivity 
,\!110-. 
' 
pH 5.9 wi!-h Fru-1,6-P? G 
100 ~ . 
80 \ 
60 
40 
20 -
-----·o---'-pH....;7.;..s ___ "_c:.2.~3:_5 __ _ 
0 
0 3 4 5 10 [alanine J mM 
Fig. 4· The influence of alanine on the activity of liver M-type pyruvate kinase at r.o mM PEP, 
2 mM ADP and pH 5·9 or pH 7·5- 0-0, reaction at pH 7.5; li-B, reaction at pH 7·5 in the 
presence of 0.5 mM Fru-r,6-P2 ; 0-0, reaction at pH 5.9; e-e, reaction at pH 5·9 in the pre-
sence of 0.5 mM Fru-1,6-P 2• The calculated Hill coefficient (n) is indicated. 
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inhibition can be observed. Both at pH 7-5 and pH 5-9 the restoration of activity by 
the addition of Fru-r,6-P2 is complete. 
These results are in contrast with the results of Imamura et al.l8 , who found 
that with the highly purified enzyme there was no restoration of the activity when 
they added Fru-r,6-P2 to the alanine-inhibited enzyme. From their results they 
concluded that the mechanism of inhibition by alanine for the L- and M-type is 
different. However, with the freshly isolated M-type the effect of alanine on the 
pyruvate kinase activity is quite similar to the results described by Schaner et al.19 
for the L-type. Since ATP affects the L-type pyruvate kinase activity in the 
same way as alanine7 •19 , we also investigated the influence of pH on the ATP inhi-
bition with theM-type. Fig. 5 shows the action of ATP at a PEP concentration of 
o.r mM and this can be compared with Fig. 3· A comparison of both figures shows_ that 
% 
activity 
100 
80 
60 
40 
20 
0 2 3 4 5 10 [ATP] mM · 
Fig. 5· The influence of ATP on the activity of liver M-type pyruvate kinase at 0.1 mM PEP, 
2 mM ADP and pH 5·9 or pH 7·5· 0~0. reaction at pH 7.5; 1111~11!1, reaction at pH 7·5 in the 
presence of 0.5 mM Fru-1,6-P2• O~Q, reaction at pH 5.9; G---8, reaction at pH 5·9 in the pre-
sence of 0.5 mM Fru-r,6-P2• 
the mechanism of ATP inhibition differs from that of alanine. The A TP inhibition is 
slightly pH dependent and the restoration of activity by the addition of Fru-r,6-P2 
is only partial, especially at pH 5-9· 
Because Imamura et al.18 observed no restoration of activity with their purified 
M-type pyruvate kinase from rat liver when Fru-r,6-P2 was added to the alanine-
inhibited enzyme, we investigated some possibilities for these differences. As reported 
earlier11 , the L-type pyruvate kinase from rat liver can exist in two forms which can 
be reversibly interconverted by sulphydril reagents. Such an interconversion could 
also be important for the M-type. Therefore, the effect of oxidizing reagents on this 
M-type from liver was studied. By incubating the M-type at 4 'C overnight in the 
presence of 2.5 mM oxidized glutathione, an enzyme with the same V as the freshly 
prepared M-type was obtained. However, the K 0.'5 for PEP is raised and the alanine 
inhibition is not affected by the addition of Fru-r,6-P2 (Table III). In contrast to the 
results obtained with the L-type from rat liver11 , the oxidation of thiol groups is not 
reversible. Neither reduced glutathione, nor mercaptoethanol was able to convert 
this "oxidized" enzyme to the freshly prepared form. There is a possibility that our 
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TABLE III 
COMPARISON OF KINETIC PARAMETERS OF THE FRESHLY PREPARED-AND "oXIDIZED" M-TYPE 
PYRUVATE KINASE FROM RAT LIVER 
The assay is performed at pH 8.0; further conditions as indicated in the legend to Fig. I. 
Freshly prepared enzyme "Oxidized" enzyme 
Ku.5 for PEP (mM) 0.14 0.30 
Km for PEP (mM) in the presence of 
0.5 mM Fru-r,6-P2 o.o3 0.23 
K 0•5 for PEP (mM) in the presence of 
r roM alanine I. 7 
Reversal of alanine ( 1 mM) inhibition 
by Fru-r,6-P2 (o.5 mM) Complete None 
partially purified preparation of the M~type is also affected by the isolation procedure. 
At pH 8.0, however, it is possible to measure the K 0 .5 of the M~type for PEP in a 
crude li_Ver homogenate and a value of 0.15 mM has been obtained. This value agrees 
with the value of 0.14 mM obtained with the partially purified M~type, which suggests 
that our M-type preparation is identical with the enzyme present in the crude liver 
homogenate. 
DISCUSSION 
By comparing the inhibition of the pyruvate kinase activities of the M~type 
of leucocytes and the M~type of liver by amino acids it was concluded' that these 
M-types were similar. However, the data of Imamura et al.18 suggested t:Oat there 
were differences. They found that, in contrast to the leucocyte enzyme, Fru-r,6-P2 
\"-{aS not able to overcome the alanine inhibition. Moreover; Jim€nez de Aslia et al. 9 
were not able to ,qhow cooperative interaction between the binding sites for PEP in 
the presence of alanine and showed a hyperbolic inhibition curve by the amino acids 
alanine and phenylalanine. With the leucocyte enzyme, however, the alanine inhi-
bition was of an allosteric nature and alanine induced cooperative interactions be-
tween the PEP binding sites8• Moreover, the alanine inhibition was pH dependent, 
whereas for the liver M~type only a slight pH dependence has been reported'. 
From the presented kinetic data, obtained with the freshly prepared enzyme, 
it must be concluded that at the higher pH values the M~type of liver can show 
cooperative interaction between the binding sites for PEP. This interaction is 
abolished in the presence of the positive effector Fru-r,6-P2 . The presence of r mM 
alanine can raise the K 0 •5 value for PEP and also under these conditions Fru-r,6-P2 
transforms the obtained curve into a hyperbolic relationship towards PEP concen-
tration. It is clear that the allosteric properties are markedly influenced by the pH. 
At a pH lower than 7-5, hyperbolic curves are obtained; Fru~r,6~P2 does not affect 
the 2-ctivity. An increase in the pH to 8.o introduces cooperative interactions and the 
K 0 . 5 value for PEP increases markedly. Above pH 8.o a further increase in pH has 
rio further affect on the allosteric properties. These effects are qualitatively quite 
similar to the results obtained with the L~type. There are, however, quantitative 
differences: {r) The pKa, possibly associated with the cooperative interaction for 
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PEP, is about 6.g for the L-type, whereas for the M-type a value of about 7-5 can 
be calculated; (2) The Hill coefficient of the L-type increases from r.o to J.O, when 
the pH is raised from 5-9 to 8.35. The increase of the n value is accompanied by an 
increase in K 0_5 for PEP from 0.3 to 2.3 mM. The Hill coefficient of the M-type raises 
only till r. 7, which means that the homotropic cooperative interaction of PEP with 
M-type pyruvate kinase is lower than with L-type pyruvate kin_ase. Also the increase 
in K 0 .5 from the M-type for PEP varies only from o.o6 mM to o.r4 mM. This shows 
that the M-type has a higher affinity for PEP than the L-type. 
The influence of the pH on the alanine inhibition seems to be of the same nature 
as that found with the L-type". At pH 7-5 the inhibition is more pronounced than 
at pH 5·9· PEP is able to overcome the alanine inhibition and Fru-r,6-P2 acts as an 
allosteric antagonist. These properties are in complete agreement with the two-state 
R ""' T model of Monod et al. 20 applied originally to the allosteric L-type liver pyru-
vate kinase by Rozengurt et a/.10, which we have extended to the M-type pyruvate 
kinase by our earlier studies on the leucocyte enzyme8• There are, however, dis-
crepancies as is also the case with the L-type pyruvate kinase21•22• One of the main 
discrepancies is the effect of ATP on the M-type pyruvate kinase. As has been 
reported earlier'·" the ATP inhibition can be partly reversed by Mg2+. From our 
data we can also conclude that the ATP inhibition is different from the alanine 
inhibition, which can be an unique property for the M-type. The n values observed 
in the presence of alanine at low PEP concentrations are also difficult to interprete 
on the basis of the R ~ T model at this moment. n values lower than unity have been 
shown earlier with yeast pyruvate kinase by Haeckel et al. 21 , who observed n values 
of 0.7 at low ADP and K + concentrations. With the L-type from liver at low PEP 
concentra.:ions such values have also been found22• We cannot conclude at the 
moment, whether these low n values are a consequence of intramolecular interactions 
between the binding sites for PEP (cj. ref. r6) or of the existence of two intercon-
vertible forms of M-type pyruvate kinase, as has been suggested by Imamura et al.'8 • 
These two forms should then possess different affinities for alanine or PEP. However, 
we were not able to show such interconversions by thiol reagents, which inakes it 
likely that, if such fonns exist, the interconversion cannot be due to oxidation or 
reduction of the -SH groups. 
The fact that the allosteric nature has not been detected earlier except by 
Imamura et a/. 18, may be due to the fact that most authors23,24 test the enzymatic 
activity at about pH 7 ·4· Indeed, at this pH it is very difficult to detect the allosteric 
interaction, because Fru-r,6-P2 stimulates the enzyme only at very low PEP con-
centrations (less than 0.05 mM). Furthermore, high purification of the enzyme leads 
to a great loss of activity9 •18•23 and can lead to a modification of the enzyme. Some 
alteration of the thiol groups may be involved in this modification, as can be con-
cluded from the properties of the "oxidized" enzyme. Comparison of the M-types of 
liver and leucocytes leads to the conclusion that these M-types are very similar. 
However, some differences are obvious. We do not observe a clear allosteric behaviour 
towards the substrate PEP with the leucocyte enzyme and in the whole pH range 
from 5·9 to 8.5 a K 0 ,5 value of 0.05 mM has been observed. Higher concentrations 
of alanine are needed to inhibit the leucocyte enzyme to the same extent as the 
M-type from rat liver and the K 0 .5 value for PEP in the presence of I mM alanine at 
pH 7·5 is 0.2 mM for the leucocyte enzyme, whereas with the M-type from liver a 
r8o TH. J. C. VAN BERKEL et al. 
value of o.68 is obtained. It is likely that these differences are due to a different 
allosteric constant (L). 
The metabolic implication of the possibility to regulate the M-type pyruvate 
kinase is not obvious. In liver the M-type pyruvate kinase is located in the non-
parenchymal cells"·" and little is known about regulation in these cell types. An 
important common property between non-parenchymal cells from rat liver and 
leucocytes is the high rate of phagocytosis of both cell types. During phagocytosis 
carbohydrate metabolism is highly activated26 and allosteric stimulation of pyruvate 
kinase activity may be part of this activation process. 
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SUMMARY 
1. The influence of the free Mg2 + concentration on the kinetic parameters of 
M2-type pyruvate kinase (A TP: pyruvate phosphotransferase, EC 2.7.1.40) from rat 
liver, isolated in the presence of the physiological free Mg2+ concentration, is in· 
vestigated. 
2. At l mM Mgi,~, and pH 7.5 the affinity of the enzyme for the substrate 
phosphoenolpyruvate is decreased as compared to 10 mM Mgir~e• whereas the affinity 
for the second substrate ADP does not change. The decrease in affinity for phos-
phoenolpyruvate at low free Mg'+ concentrations appears to be the consequence of 
the presence of a low affinity form of the enzyme. 
3. It is shown that the ATP inhibition is mainly due to Mg2+ binding and that 
it is probably qot of physiological importance. 
4. The enzyme possesses a high affinity for Fru-1,6-P, (half maximal activation 
at l ,uM) which is decreased by the addition of alanine. The affinity of the enzyme for 
Fru-1,6-P, at 0.1 mM phosphoenolpyruvate is not influenced by the free Mg'+ con-
centration. In the presence of alanine the affinity for Fru-1,6-P, is increased by in-
creasing the phosphoenolpyruvate concentration. 
5. It is concluded that at physiological concentrations of alanine, Mg2 +, ADP 
and phosphoenolpyruvate the M2-type pyruvate kinase activity is mainly dependent 
upon the Fru-1,6-P, concentration. 
INTRODUCTION 
Recent data have shown that there are at least three non-interconvertible rat 
pyruvate kinases [1-3]. The L-type pyruvate kinase is present in liver, erythrocytes 
and kidney [I] and the enzymatic activity of this form is allosterically modulated by 
phosphoenolpyruvate, K +, fructose-1,6-diphosphate (Fru-1 ,6-P2), glucose -1 ,6-di-
phosphate (Gic-1,6-P2), phosphorylated hexoses, ATP and alanine [4--8]. The pre-
sence of this form of pyruvate kinase in a cell seems to be obligatory for gluconeogen-
esis. The Mrtype is present in muscle and brain [9] and possesses fewer regulatory 
properties. The third type of pyruvate kinase, called M,-type by Imamura and 
4e 
from the Hill plot (see insert Fig. l). The obtained Ko. 5 at 10 mM Mgl,~, is 0.16 mM 
while in previous experiments with 23 mM total Mg2 + a K 0 .5 value for P-enolpyruvate 
of 0.14mMwasobtained.Loweringofthe Mgfr!e concentration to I mM results in an 
increase of the K0 . 5 value for P-enolpyruvate to 0.34 mM while the Vis only slightly 
lowered. A further decrease in the Mgir~e concentration to 0.5 mM potentiates these 
effects and the K0 . 5 value for P-enolpyruvate becomes 0.45 mM. From the Hill plot 
(insert Fig. I) it can be observed that the breakpoints of the lines drop to lower log 
vjV-v values when the free Mg2 + concentration is lowered. This indicates that at the 
lower free Mg2 + concentration the relative contribution of the enzymatic activity with 
the lower n value to the overall activity is Jess. For reason that the lowering of the free 
MgH concentration is accompanied by a lowering of the MgADP- concentration it 
might be possible that the MgADP- concentration is responsible for the reported 
effects. Therefore, we increased the total ADP and total Mg2+ concentrations at 0.5 
mM free Mg2+ in such a way that the same MgADP- concentrations were present 
both with I and 10 mM free Mg'+. Although the V was raised, the K0 .5 for P-enol-
pyruvate in both cases was 0.45 mM (not shown) which indicates that the shift in the 
K0 .5 for P~enolpyruvate is indeed due to the decrease in the Mg~r~c concentration. 
Furthermore we plotted the values obtained in Fig. I as a function of the free P-
enolpyruvate and MgPEP concentrations (not shown). When the activity is plotted 
against the MgPEP concentration the curves are abnormal, especially in the presence 
ofFru-1,6-P,, which makes it unlikely that MgPEP is the true substrate. Activity plots 
against the free P-enolpyruvate concentration yields curves qualitatively the same to 
those in Fig. 1, although the differences in K0 .5 for free P-enolpyruvate at different 
Mgfr~e concentrations are larger. However, to allow comparison with data reported in 
literature, we decided to plot the activity against the total P-enolpyruvate concentra-
tion. 
In Fig. 2 is plotted the pyruvate kinase activity under the same circumstances 
as for Fig. I except that 0.5 mM Fru-1,6-P, is present. This figure shows that in the 
presence of Fru-1,6-P2 the curves have a biphasic pattern. To investigate this pheno-
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Fig. 2. Influence of the Mgir~c concentration on the P-eno!pyruvate saturation curve of the M2-type 
pyruvate kinase at pH 8.0 in the presence of 0.5 mM fru-1,6-? 2• e--8, 10 mM Mgir~c; 11-11, 
1 mM Mgf,~c; .6.~.4, 0.5 mM Mgf,~~· 
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Fig. 3. The 1/v vs I /[PEP] plot of the My type pyruvate kinase activity at pH 8.0 tested in the absence 
and presence of Fru-1,6-P1 (0.5 mM) at different Mgf,!~ concentrations. 0-0. lO mM Mg~,";c 
present; e-e, 10 mM Mgf,!. and 0.5 mM Fru-1,6-P2 present; 0-0, 1 mM Mgf,!. present; 
a-a, I mM Mgf,!.and 0.5 mM Fru-1,6-P2 present; 6-6, 0.5 mM Mgt,!. present; A-A, 0.5 mM 
Mir,~. and 0.5 mM Fru-1,6-?2 present. 
men on more closely the 1/v vs !/[PEP] plot was L,ade (Fig. 3) from the values shown 
in Figs I and 2. In the presence of Fru-1,6-P, (0.5 mM) the ljv vs !/[PEP] curve has 
two components: a straight part at low P-enal pyruvate concentrations and a concave 
upward part at high P-enolpyruvate concentrations. This indicates that at low P-
enolpyruvate concentrations in the presence of Fru-1,6-P2 the enzyme follows 
Michaelis-Menten kinetics whereas the concave upward part is indicative for an 
allosteric response. By extrapolation of the straight part an apparent Km for the 
enzyme at low P-enolpyruvate concentrations of 0.05 mM can be calculated irrespec-
tive of the Mg:r~e concentration used. In the absence of Fru-1,6-P2 the upward con-
cave curves are characterized by two different n values (see Hill plot Fig. 1). This 
figure 3 shows clearly fuat only fue curve obtained at low P-enolpyruvate concentrations, 
and characterized by a low n value, is stimulated by Fru-!,6-P2• The latter addition 
converts tte upward concave curve into a straight line. 
It seems likely that these results reflect the presence of two forms of fue enzyme 
with dilkrent affinities for P-enolpyruvate. From results [13] reported earlier it was 
concluded that we could not discriminate between this possibility and the presence of 
negative cooperativity [13, 23]. The results obtained at different Mgfr~e concentrations. 
allow the conclusion that the Mgfr~e concentration influences the ratio between two 
different forms of the enzyme. The Hill plot (insert Fig. 1) shows that then values for 
the form active at low P-enolpyruvate concentrations decreases by lowering the 
Mgirte concentration. However, when the data are replotted by applying the V be-
longing to this form this decrease disappears and both at 1 and 0.5 mM Mgl,~. an 
value of 1.7 is obtained. This result indicates that the Mgfr!e concentration regulates 
the relative amounts of the two forms without influencing the allosteric behaviour of 
the form active at low P-enolpyruvate concentrations. 
Fig. 4 shows that the Mgfr~e concentration does not change the apparent Km 
for ADP. Both at 10 and I mM Mgf,~, the enzyme follows Michaelis-Menten kinetics 
with an apparent Km for ADP of 0.31 mM at 10 mM Mgi,~, and 0.33 mM at I mM 
Mgl,~.- Determination of the apparent Km values from the plot ljv vs 1/[MgADP] 
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Fig. 4. The 1/v vs 1/ADP plot of the Mrtype pyruvate kinase activity at pH 8.0 tested at 10 and I mM 
Mg:,!~ at different P-enolpyruvate concentrations. h.~lc,, 0.1 mM P-enolpyruvate; 0-0,0.25 mM 
P-enolpyruvate; 0~0, 0.5 mM P-enolpyruvate. The applied Mgi,~e concentrations are indicated 
in the figure. 
yields values of 0.30 and o. 27 mM, respectively. These values are in good agreement 
with the values reported earlier for M2-type from liver [24] and other tissues [3, 10, 14]. 
The afore-mentioned experiments were performed at pH 8.0 to exclude the 
presence of MgHADP and HADP2 -. At pH 7.5 the effect of the Mgf,~, concentration 
is qualitatively similar to that obtained at pH 8.0 (Table 1). At 10 mM Mgf,~, a slight 
sigmoidal response towards increasing P-enolpyruvatc concentrations is obtained 
with an value of 1.4 (not shown). At 1 mM Mg:r~e the response is a curve character-
ized by two n values of 1.1 and 2.2, while the same phenomenon occurs at 0.25 mM 
Mgir!.,. Also at this pH a replotting of the activities correlating with the lower n 
value, by applying the corresponding V, indicates that then value observed at 10 mM 
Mgir!e remains constant by lowering the Mgir~" concentration. Table I summarizes the 
K0 .5 values observed both in the absence and presence of Fru-1,6-P2 • It can be seen 
TABLE I 
EFFECT OF THE Mgi,,, CONCENTRATION ON THE Ko.> VALUE FOR P-ENOLPYRUVATE 
IN THE ABSENCE AND PRESENCE OF FRU-1,6-P, (0.5 mM) 
Assay conditions are indicated in the legends to Figs I and 2. The Ku.s in tile presence of Fru-1,6-Pz 
is calculated from the straight part of the 1/v~l/[PEP] curve (see Fig. 3). 
Free Mg2+ pH Ko.s (mM) Kn.s (mM) of the high affinity 
concentrations form measured in the 
presence of Fru-l,6-P2 
10 5.9 0.05 0.08 
I- 5.9 0.05 O.D7 
10 7.5 0.06 0.05 
I 7.5 0.28 0.06 
0.5 7.5 0.32 0.06 
0.25 7.5 0.35 0.06 
10 8.0 0.16 0.04 
I 8.0 0.34 0.04 
0.5 8.0 0.45 0.06 
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that at pH 5.9 the same K0 .5 value is obtained for land 10 mM Mgfr~c· At increasing 
pH values the effect of Mg2+ on the K0 . 5 is enforced. Further investigations however 
are needed to see if the effect of the pH on the affinity for P-enolpyruvate is due to a 
proton effect on the equilibrium of the two interconcertible forms or on the affinity of 
the low affinity form for ?-enol pyruvate. 
Although the observed activity of pyruvate kinase was linear in time during the 
assay it was stated [1, 10, 14] that slow transitions may be involved in the B""A 
equilibrium. Imamura and Tanaka[!) showed that pre-incubation with Fru-1,6-P, is 
able to change the biphasic ?-enol pyruvate dependency in the presence of Fru-1,6-P, 
into normal curves. We have shown earlier that by incubation of M 2-type pyruvate 
kinase with oxidized glutathione the ability of Fru-1,6-P, to relieve the alanine inhibi-
tion is lost [13] and higher K0 .5 values for P-enolpyruvate are obtained also at high 
MgZ+ concentrations. The same result is obtained after prolonged dialysis (3 h) of the 
enzyme in the absence of Mg2+. If the dialysed enzyme was incubated with Mg2 + 
(10 mM) + Fru-1,6-P, (0.5 M) for 30 min the original B form is restored. These data 
indicate that after a prolonged stay of the enzyme in the A form the conversion to the 
B form is a slow transition. Under these conditions also at high Mgfrtc concentrations 
the properties of the A form are obtained. 
Inhibitory action of alanine and ATP 
The inhibitory actions of alanine and A TP on the M 2-type pyruvate kinase 
have been noticed by many authors [1-3, 12-14, 18). Earlier we reported that alanine 
acts as an allosteric inhibitor [12, 13] and that the ATP inhibition differs from the 
amino acid inhibition. Imamura and Tanaka[!] reported that the ATP inhibition can 
be partly reversed by MgZ+. However, the nature of the ATP inhibition has not been 
studied in detail. For reason, that this inhibition can be of regulatory importance we 
studied the effect of ATP at low free Mg2 + concentrations. Furthermore we compared 
this effect with the inhibition by alanine. Fig. 5 shows the pyruvate kinase activity at 
increasing ?-enol pyruvate concentrations at I mM free Mg2+ in the presence of 2 mM 
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Fig. 5. M2-type pyruvate kinase activity vs ?-enol pyruvate concentration in the presence of 2 mM 
MgATP or 1 mM alanine at I mM Mg~r~e· /\····.:\, 2 mM MgATP present; A-.A. 2 mM MgATP 
and 0.5 mM Fru-1,6-?2 present; C'-·C\ I mM alanine; 8---8, I mM alanine and 0.5 mM Fru-
1,6-P2 present. 
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MgA TP or l mM alanine. In the presence of 2 mM MgATP the obtained K0 . 5 for 
P-enolpyruvate of 0.30 mM indicates that MgATP in the physological concentration 
does not change the affinity for P-enolpyruvate. This is in contrast to the effect of 
I mM alanine, which is a strong inhibitor under the applied conditions. Under both 
conditions, Fru-1,6-P2 (0.5 mM) is able to activate the enzyme and the obtained K0 •5 
values in the presence of Fru-1,6-P2 are simular whether ATP or alanine were present 
or not. 
To differentiate between the effect of ATP on the Mg2+ concentration and a 
direct inhibitory action on the enzyme we plotted in Fig. 6 the influence of ATP at 
different Mg2 + concentrations while the effect of increasing EDTA concentrations is 
plotted in the same figure. It can be seen that the inhibitory action of ATP is mainly 
%activity 
• 5 [m]•M ,, [mA]•M 
Fig. 6. The influence of A TP and EDT A on the activity of Mz-type pyruvate kinase at 0.5 mM 
PEP and pH 8.0. Open symbols are the added EDTA concentrations and the closed symbols the 
added ATP concentrations. 0-0, EDTA and I mM total MgH; 8-8, ATP and 1 mM total 
MgH; 0-0, EDTA and 5 mM total Mg"+; 11-11, ATP and 5 mM total MgH; 6-6, EDTA 
and 1 mM Mgf.~c; .A-.&, ATP and 1 mM Mgf.~.,. The 100% value is the activity at 0.5 mM P-
enolpyruvate and total I mM Mg~"'. For 1 mM Mgf,~e the 100% value is the activity at 0.5 mM P-
enolpyruvate and 1 mM Mg~r~c· 
the consequence of Mg2+ binding. At I mM total Mg2+ the inbibitory action of ATP 
can be completely explained by Mg2+ binding. EDTA used in the same concentration 
is under the applied condition even more inhibitory, which is probably due to its 
higher affinity for Mg2+, as compared with ATP. At 5 mM total Mg2+, inhibition,of 
the enzymatic activity is found at higher ATP concentrations while the data obtained 
at I mM Mgi;:, allow the conclusion that under this probably physiological condition 
[15] the A TP inhibition is very small and does not seem to be of regulatory importance. 
Affinity for Fru-1,6-P, and effect of other phosphorylated hexoses 
It is well-known that Fru-1,6-P2 activates the L-type pyruvate kinase from 
liver [8], erythrocytes [25] and yeast [26] in the micromolar range. For the M,-type 
pyruvate kinase from liver Carbonell eta!. [2] showed that 10 ,uM Fru-1,6-P, can 
overcome the alanine inhibition completely. Fig. 7 shows that the enzymatic form 
present at high Mg2+ concentrations shows a high affinity for Fru-1,6-P,. At 0.1 mM 
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Fig. 7. (A and B) The affinity of Mrtype pyruvate kinase for Fru-1,6-P2 in the absence and presence 
of alanine at: A, 0.1 mM P-enolpyruvate and B, 0.5 mM P-enolpyruvJte, pH H.O, and total Mg2+ 
concentration of 23 mM. 0-0, control; 0-C; 1 mM alanine present; 8~8, 5 mM alanine 
present. 
P-enolpyruvate full activation of the enzyme occurs already at 2 ,uM Fru-1,6-P,. Ad-
dition of I mM alanine lowers the affinity of the enzyme for Fru-1,6-P, and for half 
maximal activation a concentration of 13 ,uM Fru-I,6-P2 is needed. In the presence of 
5 mM alanine the aflinity for Fru-1,6-P, is even lower. Fig. 78 shows that at a higher 
P-enolpyruvate concentration (0.5 mM) the effect of alanine on the affinity of •the 
enzyme for Fru-1 ,6-P, is less. This effect of alanine and P-cnolpyruvatc on the affinity 
of M 2-type pyruvate kinase for Fru-1 ,6-P2 is very similar to that obtained with the 
L-type. This indicates that at high MgZ+ concentrations the experimental data can be 
explained by the earlier proposed R""T model [13] for M 2-type pyruvate kinase. 
Fig. 8 shows that a lowering of the Mg;i"' concentration to its physiological 
level of I mM does not change the affinity of the enzyme for Fru-1,6-P, at 0.1 mM 
P-enolpyruvate. The concentrations of Fru-1 ,6-P2 necessary for half maximal activa-
tion measured at high free Mg'+ (10 mM) and low free Mg2+ (I mM) are <comparable 
and this is also the case in the presence of 1 mM alanine. 
0 I 3 5 
" 
Fig. 8. The influence of the Mgf,!e concentration on the affinity of Mrtypc pyruvate kinase for Fru-
1,6-P2 in the absence and pr!.!sence of I mM alanine at pH 8.0 and 0.1 mM PEP. 0-0, 10 mM 
Mgf~e; 0-CJ, I mM Mgf~e; 11~-11, 10 mM Mgf,!e and I mM alani!le present; 41P- 8, 1 mM Mgf,!e 
and 1 mM alanine present. 
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TABLE I! 
EFFECT OF P, AND THE PHOSPHORYLATED HEXOSES ON THE ACTIVITY OF M,-
TYPE PYRUVATE KINASE 
Addition (0.5 mM) Relative activity Relative activity in the 
1%) presence of I mM alanine ( /~) 
None 28 12 
Glc-1-P 24 10 
Glc-6-P 28 12 
Glc-1,6-P2 61 14 
Gai-1-P 24 10 
Fru-1-P 27 15 
Fru-6-P 26 10 
Fru-I,6-P2 100 Ill 
P, (15 mM) 25 II 
*The 100~~ value is the activity at 0.1 mM P-enolpyruvatc in the presence of Fru-1,6-P2 
(0.5 mM) pH 8.0, and 1 mM Mgfr!c. 
The L-type pyruvate kinase from rat liver is not only activated by Fru-1,6-P2 
but also by Pi and phosphorylated hexoses [6, 7]. Since these latter compounds may 
also contribute to the "in vivo" regulation of the enzyme, we investigated the effect of 
Pi and phosphorylated hexoses on the M,-type (Table II). The only effective com-
pound besides Fru-1,6-?2 is Glc-1,6-P2• However, in the presence of alanine(! mM) (a 
physiological concentration for liver [33]) the ctfect of Glc-1,6-P, has disappeared, 
which allows the conclusion that these compounds besides Fru-1,6-P2 do not play a 
regulatory role in vivo. 
DISCUSSION 
The kinetic behaviour of M2-type pyruvate kinase of rat liver towards ?-enol-
pyruvate at low free Mg2+ concentrations can be completely explained by the pre-
sence of two interconvertible forms with different atnnities for the substrate P-enal-
pyruvate. Pogson [10] has shown with the pyruvate kinase from adipose tissue that 
the presence of EDT A in the extraction buffer modifies the enzyme, resulting in an 
enzyme with a completely different kinetic behaviour (called by Pogson Pyk-A). The 
B form of the enzyme, isolated in the absence of EDTA, shows. a high afilnity for P-
enolpyruvate (Km for P-enolpyruvate 0.06 mM) whereas with the A form a K,., of 
0.6 mM has been obtained. Recently Walker and Potter [14] have shown that rat 
liver cells, cultmed in the absence of glucose, contain this A form whereas in the 
presence of glucose the B form of M2-type pyruvate kinase was obtained. The data 
presented make it clear that isolation of M2-type pyruvate from normal liver in the 
absence of an unphysiological metal ion chelator yields an enzyme which exists in 
interconvertible forms at physiological Mg2 + concentrations. From the data presented 
(Fig. I) it can be concluded that the relative contribution of the two forms to the 
overall pyruvate kinase activity is regulated by the free Mg2 + concentration. The B 
form of M2-type pyruvate kinase which is pi1escnt at high Mg2+ concentrations shows 
a high affinity for P-enolpyruvate and it was shown earlier [13] that its properties can 
be explained on the basis of the R,.,T model of Monod eta!. [27]. In this model Fru-
lle 
1 ,6-P2 and P-enolpyruvate should favour the R state whereas alanine and the other 
inhibitory amino acids possess a higher afllnity for the T state. This paper shows that 
the B form of M;-tyre pyruvate kinase has a high allinity for Fru-1 ,6-P,. The effect of 
alanine on the allinity for Fru-l,6-P2 at different P-enolpyruvate concentrations (Figs 
7A and 7B) is in complete agreement with this earlier proposed R""T model of Monod 
et a!. [27]. Lowering of the Mgfr~c concentration introduces the A form, which has 
Jess atlinity for P-enolpyruvatc. The following scheme might help to explain the ob-
served kinetic data 
low Mg'+ 
B <"'··==='" A 
I high Mg2+ Fru-1,6-P, 
alanine 
R <====='" T 
Fru-!,6-P, 
PEP 
The A form of the enzyme is characterized by a lower affinity for the substrate P-
enal pyruvate while this form is not sensitive to Fru-I,6-P2• However, Fru-I,6-P2 can 
convert the A furm into the B form which is potentiated by high Mg2+ concentrations. 
A prolonged stay of tYe enzyme in the A form makes the A to B concersion more 
diJlkult and longer incubation times are needed. The occurrence of the intercon. 
vertible forms of M 2-type pyruvate kinase might also explain the variations in kinetic 
behaviour described in the Jiterature.lmamura and Tanaka [1] described for the high~ 
ly purified enzyme that Fru-1,6-P2 was not able to restore the alanine inhibition, a 
property which \l,.'e found after a prolonged incubation of the enzyme in the A form. 
Furthermore Costa et al. [2SJ recently described a new isoenzyme of pyruvate kinase 
in rat kidney cortex. The described kinetic properties of this enzyme are very similar 
to the properties of the A form of M 2·type pyruvate kinase. Since the authors purified 
this enzyme in the presence of 5 mM EDTA, it seems likely that the A form of M,-
type pyruvate kinase is responsible for their results. 
The given scheme also .::xplains the difference in behavicur of Fru-1,6-P2 and 
Mg2 +. Besides an eJTect of fru-1,6-P, on the A,-·B transitio~, this phosphorylated 
hexose is an allosteric activator of the B form, which explains the stimulation also at 
higher M g2 ..- concentrations. Recently a similar kind of enzyme regulation has been 
shown for phosphofructokinase [29, 30] and it will be interesting to see if this kind of 
regulation can also account for other enzym.es. 
Whether Mg1 + itself can act as a regulatory modulator of the M 2-type pyruvate 
kinase in liver seems not likely, as Veloso et al. [15] have shown that the free Mg2+ 
concentration in liver is nearly constant. From the kinetic data obtained in vitro it is 
rather speculative to draw condusions about the regulation of the enzyme in vivo. This 
remurk may accollllt for every enzyme, but is of special importance for the Ml·type 
from liver as this type is not uniformly localized in this tissue [31, 32]. However, ap-
plying the physiological concentrations of Mg2+, P-enolpyruvate and alanine (for 
these compounds there exists no large diJferences between various tissues [15, 33] the 
12e 
activity of the M 2-type pyruvate kinase would be low, unless the enzyme is activated by 
Fru-1,6-P2 (Figs 5 and 8). An distinction between the L-type pyruvate kinase and the 
M 2-type is the difference in ATP inhibition. With the L-type the iniluence of ATP is 
comparable with that of alanine [8], whereas with the M,-typc A TP inhibition under 
physiological conditions seems negliglible (Figs 5 and 6). Whether this difference in 
ATP inhibition is related with the regulation of gluconeogenesis, for which the pre-
sence of L-type seems obligatory, needs further investigation. 
The physiological meaning of the Be"' A equilibrium is not completely clear at 
the moment. As the Mgfr!e concentration for liver, brain and kidney [IS] is rather 
constant the BC"'A equilibrium will be dependent upon the Fru-1,6-P, concentration. 
This can explain the A form found in cells cultured in the absence of glucose. Under 
these conditions the Fru-1,6-P2 will be low. However, for liver and also for leucocytes 
this will imply that the equilibrium will be on the B side because tt~~se cells have easily 
available glucose present. Preliminary studies with M 2-type from different cell types 
indicate that this is also the case with M 2-type from thrombocytes, whereas for rat 
small intestine Lhl.! results are indivative for the fact that this enzyme occurs in vivo 
mainly in the A form (van Berkel, Th. J. C., de Jonge, H. R., Koster, J. F. and 
Hulsmann, W. C. unpublished). The M 2-type pyruvate kinase is widely distributed in 
glycolytic tissues [ 9] and the B;"'A equilibrium may provide an additional property 
of the enzyme to accommodate its properties to the specific requirements of the several 
tissues. 
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SUMMARY. Some kinetic properties of pyruvate kinase from rat small 
jntestine have been investigated. The relative insensitivity of the 
enzyme to ATP inhibition and the amino acid inhibition pattern 
allows the conclusion that intestinal pyruvate kinase belongs to 
the M2 -type. The pyruvate kinase activity as a function of the phosphoenol pyruvate concentration is characterized by two different 
n values. The activity correlating with the low n value is stimu-
lated by Fru-1,6-P2, whereas the activity at higher phosphoenol 
pyruvate concentrations is not influenced by this glycolytic inter-
mediate. These results, together with the partial relief of the 
amino acid inhibition by Fru-1,6-P 2 , show that two forms of the 
enzyme are present with different kinetic properties. The metabolic 
implication of the kinetic properties of pyruvate kinase for rat 
small intestine is discussed. 
Recent work has demonstrated that 
non-interconvertible types of pyruvate 
there are 
. 1-3 k~nase 
at least three 
(ATP: pyruvate 
phosphotransferase, EC 2.7.1.40) in rat tissues. The L-type is pre-
sent in liver, erythrocytes and kidney1 , the M1-type in muscle and 
brain2 , while the third type of pyruvate kinase, called M2-type by l Imamura et al. , is the most widely distributed type. The occur-
rence of M2-type pyruvate kinase has now been clearly shown in 
adipose tissue4 , kidney 2 ' 3 , leucocvtes 5 , liver1 ' 6 and hepatomas 1 ' 7 
Pogson4 has shown that this type can occur in two interconvertible 
forms, called Pyk-A and Pyk-B. Isolation of pyruvate kinase from 
adipose tissue in the absence of EDTA yields the high-affinity 
form (Pyk-B), while the low-affinity form (Pyk-A) is obtained by 
isolation in the presence of EDTA. Although this condition is 
rather unphysiological, we were able to show that in the liver at 
2+ 1 mM Mgf (a physiological condition for liver) these two forms 
ree 
of the M2-type are in equilibrium
8
. This indicates that the pre-
sence of these two forms may be of physiological importance. From 
incubation experiments it was also shown that a prolonged storage of 
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the enzyme in the low-affinity form makes its conversion to the 
high-affinity form more difficult8 . This makes it possible to con-
clude that when pyruvate kinase is isolated from a tissue under 
conditions which favour the B-form, that the detection of the A-
form indicates its presence in vivo. This paper shows that this 
is indeed the case for pyruvate kinase from rat small intestine. 
MATERIALS AND METHODS. Villous- and crypt cell suspensions ori-
ginating from the duodenal, ileal and jejunal parts of rat small 
intestine were harvested separately according to the high-fre-
quency vibration technique of Harrison and Webster9 in a medium 
containing 0.01 M Tris-HCl buffer (pH 7.5), 0.13 M NaCl and 5 mM 
EDTA. Cells and cell sheets were collected by centrifugation for 
15 sec at 800 9rnax· The cells were washed two times with the iso-
lation medium except that EDTA was omitted. Hornogenates were 
prepared in a medium containing 0.5 M Tris-HCl (pH 7.5) + 1 mM10 Mg c1 2 , by Polytran treatment as described earlier by de Jonge A more heterogeneous cell population originating from the whole 
length of the small intestine was prepared by gently scraping off 
the intestinal mucosa with a glass slide. Homogenization medium 
and technique were similar to those mentioned above. 6 Pyruvate kinase was assayed as described earlier . The assay 
mixture contained: 25 mM Tris HCl pH 7.5, 225 mM KCl, 1 mM ADP, 
0.12 mM NADH, 23 mM MgC1 2 , 0.1-0.2 mg lactate dehydrogenase and [PEP] as indicated in the legends to the figures. Duplicates were 
run with twice the amount of lactate dehydrogenase to exclude 
possible effects on this enzyme reaction. 
RESULTS 
In preliminary experiments we isolated villus- and crypt cells 
from the duodenal, ileal and jejunal parts of rat small intestine 
to investigate whether the isoenzyme patterns in the fast-dividing 
crypt and the non-proliferative villus cells would be similar and 
also whether differences along the length of the small intestine 
would occur. In these experiments (not shown) no significant 
differences in kinetic properties between the various celltypes 
were observed and the same activity dependence from the PEP con-
centration was found as shown in Fig. 1 for the intestinal scra-
pings isolated in the absence of EDTA. Scrapings obtained in the 
absence of EDTA followed by isolation of the cell fraction in the 
presence of 1 mM Mg 2+ results in a kinetic pattern characterized 
by two different n values (see Hill plot insert Fig. 1). Addition 
of Fru-1,6-P2 (0.5 mM) only stimulates the pyruvate kinase activi-
ty corresponding with then value of 1.2, whereas the activity at 
higher PEP concentration is not influenced. This result indicates 
Abbreviation: phosphoenol pyruvate PEP 
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Fig. 1 Rat small intestine pyruvate kinase activity as a function 
of the PEP concentration. 
0-0, activity in the absence of Fru-1,6-P2 ; 8-G, 0.5 mM Fru-1,6-P 2 present. The insert is the Hill plot of tfie values obtained. 
that a Fru-1,6-P2 sensitive and an insensitive form of pyruvate 
kinase may be detected in small intestine. To clarify the nature 
of this phenomenon we studied the effect of alanine and ATP on the 
pyruvate kinase activity. Fig. 2 shows that in the presence of 
1 mM alanine a strong inhibition of the pyruvate kinase activity 
is obtained while addition of Fru-1,6-P 2 to this inhibited enzyme 
does only relieve the alanine inhibition at low PEP concentrations. 
In comparison with 1 ~M alanine, ATP (2 mM) is a weak inhibitor 
of intestinal pyruvate kinase (Fig. 3). This relative insensitivi-
ty of the intestinal pyruvate kinase activity for ATP indicates 
that intestinal pyruvate kinase is of the M2-type. This conclu-
sion is further strenghtened by the amino acid inhibition pattern 
(TABLE I) which is similar to that of the M2-type from liver
11 
and 
leucocytes 5 and differs from those of the L- and M1-types
2 
Fig. 4 shows the influence of increasing alanine concentrations on 
the enzymatic activity. It can be seen that the presence of 0.5 
mM alanine results already in a 70% inhibition of the activity at 
1 rnM PEP, whereas the influence of increasing ATP concentrations 
(Fig. 5) illustrates that ATP is far less effective as inhibitor. 
Fru-1,6-P2 (0.5 mM) stimulates the alanine-inhibited enzyme at the 
lower PEP concentration only at higher alanine concentrations. 
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Fiq. 2 Rat small intestine pyruvate kinase activity as a function 
of the PEP concentration in the presence of alanine. 
0-0, control; D -0, 1 rnM alanine present; Ill- 8, l mM alanine + 0. 5 
mM Fru-1,6-P2 present. 
TABLE I 
THE INFLUENCE OF VARIOUS AMINO ACIDS ON INTESTINAL PYRUVATE KINASE 
% of activity 
Addition Concentration 
(mM) 
- Fru-1,6-P 2 + Fru-1,6-P (0.5 mM) 2 
L-Phenylalanine 1 18 39 
5 8 33 
L-Valine 1 57 68 
5 22 39 
L-Proline 1 75 77 
5 32 47 
L-Tryptophan 1 50 59 
5 20 32 
L-Glutamate l 98 91 
5 77 81 
L-Alanine 1 21 41 
5 12 38 
L-Threonine 1 48 59 
5 22 42 
L-Cystelne 1 24 42 
5 16 37 
L-Histidine 1 83 88 
5 62 72 
The 100% value is the activity at [PEP] = 1.0 mM. Further conditions 
are indicated in the materials and methods section. 
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Fig. 3 Rat small intestine pyruvate kinase activity as a function 
of the PEP concentration in the presence of 2 mM ATP. 
0-0, control; 6-6, 2 mM ATP present; A-A, 2 mM ATP + 0.5 mM Fru-
1,6-P2 present. The insert is the Hill plot of the values obtained. 
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Fig. 4 Influence of alanine on rat small intestine pyruvate 
kinase activity at two PEP concentrations in the absence and pre-
sence of Fru-1,6-P 2 (0.5 mM). 0-0, 1 mM PEP present; e-e, 1 mM PEP+ 0.5 mM Fru-1,6-P2 present; D-0 , 5 rnM PEP present;B-B , 5 mM PEP + 0.5 mM Fru-1,6-P2 present. The 100% value is the activity in the absence of alanine. 
DISCUSSION 
From the sensitivity of the intestinal pyruvate kinase 
activity towards ATP and alanine and from the amino acid inhibition 
pattern we can conclude that intestinal pyruvate kinase has to be 
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Fig. 5 Influence of ATP on rat small intestine pyruvate kinase 
activity at two PEP concentrations in the absence and presence of 
Fru-1,6-P2 (0.5 mM). 0-0, 1 mM PEP present; 1-8, 1 mM PEP + 0.5 mM Fru-1,6-Pz present; 
0-0, 5 mM PEP present and 5 mM PEP+ 0.5 rnM Fru-1,6-P2 present. The 100% value is the activity in the absence of ATP. 
classified as M2-type. This finding is consistent with the absence 
of gluconeogenesis in this tissue 12 Recently we have shown for 
the liver that this type of pyruvate kinase at physiological 
Mg~;ee concentrations can occur in two forrns 8 . The so-called 
Pyk-B form4 has a high affinity for the substrate PEP and is in-
hibited by amino acids, an inhibition which is completely relieved 
by the addition of Fru-1,6-P2
5
-
6 At lower Mgf2+ concentrations 
ree 
the Pyk-A form of the enzyme is formed which has less affinity 
for PEP. This form is more sensitive to amino acid inhibition and 
8 
this inhibition is not abolished by the addition of Fru-1,6-P2 . 
The kinetic behaviour of pyruvate kinase from rat small intestine 
can be explained completely by the presertce of both forms. Fig. 1 
shows that the form with high affinity for PEP is sensitive to 
Fru-1,6-P2 , whereas the low affinity form is not. Fru-1,6-P2 re-
lieves only the alanine inhibition of the high affinity form 
(Fig. 2). Fig. 4 shows that especially at higher alanine concen-
trations Fru-1,6-P 2 relieves the inhibition, indicating that the 
form which is less sensitive to alanine (Pyk-B) can be influenced 
by Fru-1,6-P2 . For reason that intestinal pyruvate kinase was 
isolated and assayed under conditions which favour formation of 
the Pyk-B form it can be concluded that "in vivo" in the small 
Voi.60,No. 1,1974 B10CHEMICAl AND BIOPHYSICAl RESEARCH COMMUNICATIONS 
intestine M2-type pyruvate kinase is at least partially present 
in the Pyk-A form. 
We have discussed earlier (ref. 8) that the B~A equilibri,urn 
may provide an additionalproperty for the most widely distributed 
type of pyruvate kinase to accommodate its properties to the spe-
cific requirements of the several tissues. As rat small intestine 
is the first tissue for which it is shown that a considerable 
amount of Pyk-A type is present "in vivo 11 one might speculate 
about its physiological function. As the major difference between 
B and A type is the amino acid sensitivity, the presence of A type 
might indicate that glycolysis will be inhibited when a protein-
rich diet is ingested. Preliminary experiments with isolated in-
testinal cells indeed indicate that glycolysis is inhibited in 
the presence of alanine (H.R. de Jonge, unpublished results). A 
similar inhibitory effect of amino acids from the diet on the 
glycolytic rate "in vivo" may be important because it will induce 
a glucose sparing effect, which can be of importance during 
limited carbohydrate uptake. Experiments are in progress to in-
vestigate if the relative amounts of Pyk-B and Pyk-A in intestine 
can be regulated by the diet. 
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ON THE MOLECULAR BASIS OF PYRUVATE KINASE DEFICIENCY 
I. PRIMARY DEFECT OR CONSEQUENCE OF INCREASED 
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SUM:NIARY 
r. Human erythrocyte pyruvate kinase (ATP:pyruvate phosphotransferase 
EC 2.7.1.40) can be converted into an oxidized form by incubation with oxidized 
glutathione. The oxidized enzyme can be reduced again by incubation with mer-
captoethanol, with reduced glutathione a partial reduction of the enzyme is obtained. 
z. The oxidized enzyme shows a lower affinity for the substrate phosphoenol-
pyruvate and for the allosteric effector fructose r,6-diphosphate. The thermolability 
of the oxidized enzyme is markedly increased, compared with the freshly isolated or 
reduced enzyme. 
3· The data obtained with the oxidized enzyme are discussed in relation to the 
data obtained with pyruvate kinase from pyruvate kinase-deficient patients. It is 
concluded that erythrocyte pyruvate kinase deficiency can be a consequence of an 
increased oxidized glutathione concentration in the red blood cell. 
INTIWDUCTION 
Erythrocyte pyruvate kinase (ATP:pyruvate phospbotransferase, EC 2.J.I.40) 
deficiency is a well-known cause of hemolytic anaemia. The deficiency comprises a 
heterogeneous group of disorders characterized by both quantitative and qualitative 
enzyme abnorma1ities1 . Cases of hemolytic anemia attributed to pyruvate kinase 
abnormalities have been found wi~h markedly decrease&\ moderately diminished3- 6, 
normaP, 7 or even increased8 enzyme activity. The majority of the cases showed a 
decreased affinity for the substrate phosphoenolpyruvate1;, 7 ,!1- 12, although also nor-
maP or increased13, 14 affinities for phosphoenolpyruvate have been described. Most 
of the cases showed a nonnal or even increased glycolytic rate as can he concluded 
from the glucose consumption and lactate procluction1 . TIH: hemolytic anemia has 
been ascribed to the lowered ATP level found v .. 'ith the patients1 . However, also 
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normaP5 or even increased ATP levels16 have been reported. These data suggest that 
pyruvate kinase deficiency is a very heterogeneous molecular disorder and the lack 
of relation behveen the enzymatic activity and the degree of hemolysis suggested to 
us that the alteration in the pyruvate kinase activity might be a secondary defect. 
Reports have been published of cases ·with pyruvate kinase deficiency, whicl]. are 
combined with a decreased activity of glutathione reductase17 - 19 . This prompted us 
to study the effect of oxidized glutathione on the kinetic behavior of the erythrocyte 
pyruvate kinase. Also the influence of oxidized glutathione on the stability of the 
enzyme is investigated, because it has been reported that the most common property 
in pyruvate kinase deficiency is the increased heat lability of the enzyme. The effect 
of oxidized glutathione is of special interest because the link between alterations in 
erythrocyte pyruvate kinase and the GSHjGSSG ratio might explain the increased 
hemolysis found in pyruvate kinase-deficient patients20. 
l\1ATERIA.LS Al'\D :'1-:IETHODS 
Pyruvate kinase from erythrocytes, obtained from healthy volunteers (aged 
20-35 years) was purified up to Stage 4 as described by Staal et al. 21, except that 
during the isolation procedure mercaptoethanol \Vas omitted. The final (NH4hS04 
precipitate \Vas dissolved in o.zs M Tris-HCl, pH 8.o. Pyruvate kinase activity was 
assayed by following the decrease in absorbance at 340 nm in a coupled reaction with 
lactate dehydrogenase at 23 oc according to Valentine and Tanaka22 • The triethanol-
HCl buffer (o-4 M, pH 7-5) was replaced by Tris-HCl buffer (o.zs M, pH 8.o). Rou-
tinely about o.o8 rng enzyme was included in the assay mixture. The enzyme was 
oxidized by incubation with 2.5 mM oxidized glutathione at 4 °C for the time indicated 
in the legends to the figures. For the thermostability test o.s ml of the enzyme, con-
taining precisely 2.0 mgjml protein, was incubated at 53 °C. After the times indicated 
in Fig. 5 samples were taken and immediately assayed for pyruvate kinase activity 
at 5 mM phosphoenolpyruvate in the presence of 0.5 mM fructose r,6-diphosphate 
(Fru-r,6-P2). 
ADP, phosphoenolpyruvate, NADH, Fru-r,6-P2 and oxidized glutathione were 
obtained from Boehringer (Mannheim, Germany). Reduced glutathione was obtained 
from Sigma. All other reagents were of analytical grade purity. 
H.E:)ULTS 
Fig. r shows the v vs [phosphoenolpyruvate] plot at [ADP] ~ 2 mM in the 
presence or absence of 0.5 mM Fru-r,6-P2 for the freshly prepared erythrocyte 
pyruvate kinase and the enzyme, which has been incubated with 2.5 mM oxidized 
glutathione for 8 h. \Vith the freshly prepared enzyme we obtained in the absence 
of Fru-r,6-P~ a K 0. 5 value of 0.75 mM. Addition of 0.5 mM Fru-r,6-P2 Converted the 
sigmoidal curve into a hyperbolic one and the apparent Km was now 0.15 mM. The 
enzyme which has been incUbated with 2.5 mM oxidized glutathione showed a marked 
change in these activity curves. After an 8-h incubation the apparent Km in the 
presence ofFru-r,6-P2 was raised to 0.75 mM, and thP Kn.;) in the absence of Fru-r ,6-P 2 
was about 5 ml\t It could be observed that in the presence of Frn··I,6-P;!. the same 
maximal activity was measured, indicating that no loss of maximal activity occurred 
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Fig. "r. The activity vs [phosphoenolpyruvate] plot of freshly isolated and partly oxidized human 
erythrocyte pyruvate kinase at [ADPJ = 2 mM measured in the presence and absence of Fru-I,6-
P2 (0.5 mM). 0-0, the activity of the freshly isolated erythrocyte pyruvate kinase; •-•, the 
activity of the freshly isolated erythrocyte pyruvate kinase in the presence of Fru-r,6-P~; 0-0, 
the activity of the erythrocyte pyruvate kinase after an 8-h incubation with 2.5 mM GSSG; 
.._., the activity of the erythrocyte py.i:uvate kinase after an 8-h incubation with 2.5 mM 
GSSG measured in the presence of Fru-r,6-P2• 
after partial oxidation of the enzyme. Prolonged oxidation caused a further decrease 
in the affinity of the enzyme for the substrate phosphoenolpyruvate both in the 
absence and presence of Fru-r,6-P2 (Fig. 2). After a 24-h incubation at 4 'C in the 
presence of 2.5 mM oxidized glutathione the K 0 .5 in the presence of 0.5 mM Fru-r,6-P2 
was increased to I mM, whereas the K 0 .5 value in the absence of Fru-r,6-P2 was 
higher than ro mM. Fig. 2 also shows that oxidation of the erythrocyte pyruvate 
kinase is a reversible process. When the oxidized enzyme was incubated for r h at 
Io oc with I mM mercaptoethanol the same kinetic data were obtained as with the 
freshly isolated enzyme. The K 0 .5 in the absence of Fru-r,6-P2 was lowered again 
)Jmoles min-l.mg:1 
'I 
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Fig. 2. The activity vs [phosphoenolpyruvate] plot of the oxidized erythrocyte pyruvate kinase 
and the oxidized erythrocyte pyruvate kinase after incubation for I h at ro "C with I mM 
mercaptoethanol (reduced enzyme) measured in the presence and absence of Fru-r,6-P 2 at 
[ADP] = 2 mM. 0-0, the activity of the erythrocyte pyruvate kinase after a 24-h incubation 
with 2.5 mM GSSG; .._.,the activity of the erythrocyte pyruvate kinase after a 24-h incubation 
with 2.5 mM GSSG measured in the presence of Fru-r,6-P2 ; 0-0, the activity of the reduced 
erythrocyte pyruvate kinase; •-•, the activity of the reduced erythrocyte pyruvate kinase mea-
sured in the presence of Fru-r,6-P 2• 
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to 0.75 mM whereas in the presence of Fru-I,6-P2 an apparent Km value of o.I5 mM 
was obtained. Incubation of the enzyme without GSSG at 4 oc and pH 8.0 did not 
affect the enzyme, even if the incubation period was prolonged till 5 days. Also oxygen 
bubbling through the enzyme solution for 24 h did not result in an alteration of the 
enzyme. 
Incubation of the oxidized enzyme with 5 mM reduced glutathione does not 
result in a complete restoration of the enzyme kinetics as shown in Fig. 3- After incu-
bation of the oxidized enzyme with 5 mM reduced glutathione for r h the K 0 _5 in the 
presence of 0.5 mM Fru-r,6-P2 was o.6 mM whereas in the absence of Fru-r,6-P2 a 
K 0 5 value of about 8 mM was obtained. Extension of the incubation period with 5 
mM GSH to 4 h did not influence the kinetic profile any further. However, if the partly-
reduced enzyme (by 5 mM GSH) was treated for I h with I mM mercaptoethanol, the 
reduced enzyme was obtained (cf. Fig. 2). 
!'moles mln-1-mg-1 
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Fig. 3- The activity vs [phosphoenolpyruvate] plot of the oxidized erythrocyte pyruvate kinase 
and the oxidized erythrocyte pyruvate kinase after incubation for 1 h at 10 oc with 5 mM GSH 
measured in the presence and absence of Fru-r,6-P2 at [ADP] = 2 mM; 0-Q, the activity of 
the erythrocyte pyrvate kinase after a 24-h incubation with 2.5 mM GSSG; e-e, the activity of 
the erythrocyte pyruvate kinase after a 24-h incubation with 2.5 mM GSSG mea~ured in the 
presence of Fru-I,6-P 2 ; 0-0, the activity of the oxidized erythrocyte pyruvate kinase which 
has been incubated with 5 mM GSH for I hat IO °C; B-B, the activity ofthe oxidized erythrocyte 
pyruvate kinase which has been incubated with 5 mM GSH for I hat IO oc measured in the pres-
ence of Fru-r,6-P2• 
The activity of the oxidized erythrocyte pyruvate kinase as a function of the 
phosphoenolpyruvate concentration behaves in the same way as pyruvate kinase 
from patients with a lowered affinity for the substrate phosphoenolpyruvate. In most 
of these patients the affinity for Fru-r,6-P2 is lowered6 •7•23 • Therefore, we i_nvestigated 
the activity of the normal and oxidized enzyme from control erythrocytes at in-
creasing Fru-r,6-P2 concentrations. Fig. 4 shows the pyruvate kinase activity of the 
freshly isolated, oxidized, partly reduced and reduced enzyme as a function of the 
[Fru-I,6-P2] at 0.5 mM phosphoenolpyruvate. It can be seen that the oxidized 
enzyme showed a lower affinity for Fru-r,6-P2 in comparison with the freshly isolated 
and reduced enzyme. The freshly isolated and reduced enzymes were already fully 
activated at 2 fll\1 Fru-r,6-P2 whereas with the oxidized enzyme full stimulation was 
obtained at 20 f.<M Fru-I,6-P2• The curve obtained with the freshly isolated enzy ne 
is identical with the activity curve obtained when the oxidized enzyme was incubated 
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Fig. 4· The activity vs [Fru-r,6-P2] plot of the freshly isolated, oxidized, partly reduced and 
reduced erythrocyte pyruvate kinase at [phosphoenolpyruvate] = 0.5 mM and [ADPJ = 2 m:.I. 
11-111, the activity of the freshly isolated erythrocyte pyruvate kinase and of the oxidized 
pyruvate kinase after incubation for r h at ro oc with I mM mercaptoethanol (reduced 
enzyme); 0--0. the activity of the erythrocyte pyruvate kinase after a 24-h incubation with 
2.5 mM GSSG (oxidized enzyme); 0-Q, the activity of the oxidized erythrocyte pyruvate 
kinase after incubation for r h at ro °C ·with 5 mM GSH (partly reduced enzyme). 
for I h with I m1\'i mercaptoethari6l at ro °C. VVhen the oxidized enzyme was incu-
bated \Vith 5 ml\..f reduced glutathione an intermediate curve was obtained, which 
suggests that the oxidized enzyme cannot be reduced completely by GSH, at least 
in the concentration tested. 
From Figs 1-4 we can conclude that the kinetics obtained with the enzyme 
\vhich has been incubated with 2.5 m~I GSSG are quite identical with the kinetics 
l(l 20 60 
t>me(mrn) 
Fig. s. The thermostability of the freshly isolated, partly oxidized, oxidized, partly reduced and 
reduced erythrocyte pyruvate kina:;e at 53 "C. The enzymatic activity ·was determined at 
[phosphoenolpyruvate] -- 5 ml\1, ["i\Di'_i 2 mM an(l lFru-T,fJ-?2] = 0.5 mM. m-11, freshly 
isolateU crytl1rocytc pyruvate kinase; []-·D. erythrocyte pyruvate kinase which has been 
incubate-d for.~ h with 2.5 mM CSSC (!\"u.s for phosphoenolpyruvate about 3 mM); •-e, ery-
throcyte pyruvate kinase which has been incubated for ::q h with 2.5 ml\1 GSSG (oxidized enzyme); 
6-L, oxidized erythrocyte pymval.c kinas(~ (24 h of oxidation with 2.5 mlVI GSSG) which has 
been incubated for t h with s mi\1 {;SH; () (),oxidized (~rythrocytc pyruvate kinase (24 h of 
oxidation with 2.5 mM {;Ss(;) which has been incubated for 1 h with I mM mercaptocthano1. 
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obtained with most of the patients with the affected pyruvate kinase. It has been 
concluded earlier that the most common property of pyruvate kinase from pyruvate 
kinase-deficient patients is the increased lability of the enzyme at higher temperatures. 
Blume et al. 23 showed recently that the stability of the enzyme at 53 °C can serve as 
a useful tool for the diagnosis of pyruvate kinase deficiency. Therefore, the thermo-
stability of the freshly isolated, partly oxidized, oxidised partly reduced and reduced 
enzyme at 53 'C was investigated (Fig. 5). Under the applied condition (see legend to 
Fig. 5) the freshly isolated enzyme showed, in accordance with Blume ct al. 23, only a 
slight decrease in activity. The partly oxidized enzyme (K0 5 for phosphoenolpyruvate 
about 3 mM) showed an increased thermolability whereas the oxidized enzyme (K0 5 
for phosphoenolpyruvate higher as 10 mM) lost, within ro min, nearly all activity. 
When the oxidized enzyme was reduced with 5 mM GSH (cj. for the kinetics Figs 3 
and 4) the thermolability was lowered, whereas reduction with I mM mercapto-
ethanol was able to restore the stability of the enzyme almost completely. 
DISCUSSION 
Since Valentine et al. 24 described in rg6r the first cases of non-spherocytic 
anemia with affected pyruvate kinase, more than r6o reports1 about erythrocyte 
pyruvate kinase deficiency have been published. Since a quantitative correlation 
could neither be demonstrated between the pyruvate kinase activity and the clinical 
severity nor between the pyruvate kinase activity and the degree of hemolysis, it 
was suggested earlier that a lowered pyruvate kinase activity might not be the 
primary lesion causing hemolysis25 ,26• The heterogeneity observed in the kinetics of 
pyruvate kinase from pyruvate kinase-deficient patients and the fact that the 
glycolytic rate is not affected in these patients, supports the idea that an alteration 
in pyruvate kinase activity might be a secondary effect. It has been reported20 that 
the GSHfGSSG ratio can play an important role in the hemolysis of the red blood 
cell. Therefore, the effects of oxidized glutathione on the kinetics and stability of the 
erythrocyte pyruvate kinase are of special interest. 
The presented kinetic data obtained with the oxidized enzyme are quite 
identical with the kinetic data described for most of the patients: the decreased 
affinities for phosphoenolpyruvate and Fru-r,6-P2 (refs 6, 7, 9-12 and 23). Also the 
thermostability of the oxidi~ed enzyme and the enzyme from pyrUvate kinase-
deficient patients seems identical23• Incub<ftim: r:'f the oxidized enzyme with reduced 
glutathione only influences the kinetics obtained with the oxidized enzyme to a small 
extent and also the influence on the thermostability is suboptimal. This suggests 
that it is not the GSHjGSSG ratio which is important for the pyruvate kinase enzyme 
but only the GSSG concentration. However, since we applied only one GSHfGSSG 
ratio, the definite answer has to await further experimentation. Further support for 
the r6le of glutathione as a causative factor in most cases of pyruvate kinase de-
ficiency is the description of several patients with both glutathione reductase and 
pyruvate kinase deficiency17- 19 . Deficiency in glutathione reductase increases the 
GSSG concentration, which affects pyruvate kinase. Also with three of the four 
pyruvate kinase-deficient patients described earlier by Staal and Koster13•14 , the 
glutathione reductase activity is lowered to soo/0 of controls with the same am mnt 
of young erythrocytes. Preliminary experiments with pyruvate kinase from these 
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patients suggest indeed that -SH groups are involved in the obtained abnormal 
kinetics (van Berkel, Th. J. C., Staal, G. E. ]., Koster, J. F. and Nijessen, J. G., in 
preparation). 
The question remains whether the obtained abnormal kinetics in pyruvate 
kinase-deficient patients are a reflection of the in vivo situation or a consequence of 
oxidation of the enzyme during the isolation procedure. The fact that in hemolysates 
from pyruvate kinase-deficient patients the enzyme is also altered, suggests that 
oxidation can occur in vivo. This would be a further support for the hypothesis27 that 
-SH groups can play a rOle in the regulation of the pyruvate kinase activity in vivo. 
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SUMMARY 
I. Human erythrocyte pyruvate kinase (A TP :pyruvate phosphotransferase, 
EC 2. 7.1.40) from the class of pyruvate kinase-deficient patients, characterized by an 
increased affinity towards phosphoenolpyruvate and a loss of cooperative interaction 
towards this substrate, shows less affinity for the allosteric inhibitor ATP, when 
compared to pyruvate kinase from control persons. From the obtained kinetic data 
we can conclude that the loss of cooperativity towards phosphoenolpyruvate is a 
consequence of a shift in the R "" T equilibrium to the R state. 
2. fncubation of pyruvate kinase, obtained from this class of pyruvate kinase-
deficient patients with mercaptoethanol, changes the abnormal kinetics into normal 
kinetics, as can be concluded from the change in phosphoenolpyruvate dependency 
and ATP inhibition. 
3. The effect of mercaptoethanol on the kinetics of pyruvate kinase from 
pyruvate kinase-deficient patients suggests that the alteration in the enzyme is a 
consequence of a modification of the -SH groups. It is suggested that pyruvate kinase 
deficiency is a secondary defect and that the process which causes the change in the 
-SH groups of pyruvate kinase, may also be responsible for the increased rate of 
haemolysis, found in these patients. 
INTRODUCTION 
Erythrocyte pyruvate kinase (A TP :pyruvate phosphotransferase, EC 2. 7.1.40) 
deficiency is a well-known cause of hemolytic anemia. The deficiency comprises a 
heterogeneous group of disorders, characterized by both quantitative and qualitative 
enzyme abnormalities [I, 2]. By a comparison of the clinical and biochemical data 
we earlier suggested [2], that alteration in the kinetics of erythrocyte pyruvate kinase 
from pyruvate kinase-deficient patients might be a secondary defect. It was shown [2] 
that the primary defect, responsible for the abnormal pyruvate kinase kinetics, might 
be the redox state of the thiol groups in the red blood cell. Glutathione disulfide as 
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oxidizing agent was able to oxidize the thiol groups of the isolatoJ erythrocyte pyru-
vate kinase, which resulted in a decreased affinity for one of the substrates, phospho-
enolpyruvate and the allosteric activator Fru-1 ,6-P 2 ; kinetic properties also found 
with pyruvate kinase from most of the pyruvate kinase-deficient patients. This re-
port deals with the effect of the reducing compound mercaptoethanol on pyruvate 
kinase, from pyruvate kinase-deficient patients, characterized by an increased affinity 
for the substrate phosphoenolpyruvate and a loss of the cooperative interaction 
towards this substrate [3, 4]. It will be shown, that in the altered kinetic properties 
of this class of patients thiol groups are also involved. 
MATERIALS AND METHODS 
Pyruvate kinase from erythrocytes was purified up to stage 4, as described by 
Staal et a!. [5], except that during the isolation procedure mercaptoethanol was 
omitted. The final (NH,),S04 precipitate was dissolved in 0.2 M Tris-maleate buffer 
pH 8.2 and divided into two fractions. One enzyme fraction was incubated with 
!0 mM mercaptoethanol at !0 'C for 1 h, whereas the other was incubated without 
further additions. Pyruvate kinase activity was assayed by following the decrease in 
absorbance at 340 nm in a coupled reaction with lactate dehydrogenase at 25 °C, 
according to Valentine and Tanaka [6]. The reaction mixture contained 0.2 M Tris-
maleate buffer, pH 8.2, 2.0 mM ADP, 0.09 mM NADH, 65 mM KCl, 20 mM MgSO, 
and 0.! mg lactate dehydrogemso in a final volume of 3.0 ml. The reported experi-
ments were repeated after a three-month period, at which time a complete new popula-
tion of erythrocytes is present, and these experiments were completely reproducible. 
ADP, phosphoenolpyruvate, NADH and Fru-l,6-P2 were obtained from 
Boehringer (Mannheim, Germany). Mercaptoethanol was obtained from Fluka, 
Basel. All other reagents were of an analytical grade purity. 
RESULTS 
Figs. !A and IB show the v vs [phosphoenolpyruvate] plot at [ADP] ~ 2 mM 
in the presence and absence of 0.5 mM Fru-1,6-P2 for pyruvate kinase, obtained from 
normal red blood cells. Fig. I B shows the activity curve of the enzyme after incubation 
with 10 mM mercaptoethanol, whereas for Fig. !A this compound was omitted. In 
accordance with earlier reports [5, 6] a sigmoidal curve was obtained, in the absence 
ofFru-1,6-P2, with ann value of !.7 (see Hill plot insert Fig. !A). Addition of0.5 mM 
Fru-1,6-P2 stimulates the enzymatic activity especially at low phosphoenolpyruvate 
concentrations and the sigmoidal curve was converted into a hyperbolic curve (n value 
of !.0). Incubation of the enzyme with mercaptoethanol for 1 h does not alter the 
allosteric properties and exactly the same n values, 1.7 in the absence and 1.0 in the 
presence of Fru-1,6-P2, were obtained. 
Fig. 2A shows the v vs [phosphoenolpyruvate] plot of pyruvate kinase, obtain-
ed from a patient with increased hemolysis, which has been classified as pyruvate 
kinase deficient (cf. ref. 4 patient M.V.). In agreement with an earlier report [4] the 
enzyme from this patient has lost its allosteric properties towards phosphoenolpyru-
vate and ann value of !.0 was obtained (insert Fig. !A). Incubation of this enzyme 
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Fig. 1. The activity vs [phosphoenolpyruvateJplot of normal erythrocyte pyruvate kinase, measured 
in the presence and absence of Fru-1,6-P2 (0.5 mM). The inserts are the Hill plots of the values ob-
tained in the absence of Fru-1 ,6-P2 • The calculated Hill coefficients (n) are indicated. (A) The activity 
curve after incubation without mercaptoethanol, measured in the absence ((:--;:_;)and in the presence 
of Fru-1 ,6-P2 (ill-e). (B) Activity curve after a 1-h incubation \Vith 10 mM mercaptoethanol at 10 ~c. 
measured in the absence 0--0 and in the presence of Fru-1,6-?1 ~--@11. 
in the presence of mercaptoethanol introduced an allosteric behavior tmvards phos-
phoenolpyruvate, as can be concluded from the obtained n va!ue of 1.9 (insert Fig. 28). 
Figs 3A and 38 show the 1· vs [phosphoenolpyruvate) plot of the second, 
unrelated, patient P.R. Pyruvate kinase from this patient also sho\vs a loss of its 
allosteric behavior towards phosphoenolpyruvate (n value of 1.0, insert Fig. 3A). By 
incubating the altered enzyme from this patient with mercaptoethanol, the normal 
kinetic behavior towards phosphoenolpyruvate was obtained (n value 1.7, in~ert 
Fig. 3B). 
From Figs l, 2 and 3 we can condude that the abnormal kinetics of these 
mutant enzymes can be converted into a kinetic behavior towards phosphoenol-
pyruvate, vvhich is identica! \Vith the normal enzyme. In order to investigate the nature 
of this conversion more closely, we studied the effect of ATP on the reduced and 
untreated enzyme of patient M.V. It can be seen (Fig. 4) that the untreated enzyme 
of this patient possesses a low affinity for the inhibitor ATP, whereas incubation 
with mercaptoethanol causes a shift in the inhibition curve; the affinity for ATP is 
increased, which is accompanied by a lowering of then value (calculated by the method 
of Jensen and Nester [7]) from 2.5 to 1.6. With hoth enzymes Fru-1,6-P, (0.5 mM) 
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Fig. 2. The activity vs [phosphoenolpyruvate] plot of erythrocyte pyruvate kinase from a patient 
M.V., measured in the presence and absence of Fru-1,6-P1 (0.5 mM). The inserts are the Hill plots 
of the values obtained in the absence of Fru-1,6-P2• The calculated Hill coefficients (n) are indicated. 
(A) The activity curw after incubation without mercaptoethanol, measured in the absence (0-()) 
and in the presence of Fru-1,6-P2 (!I)---e). (B) Activity curve after a I h incubation with 10 mM 
mercaptoethanol at 10 "'C, measured in the absence (0-0) and in the presence of Fru-1,6-?2 
(-Ill). 
is able to abolish the inhibition, suggesting that this effector site is intact. With 
pyruvate kinase from patient P.R. the results obtained are qualitatively similar(Fig. 5), 
although the enzyme from this patient seemed less sensitive to A TP. Comparison of 
the A TP iQhibition plots of patients and controls reveals the conclusion that the A TP 
inhibition, obtained with the patients' enzymes after incubation with mercapto-
ethanol, is similar to the inhibition plot of the controls (cf. ref. 4). This allows the 
conclusion that incubation with mercaptoethanol is able to convert the abnormal 
enzyme, isolated from the two patients into an enzyme which cannot be distinguished 
from pyruvate kinase from control persons. 
From the phosphoenolpyruvate dependence and A TP inhibition of the mutant 
enzyme of the patients, it can be concluded that the mutant enzyme is characterized 
by a shift of the R 'C" T equilibrium to the R state. Recently we showed that M-type 
pyruvate kinase from leucocytes [8] and liver [9] possess allosteric properties, similar 
to the L-type. To obtain more information about the molecular basis of pyruvate 
kinase deficiency we isolated leucocytes from the patients, described in this report, 
and characterized pyruvate kinase. No significant differences in the activity curve 
towards phosphoenolpyruvate could be detected. Also the alanine inhibition and the 
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Fig. 3. The activity vs [phosphoeno!pyruvate]plot of erythrocyte pyruvate kinase from a patient 
P.R., measured in the presence and absence of Fru~I,6~P2 (0.5 mM). The inserts are the Hill plots 
of the values obtained in the absence of Fru~ 1,6~P1 • The calculated Hill coefficients (n) are indicated. 
(A) The activity curve after incubation without mercaptoethanol, measured in the absence (0-0) 
and in the presence of Fru~1,6~P2 (o-----®1). (B) Activity curve after a l~h incubation with 10 mM mer~ 
captoethanol at 10 oc, measured in the absence C-0 and in the presence of Fru~l,6~P2 (41-<j). 
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Fig. 4. The influence of ATP on the activity of erythrocyte pyruvate kinase of patient M.V. at 0.25 
mM phosphoenolpyruvate, 0.5 mM ADP and pH 8.2. CJ--0, the activity curve after incubation 
without mercaptoethanol. @-llD, the activity curve after incubation without mercaptoethanol 
measured in the presence of Fru~l,6~P~ (0.5 mM). [J-[l, the activity curve after incubation with 10 
mM mercaptoethanol for I hat 10 °C. lil-lml1, the activity curve after incubation with 10 mM mercap-
toethancl for I hat 10 oc, measured in the presence of Fru-1 ,6-?2 (0.5 mM). The calculated Hill 
coefficients (n) are indicated. The I 00% value is the activity measured in the presence of various addi~ 
tions at [ATP] = 0 mM. 
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Fig. 5. The influence of ATP on the activity of erythrocyte pyruvate kinase of patient P.R. at 0.25 
mM phosphoenolpyruvate, 0.5 mM ADP and pH 8.2. 0--0 the activity curve after incubation 
without mercaptoethanol. e-e, the activity curve after incubation without mercaptoethanol, 
measured in the presence of Fru-1,6-P2 (0.5 mM). ·::J-LJ, the activity curve after incubation with 10 
mM mercaptoethanol for 1 hat 10 oc. 11!1-1!111, the activity curve after incubation with 10 mM mer-
captoethanol for 1 hat 10 oc, measured in the presence of Fru-1,6-?2 (0.5 mM). The 100% value is 
the activity measured in the presence of various additions at [ATP] = 0 mM. 
effect of Fru-1,6-P2 was similar to the control values, which suggest that the R ~ T 
equilibrium of leucocyte M-type pyruvate kinase is not changed in the patients. 
DISCUSSION 
Since Valentine eta!. [IO] described in 1961 the first cases of non-spherocytic 
anemia with affected pyruvate kinase, more than 160 reports [1] about erythrocyte 
pyruvate kinase deficiency have been published. No quantitative correlation between 
the pyruvate kinase activity and the clinical severity, or between the pyruvate kinase 
activity and the degree of hemolysis could be demonstrated. Most of the cases showed 
a normal or even increased glycolytic rate, as can be concluded from the glucose 
consumption and lactate production [I]. Considering those facts, we suggested that 
the alteration in pyruvate kinase might be a secondary defect [2]. The heterogeneity, 
observed in the kinetics of pyruvate kinase from pyruvate kinase-deficient patients, 
suggest that this alteration can be the consequence of different primary defects. The 
most important condition for the primary defect must be that there exists a relation 
between this defect and the increased hemolysis, found in the patients. 
Recently we showed [2] for the pyruvate kinase-deficient patients, charac-
terized by a decreased affinity for phosphoenolpyruvate and Fru-1 ,6-P,, that the 
alteration in the enzyme kinetics can be the consequence of oxidation of the thiol 
groups in the enzyme. This report shows that, also \vith patients characterized by an 
increased affinity for phosphoenolpyruvate, the thiol groups are involved in the 
enzyme modification. From the kinetic data obtained with the untreated mutant 
enzyme (a hyperbolic response to phosphoenolpyruvate and decreased sensitivity 
towards A TP), we can conclude that in the R ~ T model of Monod eta!. [12], which 
is valid for erythrocyte pyruvate kinase [5, 12], this R 'F" T equilibrium is shifted to 
the R state. It was speculated earlier [13] (based on the kinetics towards phosphoenol-
pyruvate) that the mutant enzyme, characterized by a hyperbolic activity curve 
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towards phosphoenolpyruvate in the absence as well in the presence of Fru-1,6-P2, 
looks very similar to the confor:nation which can be obtained artificially with the 
normal enzyme, by lowering the pH and the temperature. The ATP inhibition curve, 
obtained with the patients, proves that thie speculation was correct and that the 
molecular basis of the altered enzyme is a decrease of the allosteric constant L. 
J ncubation of the mutant enzymes with mercaptoethanol converts the abnormal 
kinetics to normal kinetics. Since this compound affects the -SH groups of proteins, 
it seems likely that thiol groups are involved in this conversion. By restoring the thiol 
group(s) of the mutant enzyme to the "normal" reduction grade, the R ""'T equi-
librium is shifted to the equilibrium, found with the normal enzyme and the allosteric 
constant L reaches its normal value. At the moment the primary defect, responsible 
for the mutant enzymes described here, remains uncertain. However, it seems likely 
that the primary defect is related to the reduction state of the -SH groups in the red 
blood cell. This reduction state can form the link between alterations in pyruvate 
kinase and the increased hemolysis, found in these patients. 
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